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PLATISCITY OF C. ELEGANS GERMLINE STEM CELLS UNDER NUTRITIONAL
AND METABOLIC STRESS
Kenneth Andrew Trimmer, B.S.
Advisory Professor: Swathi Arur, Ph.D.

Stem cells are integral for tissue maintenance and fertility. Therefore,
understanding how stem cells are regulated under stress is imperative. When
confronted with acute starvation, stem cells must conserve energy and metabolites to
cope with the lack of an external source. Caenorhabditis elegans germline stem cells
(GSCs) are an excellent model for studying stem cell properties and regulation as they
can divide throughout the life of the organism. While GSCs are an adult stem cell
population, their cell cycle structure more closely mimics mouse and human embryonic
stem cells with short G1 and long S phases. In this thesis, I report that adult GSCs
regulate both the G1 and G2 phases to maintain their unique cell cycle structure. I find
that the short G1 is promoted by the metabolic regulator gsk-3. Loss of gsk-3 inhibits S
phase entry and progression through transcriptional down-regulation of cdk-2. Since
metabolic signaling regulates gsk-3, I propose that controlling G1 progression may
allow the cells to buffer metabolic stress. These observations also made me wonder
how stem cells would respond to the extreme conditions of acute starvation.
Adult GSCs are known to undergo a cell cycle arrest during acute starvation, so I
investigated the mechanisms and cellular behaviors underlying this arrest. I find that
acute starvation causes a reversible G2 arrest which is independent of the canonical
DNA damage signaling arrest. Instead, this reversible G2 arrest is regulated by the
Insulin signaling and TOR signaling pathways. Detailed investigation of the TOR
signaling axis revealed that the G2 arrest is partially dependent on stress kinase
v

signaling, and is mediated by cdk-1regulation. I find that cdk-1 is both translationally
and post-translationally regulated to impose the strong starvation-induced G2 arrest.
Together, these data reveal novel paradigms through which adult GSCs maintain tissue
homeostasis and regenerate tissues to respond to either chronic metabolic stress or
acute nutritional deprivation. Given the cell cycle structure conservation between C.
elegans GSCs and mammalian embryonic stem cells, I propose that gap phase
regulation may also drive stem cell homeostasis in mouse and human embryonic stem
cells in response to environmental and metabolic perturbation.
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CHAPTER 1: INTRODUCTION
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1.1 Stem Cells
Stem cells are vital for establishing tissues during development, as well as
maintaining those tissues once formed during both development and in adulthood in
the context of tissue repair or regeneration. These tissues are made up of a variety of
different cell types, with each cell type driving distinct functions. These functions have
evolved to work in concert, keeping the organism healthy to successfully reproduce.
Despite this extensive complexity, an organism develops from a single fertilized oocyte.
Therefore, all stem cells, including a fertilized oocyte, must have two central properties:
self-renewal and differentiation. Self-renewal is the ability of a stem cell to divide and
retain its identity as a stem cell, in other words, to maintain its fate while expanding the
stem cell population. However, a stem cell may change its fate and differentiate into a
different cell type. Over the course of development, stem cells self-renew and
differentiate in response to regulation by both internal and external factors. Through
progressive waves of differentiation, a lineage is formed which provides a link between
the fertilized oocyte and the differentiated cell types in each tissue. The combination of
multiple lineages gives rise to a fate map (Figure 1). Each branching point in the fate
map is the result of a differentiation event of a stem cell. Since differentiation typically
occurs in a single direction in vivo, a useful way to group stem cells is by their potency.

1.1.1: Stem cell potency
The potency of a stem cell is defined by the number of cell types into which that
cell can differentiate. As stem cells differentiate, they lose potency and gain specific
functions. The cell types which are derived from a particular stem cell result in a cell
lineage. To that end, stem cells with a longer lineage will have higher potency. The
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potency of stem cells can be divided into four main types: totipotent, pluripotent,
multipotent, and unipotent.
Totipotency: Totipotent stem cells are able to produce all the cell types of a
complete organism as well as extraembryonic tissues (Hima Bindu and Srilatha 2011).
In mouse embryos, the fertilized oocyte and the cells resulting from its divisions until
the 8 cell stage are totipotent stem cells, after which asymmetric divisions will occur
(Johnson and Ziomek 1981). By the late blastocyst stage, cells which form the
trophectoderm and primitive endoderm are differentiated and epiblast cells will no
longer form extraembryonic tissues, losing potency (Gardner and Johnson 1973;
Gardner and Rossant 1979; Papaioannou et al. 1975; Gardner 1983) (Figure 1).
Pluripotency: Pluripotent stem cells are able to produce all embryonic cell types
(Hima Bindu and Srilatha 2011). Pluripotent stem cells such as the mouse embryonic
stem cells or human embryonic stem cells can be isolated from the inner cell mass of a
blastocyst-stage embryo (Evans and Kaufman 1981; Thomson et al. 1998; Martin
1981). Unlike totipotent stem cells, these cells do not give rise to all extra-embryonic
tissues but can give rise to all cell types of an adult organism. However, as these cells
differentiate and separate by germ layer, they lose the ability to produce all cell types
(Figure 1).
Multipotency: Multipotent stem cells can give rise to cells of multiple lineages, but
cannot give rise to all the cells that make up an organism (Hima Bindu and Srilatha
2011). Multipotent stem cells give rise to a family of related cell types. For example,
during embryogenesis, the early lung bud forms from the foregut endoderm
progenitors. These lung epithelial progenitor cells will give rise to the bronchial airway
as well as alveolar sacs, each with very different functions and cell types (Rawlins et al.
2009). Even after development, populations of multipotent stem cells are maintained
3

throughout the life of an organism to assist in regenerating tissue upon damage such
as adult hematopoietic stem cells in mammals which give rise to the blood tissue and
its various cell types (Spangrude, Heimfeld, and Weissman 1988; Wu et al. 1968)
(Figure 1).
Unipotency: Unipotent stem cells give rise to only a single type of cell (Hima
Bindu and Srilatha 2011). In gonochoristic species, this includes the germline stem
cells (GSCs) which produce only male or female gametes essential for reproduction
(Figure 1).
During embryogenesis, different levels of potency give rise to a hierarchy of stem
cells as shown in the fate map (Figure 1). Totipotent stem cells can differentiate to
produce pluripotent stem cells and extraembryonic cells. Pluripotent stem cells, in turn,
can differentiate to produce various lineages of multipotent stem cells. Through waves
of differentiation, cell types are refined until they reach their final fate as a terminally
differentiated cell in adults. However, just producing all the adult cell types is not
sufficient to form a functional adult organism. Self-renewal and differentiation must be
regulated in order to form functional tissues.

1.1.2: Stem cell fate regulation
In order to develop a functional organism consisting of complex systems of tissues
and cells from a single fertilized oocyte, many cell behaviors such as proliferation,
differentiation and migration must be coordinated. Therefore, stem cell fate changes
are tightly regulated throughout embryogenesis. Internal factors such, as asymmetric
segregation of proteins and maternal transcripts in the early Caenorhabditis elegans
(C. elegans) embryo, cell-autonomously drive fate decisions by setting up polarity
within the cell (Reviewed in Betschinger and Knoblich 2004; Cheeks et al. 2004; Evans
4

et al. 1994; Guedes and Priess 1997; Schubert et al. 2000; Seydoux and Fire 1994;
Tenenhaus, Schubert, and Seydoux 1998). External factors from developmental
signaling determine fate in response to the signaling environment, like Wnt
(Wingless/Integrated) signaling which induces a lung progenitor fate in endoderm
progenitors (Goss et al. 2009), or Notch signaling which is required for nephron
progenitors to differentiate (Chung et al. 2016). In contrast to fate regulation by internal
factors, signaling allows for fate control of populations of cells. This is especially useful
for maintaining populations of stem cells in adult animals.

1.1.3: Adult stem cells
After development is complete, adult stem cell (ASC) populations are maintained in
many tissues. Though there are other methods of repairing damaged tissues, such as
dedifferentiation in the case of facultative stem cells, ASC populations are retained to
maintain tissue function by replenishing exhausted cells or repairing tissue damage.
Many ASC populations are normally “quiescent”, which is characterized by a lack of
proliferation, such that the cells remain in a dormant state in their host tissues
(Reviewed in Rumman, Dhawan, and Kassem 2015). Upon damage to the host
tissues, these ASC populations proliferate briefly, generate progenitor cells, then reenter quiescence; the newly generated progenitor cells will then replace any cells lost
or damaged during tissue damage. This behavior can be found in a variety of ASC
populations, such as bulge stem cells in the hair follicle, or satellite cells in the muscle
(Cotsarelis, Sun, and Lavker 1990; Schultz, Gibson, and Champion 1978; Snow 1977).
Populations of ASCs such as hematopoietic stem cells are likewise maintained in
quiescence, though they assist in the maintenance of their tissue rather than
responding to damage alone (Bradford et al. 1997; Van Zant 1984). Aberrant exit from
5

quiescence can lead to depletion of these ASC populations (Shea et al. 2010; Viatour
et al. 2008). For long-term ASC maintenance, stem cell niches provide active pools of
signaling to promote both quiescence and a stem cell fate (Reviewed in Ferraro, Celso,
and Scadden 2010). However, while most populations of ASCs replenish or repair
damage of tissues, adult populations of germline stem cells continuously provide
gametes for reproduction.

1.1.4: Germline stem cells
Since GSCs will produce gametes which are central to the perpetuation of species,
it is necessary that they be as free from deleterious mutations as possible. Anytime a
cell divides, it must replicate its DNA, a process which has the potential to introduce
new mutations due to replication fidelity or DNA damage (Reviewed in Kunkel 2004;
Reviewed in Liu et al. 2016). Therefore, to prevent large changes to the DNA which will
be transferred to the next generation, the germline lineages are protected from somatic
lineages early in development in the form of primordial germ cells (PGCs).
Like other stem cells, PGC fate can be specified by either internal or external
factors. In mammals, PGCs are induced during embryogenesis from a portion of the
proximal epiblast by Bmp (Bone morphogenic protein) and Wnt signaling (Ohinata et al.
2009; Lawson et al. 1999). These PGCs then migrate along the hindgut to the genital
ridge where they will eventually incorporate into either the testes or ovaries (Molyneaux
et al. 2001; Tam and Snow 1981). In Drosophila melanogaster (D. melanogaster) and
C. elegans, PGCs are specified very early by inheriting germplasm (Illmensee and
Mahowald 1974, 1976; Wolf, Priess, and Hirsh 1983). As embryogenesis continues, the
PGCs lie dormant. However, during larval development, the PGCs divide to form
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germline stem cells which are incorporated into gonadal niches to enable the cells to
maintain their germ cell fate and produce gametes as GSCs.
While male GSC populations are typically maintained throughout the life of an
organism, female GSC populations are depleted in the adults of mammals and some
insect species (Spradling et al. 2011). In these species, GSCs are depleted by the time
embryogenesis has completed, preventing the formation of new gametes. Due to the
difficulty of studying this population in mammals, the model systems of
D. melanogaster, C. elegans, and Danio rerio, which maintain an oogenic population of
germline stem cells throughout adulthood, are often used.
Regulation of GSC fate in each organism appears to be quite different, and one
factor for this difference in regulation appears to be the structure of the niche which
maintains the GSCs. For example, the female oogenic stem cell niche in
D. melanogaster is oriented in such a manner that only the cells adjacent to the niche
maintain the GSC fate (Lopez-Onieva, Fernandez-Minan, and Gonzalez-Reyes 2008;
Wang, Li, and Cai 2008). As the GSCs divide, one daughter cell divides away from the
niche and is thus oriented away from the stem cell hub, resulting in a very clear
asymmetric division. No longer in contact with the niche, this daughter cell begins to
divide and differentiate into an oocyte with its accompanying nurse cells. However, in
the C. elegans GSC niche, the distal tip cell (DTC) extends processes which touch a
variety GSCs and provide a fate maintenance signal. In this system, as cells leave the
niche, they gradually differentiate and cease to divide.

1.1.5: C. elegans germline stem cells and their niche
C. elegans GSCs originate from two PGCs which are set aside early in embryonic
development, later dividing to form the GSCs and their differentiated progeny (Figure
7

2). Towards the end of embryogenesis, they reside medial and ventral in the animal.
The PGCs remain arrested until the larva hatches. After hatching, C. elegans
undergoes four larval stages designated L1 – L4. At mid L1, in the presence of
nutrition, the PGCs start to divide and form the GSC compartment. As the GSCs divide
and the population expands, the somatic gonad surrounding them grows laterally, with
the DTCs leading the migration of the distal end. Towards the end of L3, the DTCs
migrate dorsally then medially to form two U-shaped gonads in the adult. Throughout
gonad development, the GSCs self-renew to fill the growing gonad. Around late-L3, the
proximal GSCs begin to differentiate and enter meiosis.
In the hermaphroditic C. elegans germline, the GSCs are multipotent, able to
differentiate into both spermatozoa and oocytes. Spermatozoa are formed during L4,
after which the immature germ cells undergo a fate switch to oocyte production. The
GSC population is maintained so that it can continuously produce oocytes during
adulthood. As such, the GSCs are regulated not only in terms of terminal differentiated
fate, but the decision to self-renew or differentiate is regulated as well due to signaling
from the GSC niche.
The GSCs are maintained in a niche called the progenitor region which is defined
by the DTC (Figure 3). The DTC displays mesenchymal characteristics and extends
processes termed cytonemes. These cytonemes contain a membrane-bound Delta
homolog, lag-2, which activates Notch signaling through one of the two C. elegans
Notch receptors, glp-1 (Henderson et al. 1994; Lambie and Kimble 1991). Both the
DTC and Notch signaling are required for GSC self-renewal as removal of the DTC as
well as mutants in lag-2 or glp-1 result in loss of the GSC population (Austin and
Kimble 1987; Kimble and White 1981; Lambie and Kimble 1991). Activation of Notch
signaling drives a transcriptional program through its cofactor lag-1 which represses
8

gld-1, gld-2, gld-3, and nos-3, the main drivers of entry into meiosis (Eckmann et al.
2004; Hansen, Hubbard, and Schedl 2004; Hansen et al. 2004; Kadyk and Kimble
1998). gld-1 and nos-3, and gld-2 and gld-3 work in pairs to either repress translation of
mitotic mRNAs (gld-1, nos-3) or enhance translation of meiotic mRNAs (gld-2, gld-3)
(Eckmann et al. 2004; Hansen, Hubbard, and Schedl 2004; Jan et al. 1999; Marin and
Evans 2003; Ryder et al. 2004). Along these lines, gld-1 represses glp-1 mRNA
translation in a feedback loop (Marin and Evans 2003). As cells leave the region of glp1 activity, they transition into meiosis which can be visualized either by a nuclear
morphology reminiscent of a crescent shape, or by the accumulation of meiotic proteins
such as the synaptonemal complex proteins him-3 and syp-1 on the chromatin.
In healthy, wildtype animals, the DTC maintains a stereotypical progenitor region
length of 20 cell diameters (Figure 3A). Changes in Notch (glp-1) signaling which affect
the decision between self-renewal and differentiation can alter this length. Partial loss
of glp-1 function results in a smaller gonad with a shorter progenitor region (Dorsett,
Westlund, and Schedl 2009; Kodoyianni, Maine, and Kimble 1992; Qiao et al. 1995).
Conversely, temperature-sensitive gain of function mutations in glp-1 result in a longer
progenitor region even when glp-1 is activated for short periods of time. Constitutive
activation of glp-1 results in a complete germline tumor where germ cells never enter
meiosis (Berry, Westlund, and Schedl 1997; Pepper, Killian, and Hubbard 2003).
Downstream, gld-1;gld-2 double mutants, which inactivate two major meiosis promoting
components, result in uncontrolled proliferation and produces a germline tumor (Kadyk
and Kimble 1998). Therefore, the length of the progenitor region can be used as an
indicator of the state of the self-renewal vs. differentiation balance.
Perhaps due to the nature of this structure, there is no evidence of asymmetric
divisions as occurs in other stem cell populations. Asymmetric divisions are inherently
9

regulated, often occurring in the same direction with the differentiating daughter cell
leaving a niche. Over the course of my investigations, I attempted to observe whether
divisions in the progenitor region were regulated directionally. I tracked divisions
throughout the progenitor region and found that orientation appeared random with
regards to either the distal-proximal axis (Figure 4), or to the distal tip cell cytonemes
(Figure 5). Other groups have assayed the GSCs for evidence of asymmetric divisions
as well. Gerhold et al used live imaging of mitoses to look for differences in the duration
of cell division (Gerhold et al. 2015). Rosu and Cohen-Fix labeled populations of cells
and followed their progeny (Rosu and Cohen-Fix 2017). Neither study found any
evidence for asymmetric divisions. (Gerhold et al. 2015; Rosu and Cohen-Fix 2017).
However, while GSCs do not divide asymmetrically, their cell cycle is heavily regulated
as will be discussed in the next section.
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Figure 1: Stem cell fate map
Fate map of select lineages during mammalian development. Solid line depicts a
direct differentiation event. Dashed line depicts multiple differentiation events.
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Figure 2: C. elegans larval gonad development
Adapted from Wormbook chapter “Introduction to the germline”. ”Cartoon
representation of gonadogenesis” by E. Jane Albert Hubbard and David Greenstein
which is licensed under CC BY 2.5 (http://creativecommons.org/licenses/by/2.5/).
Shown is panel B from the original image. Cartoon representation of larval
hermaphrodite gonad development. GSCs in yellow, distal tip cell in red, meiosis in
green, sperm in dark blue, oocytes in purple, and somatic gonad in light blue.
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Figure 3: The C. elegans GSC niche
(A) Schematic representation of the GSC niche (progenitor zone) in C. elegans
oriented with the distal tip cell to the left. DTC is in blue with a cytoneme extending into
the progenitor region, germ cells are in green with GSCs (solid green), meiotic cells
(crescent shaped and green circles with blue lines). Numbers mark each cell row with a
typical 20 cell diameters from the distal tip cell to the end of the progenitor region. (B)
Genetic network of mitosis/meiosis decision. Delta ligand is provided by the distal tip
cell. C. elegans gene names are in parentheses.
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Figure 4: GSC divisions are random with respect to the distal-proximal axis
(A) Time course of dividing cells in the progenitor region. Dividing cells are
numbered. Time from the start of acquisition is shown in the bottom right of each frame.
An mCherry::HIS-51 transgene (white) labels nuclei. (B) Orientation of divisions in larva
(early L4) and adults (24 hours past L4). Graph is aligned along the axis of the germline
from distal (left) to proximal (right). Numbering along the x-axis indicates the cell row
where a division initiated. Lines depict the orientation of the metaphase plate with
respect to the distal-proximal axis. Circles depict a metaphase plate which was oriented
parallel with the plane of acquisition.
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Figure 5: GSC divisions are random with respect to the DTC cytonemes
Analysis of the orientation of mitotic divisions in the progenitor region. (A) Time
slices of a representative division. lag-2::gfp (green) labels the DTC and cytonemes, an
mCherry::HIS-51 transgene (white) labels nuclei. Images were taken as z-stacks and
assembled in Imaris. Dividing cell is oriented in the middle of the frame. Clipping planes
were used to remove overlapping nuclei and out of focus fluorescence from the DTC.
Time from the start of acquisition is shown in the bottom right of each frame. Scale bar:
10µm. (B) Analysis of whether or not divisions occurred adjacent to a cytoneme is
shown on the left. Analysis of whether adjacent divisions occurred parallel,
perpendicular, or at some angle in between, compared to the closest cytoneme.
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1.2 The Cell Cycle
In order for stem cells to self-renew, they must first divide. There are many steps
to prepare a cell for division. In order to divide, a cell must contain enough components
for two daughter cells such as cytoplasm, organelles, DNA, nutrients, and energy.
Therefore, once a cell enters the cell cycle, cell growth occurs during interphase (G1,
S, and G2 phases) which is followed by cell division during M phase. Each of these
phases and the transitions between them are regulated by cyclin dependent kinases
(CDKs) (Figure 6).

1.2.1 Cyclin dependent kinases
CDKs are a class of proteins which phosphorylate targets to drive cell cycle
progression. (Reviewed in Morgan 1995; Reviewed in Vermeulen, Van Bockstaele, and
Berneman 2003). In mammalian somatic cell culture, five distinct CDKs function to
drive cell cycle progression at each phase: Cdk2, Cdk4, and Cdk6 regulate at G1, Cdk2
regulates S, Cdk1 regulates G2, and Cdk7 activates Cdk1 and Cdk2 in all phases
(Figure 6). As each of these phases governs different steps in cell growth, CDKs
phosphorylate different substrates at each phase to drive the different cell cycle
transitions. Therefore, in order to regulate cell cycle growth and progression, each CDK
is regulated by a variety of methods: cofactor binding, inhibitor binding, localization, and
phosphorylation.
Cofactor Binding: CDKs require cofactors called cyclins to function. Cyclins
activate their partner CDK as well as determine their substrate specificity (Reviewed in
Arellano and Moreno 1997) (Figure 6). For example, while both Cdk2-Cyclin E and
Cdk2-Cyclin A complexes are required for S phase progression, each drives different
activities during DNA replication by differential phosphorylation of their targets
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(Coverley, Laman, and Laskey 2002). Cyclins are regulated by transcription throughout
the cell cycle and, except for Cyclin D, are expressed cyclically allowing CDKs to
activate at specific times, (Figure 6) (Evans et al. 1983; Pines 1991). Cyclin D isoforms
are expressed in response to growth factors and bind to Cdk4/6 to drive cell cycle entry
and G1 progression (Reviewed in Sherr 1994). Cyclin E is expressed during G1 and
binds to Cdk2 to drive S phase entry (Figure 6) (Ohtsubo et al. 1995). During S phase,
the expression of Cyclin A gradually increases and binds to Cdk2 to promote DNA
replication (Figure 6) (Girard et al. 1991; Walker and Maller 1991). Cyclin B expression
gradually increases during G2 and both Cyclin A and Cyclin B bind to Cdk1 to drive
entry into M phase (Figure 6) (Arellano and Moreno 1997; Fung, Ma, and Poon 2007;
King, Jackson, and Kirschner 1994). Coordinated regulation of cyclins through
transcriptional programs thus regulates timing of the cell cycle. For precise regulation,
the CDKs also need to be turned off when not needed, and CDK inhibitor proteins bind
to CDKs and block cell cycle progression.
Inhibitor Binding: CDK inhibitors (CKIs) bind to either CDKs or CDK complexes
and prevent their activity (Reviewed in Besson, Dowdy, and Roberts 2008). CKIs are
divided into two major classes, the INK4 family and the Cip/Kip family. The INK4 family
of CKIs (p15, p16, p18, and p19) form stable complexes with Cdk4/6, preventing
Cyclin D binding and G1 progression (Chan et al. 1995; Guan et al. 1994; Hannon and
Beach 1994; Hirai et al. 1995; Serrano, Hannon, and Beach 1993). The Cip/Kip family
of CKIs (p21, p27, and p57) inhibit CDK activity by binding to the CDK-Cyclin pair,
allowing them to regulate all cell cycle phases (Gu, Rosenblatt, and Morgan 1992;
Harper et al. 1993; Polyak, Kato, et al. 1994; Polyak, Lee, et al. 1994; Toyoshima and
Hunter 1994; Xiong et al. 1993; Lee, Reynisdottir, and Massague 1995; Matsuoka et al.
1995).
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Localization: CDKs mediate cell cycle progression by phosphorylating substrates
in the nucleus. Therefore, re-localization of CDKs or CDK-cyclin complexes restricts
their activity. A clear example of this type of regulation is the nuclear exclusion of Cyclin
B via its cytoplasmic retention sequence (CRS). The Cyclin B CRS natively binds to
cofactors which actively export Cdk1-Cyclin B complexes from the nucleus (Pines and
Hunter 1994; Yang et al. 1998). Phosphorylation of the CRS of Cyclin B by Cdk1 and
Plk1 (Polo like kinase 1) allows Cdk1-Cyclin B to remain in the nucleus which is
necessary for entry into mitosis (Borgne et al. 1999; Hagting et al. 1999; ToyoshimaMorimoto et al. 2001).
Phosphorylation: In addition to all of the mechanisms of regulation listed above,
CDKs can be also activated or inhibited by phosphorylation. Phosphorylation of CDKs
on the T loop (Cdk1 on T161, Cdk2 on T160, and Cdk4 on T172) by the Cdk activating
kinase (CAK) increases their activity and cyclin binding (Fisher and Morgan 1994;
Gould et al. 1991; Gu, Rosenblatt, and Morgan 1992; Kato et al. 1994; Morgan 1995).
However, phosphorylation in the ATP binding domain of Cdk1 (T14Y15), by Wee1 and
Myt1 (Myelin transcription factor 1) kinases, and Cdk2 result in their inhibition (Gu,
Rosenblatt, and Morgan 1992; Morgan 1995). These inhibitory phosphorylations must
be removed by the Cdc25 (Cell division cycle 25) phosphatases to activate the CDKs
(Reviewed in Kiyokawa and Ray 2008). Together, the activation and inhibitory
phosphorylation events are powerful mechanisms for regulating CDK function and can
be used to track the activity status of CDKs.

1.2.2 G1 phase regulation (Figure 7)
Once the previous mitosis is complete, the cell reaches a point where a decision is
taken to either remain in the cell cycle or exit the cell cycle. In mammalian cultured
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cells, removal of serum or growth factors results in an exit of the cell from the cell cycle
into a G0 phase; the G0 phase is also known as a state of quiescence which is
discussed later in this Chapter (1.2.6). In response to growth factors, quiescent cells
express Cyclin D, promoting reentry of the cell cycle into G1 phase (Matsushime et al.
1991). As Cyclin D transcription increases, it is thought to out-compete the INK4 CKIs
for CDK binding resulting in active Cdk4/6-Cyclin D complexes (Sherr and Roberts
1999). Progression through G1 occurs through inhibition of pRb (Retinoblastoma
protein) which is phosphorylated and inhibited by the Cdk4/6-Cyclin D complex
(Norbury, Blow, and Nurse 1991; Buchkovich, Duffy, and Harlow 1989; Kato et al.
1993).
pRb binds to the E2F-Dp1 heterodimer transcription factors and recruits histone
deacetylases which inhibit nearby transcription through epigenetic modification (Brehm
et al. 1998; Rubin et al. 2005). E2F/Dp1 complexes bind to promoters of genes that
mediate cell cycle progression such as Cyclin D, Cyclin E and Cdk1 (Bracken et al.
2004). Once pRb is phosphorylated by the Cdk4/6-Cyclin D complex, it does not bind to
E2F allowing for active E2F-Dp1 complex to form (Weintraub, Prater, and Dean 1992),
which results in an increase in the transcription of both Cyclin D and Cyclin E, allowing
for more Cdk4/6-Cyclin D and Cdk2-Cyclin E complexes to form. Active Cdk4/6-Cyclin
D and Cdk2-Cyclin E complexes, in turn, phosphorylate pRb resulting in a feed-forward
loop which leads to hyper-phosphorylation of pRb. After a certain level of CDK
activation has been achieved, the cell no longer responds to mitogen signaling as it
passes the ‘restriction point’, committing the cell to pass through the cell cycle (Pardee
1974). In addition to G1/S phase progression, this positive feedback loop promotes
transcription of proteins involved in DNA licensing, a required process of G1 (Polager et
al. 2002).
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Licensing of DNA provides a starting point for DNA replication and its regulation
helps prevent re-replication (Reviewed in Li and Jin 2010). Loss of DNA licensing
factors leads to chromosomal fragmentation, genomic instability, incomplete replication,
and can induce several types of cancer (Bagley et al. 2012; Shima et al. 2007). In order
to license the DNA, the Origin Recognition Complex (ORC), a complex of Orc proteins
(Orc1-6), identifies licensing sites and recruits Cdc6 (Cell division cycle 6) and Cdt1
(Chromosome licensing and DNA replication factor 1), forming the Pre-replication
Complex (PRC). The PRC then loads hetero-hexamers of Mcm2-7 (Mini-chromosome
maintenance) proteins, which form part of a helicase during DNA replication. The
process of licensing also appears to promote the expression of Cyclin D expression
and plays a role in activating Cdk2 complexes (Nevis, Cordeiro-Stone, and Cook 2009;
Liu et al. 2009). Since active Cdk2-Cyclin E complexes are necessary for DNA
replication, this demonstrates that both DNA licensing and pRb inhibition are necessary
for progression into S phase.

1.2.3 S phase regulation (Figure 8)
S phase of the cell cycle, or synthesis phase, is the phase in which the cell
synthesizes a new copy of its DNA. While much of the regulation during this phase
pertains to repairing DNA damage and is discussed below, the process of replication is
also regulated. At the start of S phase, DNA replication machinery is assembled at
licensed replication origins by active Cdk2-Cyclin E (Coverley, Laman, and Laskey
2002; Zou and Stillman 2000). As Cyclin A expression increased during S phase, active
Cdk2-Cyclin A complexes which sanction the origins to fire, causing the replication
machinery to begin replicating the DNA, while simultaneously inhibiting the assembly of
replication machinery at potential replication origins (Coverley, Laman, and Laskey
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2002; Copeland et al. 2010). The interplay between Cdk2-Cyclin E and Cdk2-Cyclin A
activity provides a small window in which replication machinery can be assembled
while preventing re-licensing of DNA that has already been replicated. After activation
by Cdk2-Cyclin A, replication occurs outward bi-directionally from the origin as two
replication forks. Since not all forks fire at the same time, forks can be divided into
early- and late-replicating forks. Recent reports suggest that early forks may fire in
coordination with transcriptional machinery such that replication machinery and
transcriptional machinery travel in the same direction (Chen et al. 2019). This would
avoid head-on collisions between the two competing complexes which could lead to
DNA damage (Hamperl et al. 2017). In this model, later forks would fire only if an early
fork had stalled. However, regulation of firing early vs. late forks is still relatively
unknown (Reviewed in Masai et al. 2010).
Just as there is regulation for initiating and maintaining DNA replication, there is
regulation to ensure complete DNA replication. The Atr (Ataxia telangiectasia and Rad3
related) kinase, part of the DNA damage signaling pathway described below, prevents
cell division until DNA replication has completed (Nishijima et al. 2003). However,
caffeine in high concentrations will uncouple this regulation through inhibition of Atr,
allowing for cell division to proceed even when the DNA is not completed replicated
(Schlegel and Pardee 1986; Nishijima et al. 2003).

1.2.4 G2 phase regulation (Figure 9)
Once DNA replication has completed, the cell prepares to divide. During this
period, Cyclin B expression increases resulting in the formation of active Cdk1-Cyclin B
complexes. However, before binding to Cyclin B, Cdk1 is inactivated by
phosphorylation in the endoplasmic reticulum by Myt1 on threonine 14 (T14) (Liu et al.
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1997). After binding to Cyclin B, activation of the Cdk1-Cyclin B complex requires
removal of inhibitory phosphorylations by the Cdc25 phosphatases, as well as
activation by CAK (Figure 9) (Timofeev et al. 2009; Fisher and Morgan 1994). While
removal of the inhibitory phosphorylations can occur either in the cytoplasm or nucleus,
active Cdk1-Cyclin B is required in the nucleus to drive cell division (Franckhauser et
al. 2010).
Nuclear localization of the Cdk1-Cyclin B complex is regulated by the CRS located
on Cyclin B which drives the export of Cdk1-Cyclin B complexes from the nucleus
(Pines and Hunter 1994; Hagting et al. 1999). Once the Cdk1-Cyclin B complex is
active, this export sequence is phosphorylated by Plk1 and Cdk1, inhibiting the CRS
and allowing active Cdk1-Cyclin B to enter the nucleus (Borgne et al. 1999; ToyoshimaMorimoto et al. 2001). However, the activity of nuclear-localized Cdk1-Cyclin B
complexes is inhibited by phosphorylation on tyrosine 15 (Y15) of Cdk1 by Wee1
kinases specifically to prevent cell division from occurring aberrantly (McGowan and
Russell 1995; Russell and Nurse 1987; Den Haese et al. 1995). Therefore, both Wee1
inhibition and Cdc25 activation are necessary for mitotic progression.

1.2.5 DNA damage signaling (Figure 10)
Damage to the DNA is extremely deleterious to cellular life, and in particular, it can
severely affect progression through the S and M phases of the cell cycle. To prevent
the cell cycle from continuing while DNA is damaged, there are mechanisms in place to
arrest the damaged cell during interphase. This allows time for the cell to repair the
DNA, though if the damage is too prevalent, it can lead to cell death through apoptosis.
DNA damage is caused by multiple factors and the resulting cellular responses flow
through two different kinase cascades. Double strand breaks, formed by sources
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including ionizing radiation (IR), are largely sensed by Atm (Ataxia-telangiectasia
mutated), a serine-threonine kinase (Shiloh 2003). Atr, however, responds to interstrand crosslinks, formed by sources including ultraviolet radiation (UV), and single
strand breaks in addition to double strand breaks (Reviewed in Shiloh 2003). When
either kinase is recruited to the site of DNA damage, it is activated by autophosphorylation (Liu et al. 2011; So, Davis, and Chen 2009). This results in
phosphorylation of various downstream substrates, including Chk1 (Checkpoint kinase
1) and Chk2 (Checkpoint kinase 2) which phosphorylate yet more substrates
(Reviewed in Shiloh 2003). This both initiates DNA repair as well as activates the DNA
damage checkpoints at G1/S, S, and G2/M.
G1/S Checkpoint: In response to DNA damage, Chk1 and Chk2 effector kinases
phosphorylate Cdc25a, leading to its degradation (Mailand et al. 2000). Cdc25a is
required to remove inhibitory phosphorylations from Cdk2 complexes, so its destruction
leads to inhibition of Cdk2 activity, inhibiting the G1/S transition (Falck et al. 2001; Lee,
Bielawska, and Obeid 2000). However, the p53 transcription factor appears to be a
major driver of long-term maintenance of the DNA damage checkpoint at G1/S
(Reviewed in Levine 1997). Normally, p53 is degraded by Mdm2 (Transformed mouse
3T3 cell double minute 2), but stabilization of p53 occurs due to phosphorylation from
Atm and Atr and their downstream effector kinases Chk1 and Chk2 (Liu et al. 2011; So,
Davis, and Chen 2009; Shieh et al. 1997; Banin et al. 1998; Shieh et al. 2000; Haupt et
al. 1997; Levine 1997; Tibbetts et al. 1999). p53 then increases transcription of the p21
CKI which inhibits the activity of Cdk4, Cdk6 and Cdk2 complexes leading to cell cycle
arrest at G1/S (Harper et al. 1995).
Intra-S Checkpoint: If DNA damage occurs during S phase, the cell will extend S
phase in order to attempt to repair the damage. The replication fork formed during DNA
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replication is sensitive not only to many sources of DNA damage such as inter-strand
crosslinks, double strand breaks, and pyrimidine dimers, but also to nucleotide
depletion. Together these constitute sources of replication stress which will activate the
Atm and Atr kinases triggering the intra-S checkpoint (Reviewed in Berti and Vindigni
2016). Replication stress causes stalling of the replication fork, where the DNA
polymerase can no longer progress, leading to the production of single stranded DNA
(ssDNA) (Byun et al. 2005; Pages and Fuchs 2003). ssDNA recruits the ssDNA binding
protein Rpa1 (Replication protein A1) (Reviewed in Wold 1997). While Rpa1 is involved
in unwinding the DNA during replication, it transiently binds to ssDNA from the lagging
strand as well (Fairman and Stillman 1988; Wobbe et al. 1987; Wold and Kelly 1988;
Audry et al. 2015; Reviewed in MacNeill 2001). Long term Rpa1 binding, like that found
at a stalled replication fork, will trigger the intra-S checkpoint by activating Atr (Zou and
Elledge 2003). Activation by phosphorylation of Atr, or its effector Chk1, will lead to
Cdc25a inhibition and degradation which can no longer remove the inhibitory
phosphorylations from Cdk2 complexes (Goto et al. 2019; Shen et al. 2018). Due to
this, Cdk2 complexes may be inhibited as a potential mechanism for arresting the cell.
G2/M Checkpoint: DNA damage during G2 will stabilize p53 leading to increased
transcription of p21, which also inhibits the activity of Cdk1 complexes (Harper et al.
1995). In addition to p21, p53 also promotes transcription of 14-3-3 σ, an adapter
protein which can bind to and exclude Cyclin B from the nucleus (Hermeking et al.
1997). However, the major driver of the G2/M checkpoint appears to be inhibition of
Cdk1 itself. Activation of Cdk1 requires the removal of the T14 and Y15 inhibitory
phosphorylations (Jin, Gu, and Morgan 1996). Cdc25c phosphatase normally removes
these, but if it is phosphorylated by the Chk1 and Chk2 kinases not only is its activity
inhibited, but it is actively exported from the nucleus by 14-3-3 proteins (Falck et al.
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2001; Sanchez et al. 1997; Peng et al. 1997; Lopez-Girona et al. 1999; Zeng et al.
1998). This prevents the removal of inhibitory phosphorylations (T14Y15) on nuclear
populations of Cdk1; keeping it in an inhibited state and preventing the G2/M transition.

1.2.6 Quiescence
Many adult stem cell populations are maintained in a state of quiescence at the
G0 phase of the cell cycle (Reviewed in Rumman, Dhawan, and Kassem 2015). This is
a state akin to hibernation, where the cell does not proliferate, but is paused until it
receives signals to re-enter the cell cycle at G1, progress through the cell cycle, and
divide. Mechanistically, entry into quiescence is thought to be driven by low Cyclin D
expression during G2 and low CDK activity at the end of M phase of the previous cell
cycle (Spencer et al. 2013; Sa et al. 2002). Once in G0, quiescence is maintained by
expression of CKIs and pRb (Viatour et al. 2008; Cheng et al. 2000; Matsumoto et al.
2011; Zou et al. 2011; Hosoyama et al. 2011; Sankaran, Orkin, and Walkley 2008). Reentry into the cell cycle is thought to be driven by the expression of Cyclin D, which
activates Cdk4/6 (Ladha et al. 1998). Therefore, at a cell cycle level, regulation of
quiescence appears to utilize G1 regulators.

1.2.7 Alternate cell cycle regulation
The cell cycle regulation described above results in well-defined gap phases which
last for significant portions of the cell cycle. However, early embryonic cells from C.
elegans, D. melanogaster and Xenopus laevis require rapid expansion, and thus
abbreviate the gap (G1 and G2) phases, which when coupled with rapid DNA
replication, results in an exceedingly fast cell cycle to generate the requisite number of
cells for the onset of early gastrulation events (Edgar and McGhee 1988; Kermi, Lo
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Furno, and Maiorano 2017; Graham 1966b, 1966a; Takada and Cha 2011). Mouse
embryonic stem cells (mESCs) also display rapid expansion in culture. While they
maintain a G2 phase and S phase length similar to that of differentiated mouse somatic
cells, the G1 phase is abbreviated (Stead et al. 2002). Their abbreviated G1 phase
appears to be due to a constant expression of Cyclin E, Cyclin A, and Cdk2, allowing
these cells to rapidly enter S phase (White and Dalton 2005; Stead et al. 2002) (Figure
11). Accordingly, they do not appear to engage the G1/S checkpoint in response to
DNA damage, only the G2/M checkpoint (Chuykin et al. 2008; Hirao et al. 2000). While
p53 is expressed in these cells, it isn’t stabilized in response to DNA damage (Chuykin
et al. 2008). Thus, some cells may not utilize all aspects of the regulation above.

1.2.8 Cell cycle structure of the C. elegans GSCs
In adult C. elegans GSCs, the cell cycle structure and its regulation are reminiscent
of mESCs. The GSCs cycle continuously and asynchronously. In addition, from BrdU
(5-bromo-2'-deoxyuridine) and EdU (5-ethynyl-2’-deoxyuridine) labeling studies, there
is no evidence of quiescence in this population (Crittenden et al. 2006; Fox et al. 2011).
The cell cycle structure and regulation of GSCs appear to be similar throughout the
progenitor zone. With the total cell cycle length ranging from 8 – 12 hours depending
on the study, a majority of the cells are in S phase (~60-70%) with a very low
percentage in either M or G1 phase (~5% each) (Crittenden et al. 2006; Fox et al.
2011). Analysis of cell cycle regulators has shown that there is constant expression of
Cyclin E (cye-1) and Cdk2 (cdk-2), and CDK-2 appears to be active in all cells (Fox et
al. 2011; Brodigan et al. 2003). Active CDK-2 is required for cell cycle progression
since RNAi of cye-1 and cdk-2 lead to a cell cycle arrest (Fay and Han 2000; Fox et al.
2011; Furuta et al. 2018). However, the sole Cdk4/6 homolog, cdk-4, is not required for
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cell cycle progression in the germline (Fox et al. 2011). Therefore, it is likely that
constant CDK-2 activity promotes the short G1 and that the normal G1 regulators are
unnecessary. Depletion of the Cdk1 homolog (cdk-1) also results in cell cycle arrest, so
it is likely required for the G2/M transition in addition to the G1/S transition (Boxem,
Srinivasan, and van den Heuvel 1999).
Along those lines, DNA damage signaling is functional in GSCs as well. IR and UV
damage each lead to cell cycle arrest in GSCs (Gartner et al. 2000; Stergiou et al.
2007). IR and UV treatments result in an increase in apoptosis in the germline during
meiosis, though to date there is no evidence of cell death within the GSC population.
Moreover, similar to the mammalian context, deletion of the Atm homolog (atm-1)
appears to abrogate the IR arrest, whereas deletion of the Atr homolog (atl-1) will
abrogate both the IR and UV induced cell cycle arrest (Garcia-Muse and Boulton 2005;
Lee et al. 2010). However, the IR-induced arrest is not abrogated by deletion of the p53
homolog (cep-1) supporting the lack of an active G1/S checkpoint in these cells
(Schumacher et al. 2001). While it is important to regulate the cell cycle in response to
DNA damage, raw materials in the form of nutrients are required for any cell growth to
occur. Therefore, eukaryotic cells have developed additional signaling pathways to
detect internal and external nutrient and metabolite availability.
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Figure 6: Cyclin and CDK regulation of the mammalian cell cycle
Overview of the mammalian cell cycle. Cells which do not receive mitogens will exit
into a G0 (quiescent) state. Cyclins are expressed temporally to activate their partner
CDK. Towards the end of G1, as cells pass the restriction point (R) they are committed
to the cell cycle and no longer require mitogens.
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Figure 7: Mammalian G1 regulation
Overview of G1 regulation in mammalian cells. In response to mitogens, Cyclin D
levels rise and pRb is inhibited, promoting cell cycle regulator transcription in a positive
feedback loop leading to increased pRb inhibition. Cells license the DNA for replication.
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Figure 8: The role of Cdk2 in regulating DNA replication
Cdk2-Cyclin E activity promotes loading of the DNA polymerase and other
replication factors. Cdk2-Cyclin A activity promotes elongation of the nascent DNA
strands while inhibiting re-licensing by export of DNA licensing factors.
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Figure 9: Cdk1 Regulation at the G2/M boundary
Cdk1-Cyclin B activity and nuclear localization is regulated by a number of
phosphorylation and de-phosphorylation events. Phosphorylation on T14 and/or Y15 of
Cdk1 are inhibitory. Phosphorylation on T161 of Cdk1 results in its activation.
Phosphorylation on the CRS of Cyclin B is required for nuclear localization of the Cdk1Cyclin B complex.

32

Figure 10: Cell cycle control by DNA damage signaling
Overview of cell cycle control in response to DNA damage at different cell cycle
stages.
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Figure 11: Altered cell cycle regulation in mESCs
Overview of cell cycle phase proportions and cyclin expression in mESCs.
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1.3 Metabolic and Nutritional Regulation
For organisms to survive, it is necessary to receive a constant influx of nutrients.
These nutrients are necessary to sustain tissues and cells in a working state. If this
need is not met, it can result in harm to the organism’s tissues and cells. Therefore, it is
important for an organism to be able to sense its environment and determine whether
those nutrients are available. In response to such signals, cells and tissues modulate
their cellular behavior to adapt to the environment and nutritional availability. One
organism which has evolved a number of methods of adjusting to a lack of external
nutrients is C. elegans. For example, during early larval development, lack of nutrients
or overcrowding drives the animal into an alternate developmental state termed
“dauer”. In this state, the animals are metabolically repressed and can sustain long
periods of starvation. Return to normal nutritional conditions results in reentry of the
dauer stage animals into L4 and normal development ensues. GSCs, like the somatic
cells, have also developed methods to adapt to nutrient availability. Under replete
conditions, the C. elegans GSCs are constantly dividing. The GSCs adjust to changes
in nutrient availability in a rapid manner, making it a good model system to study the
effects of starvation on continuously dividing populations of cells. In C. elegans GSCs,
most nutritional signaling appears to pass through either an insulin – PI3K
(Phosphoinositide 3 Kinase) – AKT (Thymoma viral proto-oncogene) signaling axis or
TOR (Target of rapamycin) signaling (Figure 12). Therefore, I will focus on those two
pathways for this chapter.

1.3.1: Insulin Signaling
Insulins and insulin-like peptides are a class of metabolic signaling peptides which
promote the uptake and storage of systemic glucose as glycogen (Fukumoto et al.
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1989; Suzuki and Kono 1980). Binding of insulin to the insulin receptor activates a
number of signaling pathways involved in metabolism, cell growth and proliferation
(Reviewed in De Meyts 2000; Reviewed in Taniguchi, Emanuelli, and Kahn 2006). The
insulin receptor is a receptor tyrosine kinase (RTK) which functions as an α2β2
tetramer (Olson, Bamberger, and Lane 1988; Schenker and Kohanski 1991). The
insulin receptor gene encodes both subunits, with the α-subunit responsible for ligand
binding, and the β-subunit responsible for kinase activity (Deutsch et al. 1983; Kasuga,
Hedo, et al. 1982; Pilch and Czech 1979; Shia and Pilch 1983; Yip, Moule, and Yeung
1982). Upon insulin binding, it auto-phosphorylates on intracellular tyrosine residues
leading to its activation (Kasuga, Zick, Blith, et al. 1982; Kasuga, Zick, Blithe, et al.
1982; Rosen et al. 1983; Van Obberghen et al. 1983). In mammals, this leads to
phosphorylation of the insulin-receptor substrate (IRS) proteins which become adapters
and activate downstream signaling complexes. Activation of these adapters recruits
and activates downstream signaling modules including the PI3K-AKT signaling axis.

1.3.2: The PI3K-AKT signaling axis
Phosphoinositide 3 kinases (PI3Ks) are activated in response to a variety of Gprotein coupled receptors (GPCRs) and RTKs (Reviewed in Vanhaesebroeck et al.
2010). PI3Ks are heterodimers that are made up of a regulatory and a catalytic subunit.
They are activated by protein-protein interactions through recruitment to an activated
signaling adapter (Klippel et al. 1996). In response to activation, PI3Ks phosphorylate
PIP2 (Phosphatidylinositol 4,5-diphosphate) to produce PIP3 (Phosphatidylinositol
3,4,5-triphosphate) (Reviewed in Vanhaesebroeck et al. 2010). Pten (Phosphatase and
tensin homolog) negatively regulates this activity by dephosphorylating PIP 3 to PIP2.
PIP3 functions as a second messenger and activates a number of proteins with PIP 336

recognition domains including AKT (Franke et al. 1995). AKTs are serine-threonine
kinases which are recruited to the membrane through their PIP3 binding domains and
are subsequently activated by phosphoinositide-dependent kinase 1 (Alessi et al.
1997). Upon activation, AKTs will phosphorylate and inactivate multiple downstream
effectors such as the FOXO (Forkhead box O) transcription factors, Gsk3β (Glycogen
synthase kinase 3 beta), and Tsc2 (Tuberous sclerosis 2), which forms a complex with
Tsc1 (Tuberous sclerosis 1), hereafter referred to as the TSC. The FOXO transcription
factors are involved in regulating a number of cellular processes such as cell cycle
control, stress response, and apoptosis (Reviewed in Tran et al. 2003). Gsk3β and the
TSC both regulate TOR signaling in mammals.

1.3.3: TOR Signaling
Mtor (Mechanistic target of rapamycin) is a serine-threonine kinase which mediates
TOR signaling in its response to energy, nutrient, and metabolite cues by regulating cell
growth, proliferation, survival and metabolism (Reviewed in Saxton and Sabatini 2017).
Mtor functions in two separate complexes designated TORC1 (Mtor, Rptor (Regulatory
associated protein of MTOR, complex 1), and Mlst8 (MTOR associated protein LST8
homolog (S. cerevisiae))) and TORC2 (Mtor, Rictor (RPTOR independent companion
of MTOR, complex 2), mLST8, Mapkap1 (Mitogen-activated protein kinase associated
protein 1), and either Prr5 (Proline rich 5 (renal)) or Prr5l (Proline rich 5 like)).
The TORC2 complex recognizes PIP3 through its Mapkap1 cofactor, leading to
activation and regulation of cell survival and proliferation (Jacinto et al. 2006). Many of
its functions are executed through phosphorylation of AKT (Sarbassov et al. 2005).
However, this activating phosphorylation appears important only for certain substrates
of AKT. For example, phosphorylation of AKT downstream to TORC2 is required for
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phosphorylation and inactivation of the FOXO transcription factors, but does not affect
Tsc2 phosphorylation (Guertin et al. 2006; Jacinto et al. 2006). Thus, TORC2 activation
of AKT does not affect TORC1.
The TORC1 complex utilizes the Rheb (Ras homolog enriched in brain) GTPase to
activate and regulate autophagy, metabolism, and protein synthesis. In mammals, a
large pool of Rheb protein is thought to be bound to the lysosome, and so recruitment
of TORC1 to the lysosome plays a large role in its activation (Inoki et al. 2003; Tee et
al. 2003). From work in mammals, Rag (recombination activating) GTPase activity
recruits TORC1 to the lysosomal surface in response to amino acid sensing proteins.
Activation of TORC1 leads to phosphorylation of its downstream effectors some of
which include p70s6k (ribosomal protein S6 kinase, polypeptide 1), Eif4ebp (Eukaryotic
translation initiation factor 4E binding protein), Atg14 (Autophagy related 14), and Hif1a
(Hypoxia inducible factor 1, alpha subunit)).
However, activation of TORC1 requires more than amino acid sensing. Other
upstream signals from energy status (by sensing ATP) and growth factor signaling are
required for full TORC1 activation. Low energy status, as well as hypoxia and DNA
damage, is sensed by AMPK (AMP-activated protein kinase) and can either directly
regulate TORC1 by phosphorylation and inhibition of Rptor, or by phosphorylation and
activation of Tsc2 (Gwinn et al. 2008; Inoki, Zhu, and Guan 2003; Feng et al. 2007;
Brugarolas et al. 2004). Tsc2, which is downstream to the Insulin-PI3K-AKT signaling
axis, inhibits Rheb through the TSC which subsequently inhibits TORC1 activation
(Inoki et al. 2003; Menon et al. 2014; Tee et al. 2003). Phosphorylation of Tsc2
dissociates it from Tsc1 and the lysosomal surface, allowing Rheb to activate TORC1
(Menon et al. 2014). Other regulators of the TSC include the Ras-MAPK (Mitogen
associated protein kinase) pathway and Gsk3β.
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1.3.4: Gsk3β
Gsk3β functions in several signaling pathways, such as the insulin, TOR and Wnt
pathways, to regulate proliferation, differentiation, and apoptosis (Bouskila et al. 2008;
Campbell et al. 2012; McManus et al. 2005; Parisi et al. 2011), in addition to its original
role of inhibiting glycogen synthase (Larner et al. 1968; Rylatt et al. 1980). This poises
Gsk3β as an integrator of various signaling pathways. Gsk3β is a serine-threonine
kinase which is constitutively active when first translated. Phosphorylation events thus
inactivate Gsk3β unlike most other kinases, where phosphorylations are necessary for
their activity (Jope and Johnson 2004). Specifically, phosphorylation on Ser-9 on the Nterminus by various kinases, such as AKT and p70s6k, will inhibit the kinase. Since
Gsk3β phosphorylates its substrates on serines or threonines which are 3-5 amino
acids away from a phosphorylation, phosphorylated Ser-9 functions as bait, blocking
the kinase binding pocket and preventing other substrates from binding.

1.3.5: Nutritional Signaling in cell cycle regulation in yeast, flies and vertebrate
systems
Downstream from the insulin receptor, the Ras-MAPK pathway is well known for
activating Cyclin D transcription resulting in G1 progression as previously discussed
(Chapter 1.2.2). Additionally, the PI3K-AKT module appears to promote G1 progression
as well by increase Cyclin D and Cyclin E expression in response to insulin-like growth
factors (Mairet-Coello, Tury, and DiCicco-Bloom 2009). Similarly, TOR signaling
regulates the G1 phase of the cell cycle as well.
From studies in yeast and mammalian cell culture, downregulation of, or mutations
in, Mtor and its downstream effectors result in a G1 arrest (Abraham and Wiederrecht
1996; Fingar et al. 2004; Rohde, Heitman, and Cardenas 2001). However, in
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embryonic stem cells, removal of the downstream effector p70s6k only affects
proliferation rate mildly suggesting a different regulation (Kawasome et al. 1998).
Additionally, there is evidence for the involvement of nutritional signaling in G2
regulation as well.
In Drosophila germ cells, there is evidence that Insulin signaling and TOR signaling
independently regulate G2 (Hsu, LaFever, and Drummond-Barbosa 2008; LaFever et
al. 2010). In fission yeast, the Mtor homolog for the TORC1 complex, Tor1, signals
through stress kinases to regulate Cdc25 (Lopez-Aviles et al. 2008; Lopez-Aviles et al.
2005). In budding yeast, Tor1 signals through PP2A (Protein phosphatase 2) which is
required for polo-like kinase translocation into the nucleus, driving mitotic progression
(Nakashima et al. 2008). This provides a link between TOR signaling and cell cycle
regulators.

1.3.6: Nutritional Signaling in C. elegans
C. elegans is a free-living nematode that is often found on rotting fruits and is
uniquely sensitive to nutritional availability in its surroundings. It has evolved a number
of adaptations to deal with a lack of nutrients, including cell cycle arrest of the PGCs
(Fukuyama, Rougvie, and Rothman 2006), and an alternate developmental stage
named dauer (Golden and Riddle 1984). Upon hatching, if no nutrients are available,
the PGCs maintain a G2 arrest until food is available. If nutrition becomes unavailable
during L2 stage of development, the worm enters the alternate developmental pathwaydauer. As a dauer, C. elegans can survive for months without food, and when replete
conditions are available, it will molt into an L4 and continue its development (Golden
and Riddle 1984). Thus, nutritional signaling plays important roles for the survival of
this organism.
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Most of the nutritional signaling components described above are conserved in C.
elegans (Table 1) with a few exceptions. While the C. elegans insulin receptor homolog
(daf-2) appears to have a similar gene structure for encoding the receptor, DAF-2 has a
C-terminal extension which may function as a signaling adapter similar to the IRS
proteins (Kimura et al. 1997). Although there are functional IRS homologs in C. elegans
(ist-1, aap-1), these are not necessary for dauer formation, suggesting that daf-2 itself
may be able to function as the signaling adapter for the PI3K homolog age-1 (Munoz
and Riddle 2003). In addition, C. elegans does not generate insulin. Instead, 40
different insulin-like peptides are secreted from the sensory neurons to regulate the
insulin receptor and mediate its effects (Li, Kennedy, and Ruvkun 2003; Kawano et al.
2000; Duret et al. 1998; Pierce et al. 2001).
Links between Insulin signaling and TOR signaling are few. To date, no Tsc1 or
Tsc2 homologs have been identified in C. elegans. Since the TSC forms a major link
between Insulin signaling and TORC1 in mammals, this suggests that the Insulin
signaling and TOR signaling may not crosstalk in C. elegans. Similarly, there is little
evidence that TORC2 functions through AKT. Mutations in the Rictor homolog rict-1
produce a number of phenotypes such as increased fat storage, and small animal size
(Jones et al. 2009; Soukas et al. 2009). However, while the increased fat storage
phenotype is observed in the AKT homolog, akt-1 or akt-2, mutants, the phenotype is
enhanced in double mutants with rict-1, suggesting that the two pathways function in
parallel (Jones et al. 2009; Soukas et al. 2009). One link that does exist, however, is
that the FOXO homolog daf-16 negatively regulates the expression of the Raptor
homolog daf-15 (Jia, Chen, and Riddle 2004). Together, these observations suggest
that Insulin signaling and TOR signaling may function relatively separately in C.elegans
compared to mammals.
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1.3.7: Nutritional Signaling in the C. elegans germline
In the C. elegans germline, nutritional signaling has been shown to regulate both
developing oocytes as well as GSCs. In developing oocytes, the insulin receptor daf-2
provides the signal to activate let-60-mpk-1 (Ras-Mapk1) signaling to control oocyte
production (Lopez et al. 2013b). In larval GSCs, mutation of the daf-2 receptor results
in decreased proliferation in a daf-16 dependent manner (Michaelson et al. 2010). In a
study on the TOR signaling downstream effector rsks-1 (p70s6k), it was found that daf2rsks-1 double mutants enhanced the rsks-1 single mutant phenotype for low GSC
proliferation in larval stage L4 animals which suggests that Insulin signaling and TOR
signaling drive proliferation in parallel pathways. (Korta, Tuck, and Hubbard 2012).
Together, these studies raise the possibility that nutritional signaling may control the
cell cycle in C. elegans GSCs. The mechanisms that mediate this remain unknown.
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Figure 12: The Insulin and TOR nutritional signaling network
Overview of common nutritional signaling network components and their
connectivity. Red and blue arrows depict different inputs into AKT, which produce
different responses. The blue input produces only the purple response, while the red
input produces both red and purple responses.
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Table 1: Nutritional signaling homologs in C. elegans
Table listing the mouse nutritional signaling components on the left, and their C.
elegans homologs on the right. Question marks denote that there is no known homolog
in C. elegans.
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Chapter 2: Materials and Methods

Some of the contents of this chapter are reproduced/adapted with permission from
“Furuta et al. 2018” with permission from Development
(http://www.biologists.com/development).

Full citation:
Furuta, T., H. J. Joo, K. A. Trimmer, S. Y. Chen, and S. Arur. 2018. 'GSK-3 promotes
S-phase entry and progression in C. elegans germline stem cells to maintain tissue
output', Development, 145, doi: 10.1242/dev.161042

2.1: Materials

2.1.1: Chemicals and Buffers
Chemicals
Hydroxyurea
16% Paraformaldehyde
3% Paraformaldehyde

Methanol
30% Normal Goat Serum
DAPI
K2HPO4 (pH 7.2)
1x PBS
Tween 20
M9 buffer

Sterile M9T

Information
(Sigma-Aldrich, cat. no. H8627)
(Electron Microscopy Sciences, cat. no.
15710)
20% (v/v) 16% Paraformaldehyde in
(0.1M) Potassium Phosphate buffer at
pH 7.2
(Electron Microscopy Sciences, cat. no.
18510)
(Sigma-Aldrich, cat. no. D9542
(SIGMA-ALDRICH, cat. no. P3786)
(SIGMA Life Science, cat. no. P2194)
(Fischer Scientific, cat. no. BP337-500)
(Stiernagle 2006) (3 g KH2PO4, 6 g
Na2HPO4, 5 g NaCl, 1 ml 1 M MgSO4, H2O
to 1 liter. Sterilize by autoclaving.)
M9 Buffer with 0.1% Tween sterilized
using a 0.22µm filter
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Click-iT® Plus EdU Alexa Fluor® 594
Imaging Kit
Alexa Fluor 647 picolyl azide

(ThermoFisher Scientific, cat# C10639)

Cupric Sulfate
Proteinase K
Worm lysis buffer

(Sigma-Aldrich, cat. no. C-7631)
(10 mg/mL) (Roche, cat. no. 3115879001)
5% (v/v)10mg/mL Proteinase K in 1X
PCR buffer
(Genesee Scientifitc, cat. no. 42-143)

Apex Hot Start Taq BLUE Master
Mix, 2X
Agarose
Ethidium Bromide
L-Lysine-monoHCL
Sodium Periodate (NaIO 4 )
Vectashield Anti-fade

(ThermoFisher Scientific, cat# A10277)

(Sigma-Aldrich, cat. no. A6877
(Sigma-Aldrich, cat. no. 46067)
(Sigma-Aldrich, cat. no. L-9037)
(Sigma-Aldrich, cat. no. S1878)
(Vector Labs, cat. no. H-1000)

2.1.2: C. elegans Strains and Culture
Strains were made and handled using standard methods (Brenner 1974).
Strains used in this study:
Strain
Genotype
N2
Wildtype
AUM1239 naSi2[mex-5p>mCherry::his51::nos-2 3’UTR>GFP::his-51::nos-2
3’UTR] II; (? - unc-119 [ed3]) III.
AUM1246 naSi2 [pmex-5>mCh::his-51::nos-2 3’ UTR>GFP::his-51::nos-2
3’UTR] (II); qIs56 (plag-2::GFP::lag-2 3’UTR) (V)
ttTi5605 II; unc-119(ed3) III
EG4322
unc-119(ed3) III; oxTi365 V
EG8082
AUM1012 gsk-3(nr2047)/hT2[bli-4(e937)let-?(q782) qIs48] I; unc-119(ed3)III/
hT2 [bli-4(e937)let-?(q782) qIs48] (I; III)
AUM1054 gsk-3(tm2223) I/ hT2 [bli-4(e937)let-?(q782) qIs48] (I; III)
glp-1(bn18ts) III
BS121
glp-1(ar202ts) III
BS3148
AUM1081 gsk-3(tm2223) I/ hT2[bli-4(e937)let-?(q782)qIs48] (I;III). Line 1
AUM1082 gsk-3(tm2223) I/ hT2[bli-4(e937)let-?(q782)qIs48] (I;III). Line 2
AUM1260 gsk-3(nr2047)/oxTi398 I
AUM1262 gsk-3(nr2047)/oxTi398 I; gtIs64[mcm-3::GFP]; odIs57[Ppie1::mCherry::H2B]. Line 1
AUM1266 gsk-3(nr2047)/oxTi398 I; gtIs64[mcm-3::GFP]; odIs57[Ppie1::mCherry::H2B]. Line 2
AUM1279 gsk-3(nr2047)/ oxTi398 I; ddIs30[Ppie-1::YFP::CDK-2]
AUM2026 gsk-3(nr2047)I;unc-119(ed3) III; vizIs26[Ppie-1::GFP::GSK3(WT)::pie-1 3’UTR unc-119(+)]
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AUM2027 gsk-3(nr2047)I;unc-119(ed3) III; vizIs27[Ppie-1::GFP::GSK3(WT)::pie-1 3’UTR unc-119(+)]
AUM2028 gsk-3(nr2047)I;unc-119(ed3) III; vizIs28[Ppie-1::GFP::GSK3(WT)::pie-1 3’UTR unc-119(+)]
AUM2029 gsk-3(nr2047)I;unc-119(ed3) III; visIs29[Ppie-1::GFP::GSK3(WT)::pie-1 3’UTR unc-119(+)]
AUM2083 vizSi44 [Pmex-5::GFP::GSK-3(WT)::tbb-2 3’UTR unc-119(+)]
*ttTi5605 II; unc-119(ed3) III
AUM2059 vizSi20[Pmex-5::GFP::GSK-3 [K65A,E77A,D180A,D161A]::gsk-3
3’UTR] *ttTi5605 II; unc-119(ed3)III
AUM1295 gsk-3(nr2047)/ hT2 [bli-4(e937)let-?(q782) qIs48] I; vizSi20[Pmex5::GFP::GSK-3 [K65A,E77A,D180A,D161A]::gsk-3 3’UTR]
*ttTi5605 II; unc-119(ed3)/hT2 [bli-4(e937)let-?(q782) qIs48]III
unc-119(ed3) III; gtIs64 [pie-1p::GFP(lap)::mcm-3 + unc-119(+)]
TG1753
ltIs37 [pie-1p::mCherry::his-58 + unc-119(+)]
unc-119(ed3) III; ddIs30 [Ppie-1::YFP::CDK-2 (K03e5.3a) uncTH98
119(+)] II
gsk-3(nr2047) I/ hT2 [bli-4(e937)let-?(q782) qIs48)] (I; III)
WM69
AUM1294 gsk-3(nr2047) I/ hT2 [bli-4(e937)let-?(q782) qIs48)] (I; III);glp1(ar202ts)III/hT2 [bli-4(e937)let-?(q782) qIs48)] (I; III)
AUM1293 gsk-3(nr2047) I/ hT2[bli-4(e937)let-?(q782) qIs48)] (I; III); glp1(bn18ts) III/ hT2 [bli-4(e937)let-?(q782) qIs48)] (I; III);
ttTi398 [Peft-3::tdTomato::H2B::unc-54 3'UTR Cbr-unc-119(+)]
EG7843
ttTi413 [Peft-3::tdTomato::H2B::unc-54 3'UTR Cbr-unc-119(+)]
EG7844
AUM2073 vizSi34 [cdk-2[Promoter]::NLS::GFP::tbb-2 3’ UTR] *ttTi5605 II;
unc-119(ed3) III
3’UTR]
AUM2071 unc-119(ed3);vizSi32[cdk-2[Intron1]::NLS::GFP::tbb-2
*oxTi365 V
AUM1339 gsk-3(nr2047) I / ht2 [bli-4(e937)let-?(q782) qIs48)] (I; III);vizSi32
[cdk-2[Intron1] ::NLS::GFP::tbb-2 3’UTR] *oxTi365 V
JJ2213

zuIs252[Pnmy-21::PGL-1::mRFP; unc119(+)] unc119(ed3)III

AUM1076 gsk-3(nr2047) I / ht2 [bli-4(e937)let-?(q782) qIs48)] (I; III);
zuIs252[Pnmy-21::PGL-1::mRFP; unc119(+)] unc119(ed3)III
AUM1079 gsk-3(tm2223) I / ht2 [bli-4(e937)let-?(q782) qIs48)] (I; III);
zuIs252[Pnmy-21::PGL-1::mRFP; unc119(+)] unc119(ed3)III
atm-1(gk186) I
VC381
atl-1(tm853) V/nT1 [unc-?(n754) let-? qIs50] (IV;V)
DW101
AUM1449 atm-1(gk186) (I); naSi2 (II); atl-1(tm853)/tmC12(V)
daf-2(e1370) III
CB1370
AUM1018 rsks-1(ok1255)/hT2 GFP [bli-4(e937)let-?(q782) qIs48) I; III
AUM1291 daf-2(e1370)rsks-1(ok1255) III
AUM1479 let-363(viz27[del2196-2287ins5xG])
sur-6(or550) I
EU1062
AUM2082 vizSi43[Pmex-5::GFP::cdk-1(cDNA)::cdk-1 3’UTR,
unc119(+)]*ttTi5605II; unc-119(ed3)III
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KB3

kgb-1(um3) IV

2.1.3: Antibodies
The following primary antibodies were used: rabbit anti-HIM-3 (5347.00.02, Sdix)
(1:1000); rabbit anti-REC-8 (29470002, Novus); mouse anti-phospho-Histone H3
(Ser10) (05-806, Millipore) (1:500); rabbit anti-GFP (ab6556, Abcam) (1:400); rabbit
anti-CYE-1 and anti-CDT-1 were gifts from Dr. Edward T. Kipreos (University of
Georgia); guinea pig anti-Lamin was a gift from Dr. Kelly Liu (Cornell University)
(1:800); Anti-alpha Tubulin (T9026, Sigma) (1:1000); rabbit anti-CDK-1, a gift from Dr.
Jill Schumacher (MD Anderson Cancer Center), was received as serum and IgG
purified (1:50); rabbit anti-(pT14pY15) Cdk1 (44686G, Biosource) (1:200); rabbit anti(pS345) Chk1 (2341, Cell Signaling) (1:400).
The following secondary antibodies were used at (1:1000): donkey anti-mouse
Alexa 594 (A21203, ThermoFisher Scientific), goat anti-mouse Alexa Cy5 (A10524,
ThermoFisher Scientific), goat anti-mouse Alexa 488 (A21202, ThermoFisher
Scientific), goat anti-rabbit Alexa 488 (A11008, ThermoFisher Scientific), donkey antirabbit Alexa 594 (A21207, ThermoFisher Scientific), goat anti-guinea pig Alexa 594
(A11026, ThermoFisher Scientific), anti-rabbit HRP (1858415, Pierce Biotechnology),
and anti-mouse HRP (1858413, Pierce Biotechnology) secondary antibodies.

2.1.4: Transgenic construction of GFP::GSK-3
To generate a GFP::GSK-3 construct, the gsk-3 coding region from the start codon
to the translation stop was amplified as one PCR product of 5.5 Kb with KOD
polymerase (Novagen, Madison, WI), using the following primers:

49

attb1 GSK-3 ggggacaagtttgtacaaaaaagcaggcttgATGAATAAGCAGTTACTATCGT
attb2 GSK-3 ggggaccactttgtacaagaaagctgggtTTAAGCCGATGGGCCAGCCACA
After amplification from N2 cDNA, the fragment was cloned into the pDONR221
vector of the gateway system using BP reaction. The pDONR plasmid was then
sequenced to confirm integrity and recombined into the pID3.02 pie-1 GFP plasmid
(pENTR) containing the unc-119 transformation marker using the gateway LR reaction
to generate pSYC003[Ppie-1::GFP::GSK-3::pie-1 3’UTR]. Microparticle biolistic
transformation was used to create low-copy integrated transgenic lines in unc-119(ed3)
animals as described (Praitis 2006). Wildtype animals were individually cloned and
assayed for integration of the transgene. Six integrated lines were obtained and named
vizIs26, vizIs27, vizIs28, vizIs29, vizIs30 and vizIs31.
To generate mex-5 driven GSK-3 transgenes, the full-length coding region of gsk-3
was amplified from N2 cDNA and cloned via the Gateway system into pDONR221. The
clones were verified for sequence integrity, and combined with Pmex-5::GFP (pJA245)
and the tbb-23 3’UTR (pCM1.36). The final clone, Pmex-5::GFP::GSK-3::tbb-2 3’UTR,
was cloned into the destination vector pCFJ150 via LR clonase reaction. The pSYC001
plasmid, obtained from the LR reaction, was sequence verified for integrity.

Kinase dead GSK-3 was generated by modifying pSYC001 with a series of sitedirected mutagenesis using the following primers:
GSK-3_K65A_FP: AAATGAAATGGTTGCAATCgctAAAGTTCTTCA,
GSK3_K65A_RP: GTTTGTCCTGAAGAACTTTagcGATTGCAACCA,
GSK3_E77A_FP: CAAACGATTCAAGAATCGTgctCTACAGATTAT
GSK3_E77A_RP: ATTTTCGCATAATCTGTAGagcACGATTCTTGA
GSK3_D161A_FP: CATTGGAATCTGTCACCGTgctATTAAGCCTCA
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GSK3_D161A_RP: GCAAATTCTGAGGCTTAATagcACGGTGACAGA
GSK3_D180A_FP: CGGAGTGCTTAAGCTCTGTgctTTTGGATCTGC
GSK3_D180A_RP: AATATTTGGCAGATCCAAAagcACAGAGCTTAA.
The final GSK-3(KD) pENTR clone pSYC099 was sequenced to verify all the
modifications.
To generate mex-5 driven GSK-3 transgenes, pSYC001(GSK-3(wt)), or
pSYC099(GSK-3(KD K65A, E77A, D161A, D180A)) was combined with Pmex-5::GFP
(pJA245), tbb-2 3’UTR (pCM1.36), and inserted into the pCFJ150 destination vector
using the multi fragment gateway system. The final expression constructs
pHJJ002(Pmex-5::GFP::GSK-3(wt)::tbb-2 3’UTR) or pSYC100 (Pmex-5::GFP::GSK3(KD)::tbb-2 3’UTR) were sequenced for the junctions.
These constructs were injected into EG4322 worms for Chromosome II integration,
and selected as described previously (Drake et al. 2014; Zeiser et al. 2011).

2.1.5: CDK-2 transcriptional reporter construction
A 2kb region directly upstream of cdk-2 exon 1 (Wormbase Ver 258) was amplified
for the “promoter” construct using the following primers:
GGGGACAACTTTGTATAGAAAAGTTGATcgcgggaagataagtggagagggag
GGGGACTGCTTTTTTGTACAAACTTGTttttccacttttaaccagcattttt.
1880bp (Wormbase Ver 258) of Intron 1 was amplified using the following primers:
GGGGGACAACTTTGTATAGAAAAGTTGATgtgttacaagttctttgtgcaa
GGGGACTGCTTTTTTGTACAAACTTGTctggaagataattaagattttc.
The amplified fragments were cloned into pDONR P4P1R vector using BP reaction
to make pENTR clones, pSYC122, and pSYC111. SV40NLS::GFP with synthetic
introns was amplified from pPD95.67 using the following primers:
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GgggacaagtttgtacaaaaaagcaggcttgATGACTGCTCCAAAGAAGAAGCG,
ggggaccactttgtacaagaaagctgggtCTATTTGTATAGTTCATCCATGCC
and cloned into the pDONR221 vector. The plasmids were assembled with the tbb2 3’UTR, pCM1.36 and pCFJ150 for MosSCI recombination site using Gateway LR
reaction. Final expression plasmids were pSYC112 (Intron cdk-2::SV40NLS::GFP::tbb2 3’UTR MosSCIsite ttTi5605) and pSYC123 (promoter cdk-2::SV40NLS::GFP::tbb-2
3’UTR MosSCIsite ttTi5605), sequenced for integrity.

2.1.6: let-363(viz27[del2196-2287ins5xG]) allele construction
A loss of function allele for let-363, was made by removal of the fkbp12-rapamycin
binding (FRB) domain using CRISPR. A coCRISPR strategy was based on (Paix,
Folkmann, and Seydoux 2017). Two potential CRISPR cut sites flanking the FRB were
identified and the corresponding crRNAs ordered from Dharmacon:
TTGTTCGTTGCGCAATTCTG
ACTTGCCACTTTGAACTCGT
The repair template was designed to remove a 381bp segment of genomic DNA
corresponding to Trp2196 - Thr2287 of let-363 and substituting a 5xG linker and
introducing a restriction site for StuI. This resulted in an ssODN as shown below with
the 5xG linker in red and the silent mutations to introduce the StuI site in lowercase:
GTGACAGAAGAGCTTGTTCGTTGCGCAATTCTGGGAGGAGGTGGaGGccTGAACT
CGTTGGATCTTGTCTACGTATCACCTAATTTGG
The CRISPR injection mixture was injected into N2, and roller F1s were screened for
the mutation by PCR using the following primers:
AGTTGAAGTGCGCATATGTAGAA
ACTATTGGAGCTGATGGATCGT
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These primers produce a wildtype band of 675bp, a band at 290 if both crRNAs cut
without repair, and a band at 309bp for both cuts with repair. 6 lines were isolated with
the correct bands, and genomic DNA was sent for sequencing using the primers above.
5 lines returned with the expected sequence.

2.2: Methods

2.2.1: Germline dissection and staining
All animals were dissected as adults at 24 hours past the L4 stage of development,
unless otherwise mentioned. Germlines were dissected as described previously (Arur
et al. 2011; Arur et al. 2009; Drake et al. 2014; Suen et al. 2013). For antibody staining,
dissected germlines were fixed with 3% paraformaldehyde with 100mM K 2HPO4 (pH
7.2) for 10 min, and post-fixed with 100% methanol at -20C for at least 30 min. Fixed
germlines were blocked with 30% normal goat serum (NGS) at room temperature for 1
hour, and incubated with primary antibodies diluted in 30% NGS at 4C overnight. After
three washes, the germlines were treated with secondary antibodies diluted in 30%
NGS at room temperature for 2 hrs. Antibody-treated germlines were then stained with
2μg/ml DAPI (4',6-diamidine-2-phenylindole dihydrochloride) in PBST buffer (8mM
Na2HPO4, 150mM NaCl, 2mM KH2PO4, 3mM KCl, 0.05% Tween® 20, pH 7.4) for 20
min, washed and finally suspended in 10μl of Vectashield (anti fade agent).

2.2.2: Analysis of germ cell numbers
Cell numbers were counted using ImageJ and a custom macro I wrote. This macro
assists the user in counting nuclei with a z-stack when nuclei are present in more than
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one slice. Briefly, the user uses the point selection tool to mark nuclei. The macro then
counts the cell and puts markers on the surrounding slices at the same (x, y)coordinates (Fig 13A). This allows the user to view which nuclei have already been
marked on a different slice.

2.2.3: EdU Labeling (Feeding)
EdU feeding experiments were performed as described previously (Fox et al.
2011). Briefly MG1693 was grown with 20uM EdU and seeded onto NGM plates.
Hermaphrodites were transferred to EdU plates and incubated for either 30 minutes or
the amount of time specified. Animals were then dissected and processed for antibody
staining.

2.2.4: Development of the EdU Labeling by Soaking
To determine whether soaking adult hermaphroditic worms with the EdU analog
allowed for efficient incorporation and detection, I soaked worms for 10 minutes with a
series of EdU concentrations (50, 100, 200, 500 µM final concentrations) in M9 buffer
with 0.1% Tween (M9T). I found that the concentration of EdU did not affect EdU
signal intensity or background (Figure 14), so I proceeded with a concentration of 500
µM in the work described here.
To compare EdU incorporation rate via soaking to the previous feeding EdU
method, I performed the 30 minute EdU feeding assay and the 10 minute soaking
assay in parallel and compared the percent of EdU labeled cells out of the total
proliferative cells, or S phase index. The S phase index measured in germline stem
cells was similar between EdU incorporation via feeding or soaking (67%±13% and
55%±7% respectively) (mean±SD) (Fig. 13 B, C). The 10-minute soak seems to be a
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more accurate representation of the S phase index, since it labeled only those cells that
were replicating in a time window of 10 minutes. Overall, these data suggest that
soaking the worms for 10 minutes in a solution of EdU is as effective as previous
methods at identifying cells in S phase, and provides a rapid and efficient method of
EdU incorporation.

2.2.5: Final method used for EdU incorporation by soaking
N2 worms were grown on nematode growth medium (NGM) plates with E. coli
OP50 bacteria to 24 hours past mid-L4, then washed off plates into 1.5 mL eppendorf
tubes using M9T (M9 buffer, 0.1% Tween), washed 2 times with M9T, liquid was
removed to 100 µL, and worms were transferred to a well of a flat-bottom 48 well plate.
50 uL of liquid was removed and 50 µL of a 1mM solution of EdU in M9T was added
(500µM final) and incubated at room temperature in the dark for 10 or 15 minutes.
Following incubation, worms were transferred to 1.5 mL eppendorf tubes and washed
once with PBST, followed by either starvation, feeding, or dissection and processing as
required.

2.2.6: EdU Processing
After animals were dissected and fixed, germlines were processed using the ClickiT® Plus EdU Alexa Fluor® 594 Imaging Kit (ThermoFisher Scientific, cat# C10639)
per the manufacturer’s recommendations, with a minor modification. Instead of the
copper protectant provided with the kit (Component E), 2 mM CuSO4 was used. To
visualize EdU incorporation at 647nm, Alexa Fluor 594 picolyl azide (Component B)
was substituted with Alexa Fluor 647 Azide (ThermoFisher Scientific, cat# A10277) at
5µM final concentration.
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2.2.7: Measuring progenitor zone length, M phase and S phase indices
Progenitor zone length was measured by counting the number of rows from the
distal tip until either the onset of the first HIM-3 positive nucleus or the first crescent
shaped nucleus. Each nucleus was visualized by DAPI. M phase index was calculated
as percent of number of pH3 positive cells in the progenitor zone over the total number
of cells in the progenitor zone. S phase index was calculated as a percent of EdU
positive cells in the progenitor zone over the total number of cells in the progenitor
zone. The criterion used for distinguishing the progenitors from meiotic cells was the
absence of HIM-3.

2.2.8: Measuring the adjusted division index
Progenitor zone length was measured by counting the number of rows from the
distal tip until either the onset of the first HIM-3 positive nucleus or the first crescent
shaped nucleus. Each nucleus was visualized by DAPI. Germlines were stained with
pH3 to detect dividing cells The adjusted division index (ADI) was calculated as the
number of pH3 positive cells in the progenitor zone divided by the progenitor zone
length in cell diameters (# of pH3 / Cell Rows).

2.2.9: Larval germ cell counts
Larval germ cell counts were performed using whole mount visualization of
zuIs252[PGL-1::mRFP] and DAPI. Counts were performed at L1, early L2, early L3 and
early L4 in both wildtype and two gsk-3 alleles (tm2223 and nr2047).
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2.2.10: Allelic detection PCR
Single worms were picked into 5µL of worm lysis buffer in a 200µL PCR tube. The
sample was frozen at -80°C for at least 1 hour. A PCR machine was used to first lyse
the worm by heating the tube to 65°C for 60 minutes, followed by inactivation of
proteinase K at 95°C for 15 minutes, followed by a hold at 4°C. PCR was performed by
adding 9 uL of “master mix” to each tube: 6uL of 2X Apex PCR mix, 1uL of each primer
(10µM), and water for any remaining volume. PCR reaction was run for 35-40 cycles.
PCR bands were then resolved by running the reaction on a 1-2% agarose gel in TBE
with 2.5uL per 50mL of 10% (v/v) Ethidium Bromide. Gels were imaged on a Biorad
GelDoc™ XR+. The following primers were used for detecting specific alleles:

oxTi398 detection
TF001

GGTGGTTCGACAGTCAAGGT

TF003

ggaatagcgctgagacacag

TF004

ggactccgaatggattcatc

Detects 471bp PCR product in WT and 298bp in oxTi398

ddIs30[YFP::CDK-2] detection
TF010

aaaatgttcactgataagcacac

GFP676F

GATGGAAGCGTTCAACTAGCAGAC

Detects 275bp PCR product in ddIs30

gsk-3(nr2047) detection
gSeq Mid B1 GAACGGAGAAGCTGATACATG
nr2047 MuF CTACATGGCTGATAGCTTGG
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nr2047 MuB CCGGGAAATGGCTTGATCTA
Detects 350bp PCR product in WT and 530bp in nr2047.

atm-1(gk186) detection
atm-1(gk186) F

CAAAAAATTATCACATAATACG

atm-1(gk186) R

GGAAGCGTTCTTTTCGTCATCA

atm-1(gk186) Rint CTTCCAGTTGGCTGATGCATAC
Detects 450bp PCR product in WT and 200bp in delFRB

atl-1(tm853) detection
atl-1(tm853) F

TCGAGTTGGCTCAAAATGGGA

atl-1(tm853) R

ACTGGAAAGCAACGACCAGT

atl-1(tm853) Rint

CAGTTCCCAGACACGACTGA

Detects 675bp PCR product in WT and 310bp in delFRB

rsks-1(ok1255) detection
rsks-1(ok1255) F

GGAGATGCGGAAGCTATGCTC

rsks-1(ok1255) R

CACCAGCTCTCGACATAGACG

rsks-1(ok1255) Rint CCATATCCTCCCTTGCCAAGAAC
Detects 200bp PCR product in WT and 420bp in ok1255

let-363(viz27[del2196-2287ins5xG]) detection
let-363(delFRB) F

AGTTGAAGTGCGCATATGTAGAA

let-363(delFRB) R ACTATTGGAGCTGATGGATCGT
Detects 675bp PCR product in WT and 310bp in delFRB
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2.2.11: PLP mounting for GFP visualization
To assay the vizSi32[Intron cdk-2::NLS::GFP::tbb-2 3’UTR] reporter in the wt and
gsk-3(nr2047) backgrounds, the animals were dissected in the same dish 24hrs past
L4 in PBST and fixed for 3 min using 4% PLP (Hixson et al. 1981) with 4μg/ml DAPI.
After washing the fixed germlines three times with 1x PBST, germlines were mounted
on a 2% agarose pad and observed immediately. The pictures were taken on the same
slide with identical exposure and gain for the GFP channel.

2.2.12: Image acquisition and processing
For full germlines, each gonad was captured as a montage. The focal plane was
maintained throughout the experiment, and each image was captured with overlapping
cell boundaries at 40x or 63x objectives (Arur et al. 2009). For analysis of distal
regions, a z-stack was acquired through the entire distal region using sections 0.6 μm
thick. While analysis is performed on all sections, only the top planes were used for
figures. All epifluorescence images were taken on a Zeiss Axio Imager upright
microscope by using AxioVs40 V4.8.2.0 SP1 micro-imaging software and a Zeiss Axio
MRm camera. All confocal images were taken on a Zeiss LSM800 laser point scanning
confocal using Zen 2.5 (blue edition). The montages and images were then assembled
in Adobe Photoshop CS5.1 and processed identically.

2.2.13: Quantitative real-time PCR (qRT-PCR)
Total RNA was isolated from at least 100 dissected germlines using the miRNeasy
Mini Kit (Qiagen). cDNA was synthesized from 500 ng of total RNA using the iScript
cDNA Synthesis Kit (Bio-Rad Laboratories). cDNA was amplified for qRT-PCR using
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iTaq Universal SYBR Green Supermix (Bio-Rad Laboratories) according to the
manufacturer’s instructions. Amplified cDNA was monitored after each cycle and the
ΔCt was measured using the CFX96 Real time system (Bio-Rad Laboratories). The
relative expression rate was determined using the ΔCt method as described in the
manufacturer’s instructions (Bio-Rad Laboratories). Average expression of the
reference gene act-1 was used to control for template levels.

2.2.14: RNA interference (RNAi) analysis
RNAi was performed by feeding as described previously (Arur et al. 2009).The let363 RNAi clone was generated by amplification of an N-terminal fragment of let-363
cDNA (203bp-1149bp) from an in house N2 cDNA library with the following primers:
let-363_FP_Not1

ATGCGCGGCCGCaggctgctcgagaactcagcagatatgt

let-363_RP_Pst1

ATGCCTGCAGtattatctgacgaacacaatcgagtatcttc

Each primer contained a restriction enzyme cutting site for either Not1 or Pst1. The
amplicon was digested by Not1 and Pst1 to insert into the pPD129.36 vector RNAi
expression vector. dpl-1, efl-1, lin-35, pmk-1, pmk-2, kgb-1, jnk-1, wee-1.3, ifg-1 RNAi
clones were sequence verified from either the Vidal ORFeome Library, or Ahringer
RNAi library. RNAi clones were grown overnight on solid LB agar plates containing
100μg/ml of Ampicillin and 50μg/ml of Tetracyclin at 37°C. Single colonies were then
inoculated into LB liquid cultures containing 100μg/ml of Ampicillin and 50μg/ml of
Tetracyclin and grown to necessary densities as described previously (Arur et al.
2009). The cultures were then seeded onto the standard NGM agar plates
supplemented with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and containing
100μg/ml of Ampicillin and 50μg/ml of Tetracyclin. Fresh plates were incubated at room
temperature for at least 3 days to allow for bacterial lawn growth. For P0 RNAi, L4
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stage animals of the genotype listed were transferred to RNAi plates, and dissected for
analysis at the listed time point. For P0 hatch RNAi, L4 stages animals from the listed
genotype were allowed to lay progeny on the RNAi plates for 24 hours. Mothers were
then destroyed and the progeny was allowed to grow. L4s were then transferred to new
RNAi plates of the same type and incubated for the listed time. For F1 RNAi, L4 stages
of wildtype or gsk-3 heterozygous animals were allowed to lay progeny on the RNAi
plates for 24 hours, and transferred to a fresh RNAi plate every 24-hours for an
additional three days. Progeny which were laid after the first day were used. Wildtype
and gsk-3 homozygous F1 progeny from these plates were then synchronized at midL4 stage and dissected for analysis at 48 hours past mid-L4.

2.2.15: Western Blot analysis
Wildtype (N2), and vizIs27 L4 hermaphrodites were hand-picked (250 for each
lane), grown for 24 hours and then harvested for western analysis as previously
described (Arur et al. 2011; Arur et al. 2009). The extracts were resolved on 10% SDSPAGE, transferred to PVDF membrane, and probed with antibodies to GFP (made in
house, used at 1:500, (Lopez et al. 2013a)) and alpha tubulin (1:1000). Western blots
were developed using SuperSignal West Pico Chemiluminescent Substrate (Pierce,
Rockford, IL), on Kodak BioMax MS films.

2.2.16: Hairpin Chain Reaction based fluorescence in situ hybridization (FISH)
cdk-1 mRNA, cdk-2 mRNA, and pgl-1 mRNA FISH were performed using hairpin
chain reaction as described (Gao et al. 2017; Choi et al. 2016; Xuan and Hsing 2014)
except that the analysis in the present study was conducted on dissected germlines
that were fixed in 3% Paraformaldehyde, 0.25% glutaraldehyde solution at room
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temperature for 2 hours. The probes were obtained from Molecular Instruments. Inc
(Berkley, CA) and manufacturer’s instructions followed.

2.2.17: Starvation assays
Worms were grown on NGM plates with E. coli OP50 bacteria to 24 hours past
mid-L4, then washed 4 times with sterile M9T and transferred to unseeded plates. All
starvation was performed on 100mm agarose plates (2% agarose, 0.3% NaCl, 0.5%
cholesterol, 1mM CaCl2, 1mM MgSO4, 25mM KH2PO4 pH6) for the indicated times. If
re-feeding was required, worms were washed off NGM plates using M9T, and plated
onto seeded NGM plates.

2.2.18: Hydroxyurea treatment
300µL of 850M Hydroxyurea was spread onto a 10cm NGM plate seeded with
OP50 for a final concentration of 25mM. Plates were incubated overnight. Animals
were picked onto the hydroxyurea plate and incubated for 12 hours.

2.2.19: TEM microscopy
Samples were fixed with a solution containing 3% glutaraldehyde plus 2%
paraformaldehyde in 0.1 M cacodylate buffer, pH 7.3, then washed in 0.1 M sodium
cacodylate buffer and treated with 0.1% Millipore-filtered cacodylate buffered tannic
acid, postfixed with 1% buffered osmium, and stained en bloc with 1% Millipore-filtered
uranyl acetate. The samples were dehydrated in increasing concentrations of ethanol,
infiltrated, and embedded in LX-112 medium. The samples were polymerized in a 60 C
oven for approximately 3 days. Ultrathin sections were cut in a Leica Ultracut
microtome (Leica, Deerfield, IL), stained with uranyl acetate and lead citrate in a Leica
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EM Stainer, and examined in a JEM 1010 transmission electron microscope (JEOL,
USA, Inc., Peabody, MA) at an accelerating voltage of 80 kV. Digital images were
obtained using AMT Imaging System (Advanced Microscopy Techniques Corp,
Danvers, MA).
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Figure 13: Comparison of feeding and soaking EdU methods
Analysis of S phase index. (A) Dissected germline oriented with distal tip to the left.
Animal was soaked in EdU for 10min followed by dissection and staining for DAPI (top)
and EdU (bottom). Cells are numbered and labeled using the ImageJ macro. Scale bar:
20µm. (B) S phase index measured in a 30 minute feeding EdU pulse vs. in a 10
minute soaking EdU pulse.
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Figure 14: Soaking in higher concentrations of EdU does not affect background
Dissected germlines from wildtype animals after exposure to EdU by soaking.
Concentration of EdU is displayed for each panel. Distal tip is outlined with a dashed
line and oriented to the left. Stained with DAPI (white), EdU (green), pH3 (red), and
HIM-3 (blue).
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CHAPTER 3: gsk-3 TRANSCRIPTIONALLY REGULATES cdk-2 TO PROMOTE G1
AND S PHASE PROGRESSION TO PROMOTE GSC PROLIFERATION
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Chapter 3: gsk-3 transcriptionally regulates cdk-2 to promote G1-S phase of the
cell cycle and GSC proliferation

Some of the contents of this chapter are reproduced/adapted with permission from
“Furuta et al. 2018”. Permission is from Development
(http://www.biologists.com/development).

Full citation:
* Furuta, T., * H. J. Joo, * K. A. Trimmer, S. Y. Chen, and S. Arur. 2018. 'GSK-3
promotes S-phase entry and progression in C. elegans germline stem cells to maintain
tissue output', Development, 145, doi: 10.1242/dev.161042
* Equal contribution, alphabetically ordered

3.1: Introduction
Cells proliferate and regulate tissue development or turnover in response to
environmental and metabolic fluxes. Several key metabolic or environmental factors
and pathways have been identified (Chapter 1.3) that regulate proliferation. In this
chapter, I will focus on the role of gsk-3 in regulating cell proliferation of the germline
stem cells to maintain a pool of proliferating stem cells.
Gsk3β plays many roles in response to both environmental and cell-cell cues as
discussed previously (Chapter 1.3.4). Because Gsk3β is a kinase, it both regulates
downstream substrates for its function and is often regulated by environmental and
physiological inputs. In collaboration with two other members of the lab, we uncovered
a role for gsk-3 in regulating plasticity of the C. elegans GSCs in response to nutritional
and metabolite changes.
67

GSK-3 was identified as a substrate of MPK-1 signaling during germline
development (Arur et al., 2009). To understand its function in germline development,
we acquired two deletion alleles (nr2047 and tm2223). The nr2047 allele carries a
deletion with breakpoints located in introns 2 and 3, completely removing the 3 rd exon;
tm2223 allele carries a deletion removing a portion of exon 3. Exon 3 houses the
kinase domain, thus both of these alleles remove a similar portion of the kinase domain
and result in frameshifts leading to truncated proteins (Figure 15). Because the two
deletion alleles remove a significant portion of the kinase domain, we hypothesize that
these are strong loss of function alleles.
Each of the two gsk-3 alleles results in viable adult animals when segregated from
a heterozygous parent. The adult homozygous animals are sterile, and the few
embryos laid born die early due to polarity defects (Schlesinger et al. 1999). While
assaying the function of gsk-3 in relation to the let-60/mpk-1 signaling pathway we
noticed a dramatic phenotype in the adult germlines from homozygous gsk-3 alleles:
the pool of GSCs in the adult germline was dramatically reduced. Thus, we set out to
determine the role of gsk-3 in regulating GSC function.
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Figure 15: gsk-3 mutant allele structure
(A) Stick diagram of the gsk-3 gene with the exons and kinase domain labeled.
Deletion break points for the nr2047 and tm2223 alleles are displayed. (B) Stick
diagram of the gsk-3 mRNA with exons and kinase domain labeled. Arrows with “A”
label the active site residues which transfer a phosphate to the substrate (K65, E77,
D161, and D180). Arrows with “B” label residues which bind to primed substrates (R76,
R160, K185). The arrow with “T” labels the phosphorylation site on the t-loop which
opens up the catalytic site.
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3.2: gsk-3 Regulates GSC Proliferation in a Germline Autonomous and
Kinase-dependent Manner during Larval and Adult Development
The adult wildtype C. elegans germline harbors a population of ~200-250 GSCs
maintained by Notch signaling in the progenitor zone (Berry, Westlund, and Schedl
1997; Fox and Schedl 2015; Fox et al. 2011) (Figure 3). As the GSCs move away from
the distal tip cell (DTC) (Figure 3) they differentiate and enter meiosis at ~20-22 cell
diameters, in both larval (specifically the last stage of larval development, the larval
stage 4 or L4) and adult germlines. However, in the gsk-3 mutant alleles (both nr2047
and tm2333) the progenitor region contained only ~90 GSCs, which is significantly
fewer than the ~200-250 found in wildtype (p<0.001) (Figure 16A, 16B). To determine
whether the lower number of GSCs in the adult germline was due to a defect in the
early expansion of the GSC population, or lack of maintenance of an established adult
GSC population, we analyzed larval developing germlines. The number of GSCs in
gsk-3 mutants was significantly reduced as early as L3, with 14 germ cells compared to
the wildtype ~34 germ cells (Table T2). These data suggest that the defect in gsk-3
mutant GSCs may occur at the stage of stem cell expansion, which occurs during larval
development. By L4 stage and into adulthood, the gsk-3 mutant reached and
maintained a population of ~90 GSCs throughout adulthood (Figure 16D). Together,
these data suggest that the GSCs fail to expand in number in the gsk-3 mutants during
early larval stages, and the number established during larval development is then
maintained into adulthood.
During larval development, several environmental and pheromone pathways
regulate germline development, whose signals are relayed to the germ cells regulated
through the sensory neurons (Reviewed in Korta and Hubbard 2010). To test whether
the GSC defect was due to a germline autonomous function of gsk-3, we generated
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germline-specific GFP::GSK-3 transgenes driven by either a pie-1 or a mex-5 germline
specific promoter (Merritt et al. 2008) and regulated by a tbb-1 3’ UTR for even
expression. The transgenes were each integrated at a single site in the C. elegans
genome, and both constructs drive wildtype GSK-3 in the germline (Figure 17A).
Expression of a germline driven GFP::GSK-3 at a single copy knock-in localizes to
nuclear and cytoplasmic compartments in the progenitor zone (Figure 17B). This
transgene is expressed only in germ cells and so did not rescue any of the somatic
defects of the gsk-3 mutants, such as small size and uncoordinated movements, as
would be expected from the restricted promoter activity (Gleason, Szyleyko, and
Eisenmann 2006; Maduro et al. 2001). Expression of the transgene completely rescued
the GSC defect in gsk-3 mutants (Figure 17C-E), suggesting that gsk-3 functions
autonomously in the germline to regulate the expansion of the GSC population.
To determine whether the role of gsk-3 in regulating GSC expansion was
dependent on its kinase activity, we mutated the kinase core residues (K65, E77, D161
and D180) to alanine to generate a kinase dead GSK-3 transgene (Doble and
Woodgett 2003). The resulting transgene, GFP::GSK-3 (K65A, E77A, D161A and
D180A) which we refer to as GFP::GSK-3 kinase-dead (GFP::GSK-3 KD), is driven by
the same germline specific promoter used to express the wildtype GFP::GSK-3 above.
While GFP::GSK-3 and GFP::GSK-3 KD are expressed at similar levels and in similar
cellular compartments in the GSCs (Figure 17B, 18A), GSK-3 KD did not rescue the
GSC defects (Figure 18B). These data together demonstrate that gsk-3 functions
germline-autonomously in a kinase-dependent manner to regulate GSC expansion.
To determine whether the defects in GSCs were indeed due to lack of stem cell
expansion vs increased differentiation of GSC population which would artificially mimic
a GSC expansion defect, we tested whether gsk-3 mutant GSCs have increased
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differentiation or loss of self-renewal. The length of the progenitor zone can be used to
determine the balance of self-renewal with differentiation as discussed previously
(Chapter 1.1.5). If the length is 20-22 cell diameters, there is likely no change in the
rate of differentiation, however, if the length is increased, it would suggest increased
self-renewal at the expense of differentiation. The length of the progenitor zone was
maintained at 20-22 cell diameters from the DTC in both wildtype and gsk-3 mutants,
suggesting that the defect in GSC population in gsk-3 mutants is not due to altered
differentiation (Figure 16C, 16E, 17C, 17E).
We next investigated whether the gsk-3 mutant GSCs remained responsive to
Notch signaling for self-renewal. To determine this, we assayed GSCs in conditions
with decreased or increased Notch receptor (glp-1) activity by utilizing the glp-1
temperature-sensitive alleles bn18ts (reduction of function) and ar202gf (gain of
function). Both of these alleles behave similarly to wildtype at the permissive
temperature of 15°C, but at the restrictive temperature of 25°C, GSCs will exclusively
differentiate (bn18ts) or self-renew (ar202gf) (Figure 19) (Dorsett, Westlund, and
Schedl 2009; Kodoyianni, Maine, and Kimble 1992; Pepper, Killian, and Hubbard 2003;
Berry, Westlund, and Schedl 1997). The animals were shifted to the restrictive
temperature as embryos to assay their respective phenotypes. The wildtype or gsk3(nr2047) mutants do not display any temperature-sensitive behavior and at all
temperatures the GSCs are maintained at numbers similar to those found previously
(Figure 19A, B). When glp-1(bn18ts) and gsk-3(nr2047);glp-1(bn18ts) mutants are
assayed at the permissive temperature, germlines produce both GSCs and meiotic
cells (Figure 19C). At the restrictive temperature, however, both the glp-1(bn18ts) and
the gsk-3(nr2047);glp-1(bn18ts) double mutant results in loss of the GSC population
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with only sperm produced in 100% of adult germlines (Figure 19D). These data suggest
that the gsk-3 mutant GSCs require glp-1 activity to self-renew.
Next, to determine whether the gsk-3 mutant GSCs self-renew in response to
increased Notch signaling, we investigated the glp-1(ar202gf) gain of function allele. At
the permissive temperature of 15oC, glp-1(ar202gf) mutant and the
gsk-3(nr2047);glp-1(ar202gf) mutants maintain GSCs and meiotic cells in adults(Figure
19E). In contrast, shifting glp-1(ar202gf) or gsk-3(nr2047);glp-1(ar202gf) mutants
(again as embryos) to the restrictive temperature of 25°C results in tumorous germlines
as the GSCs self-renew at the expense of differentiation (Figure 19F). The
gsk-3(nr2047);glp-1(ar202gf) mutant tumors, however, appear “skinnier” relative to
glp-1(ar202gf) single mutant tumor (Figure 19E, 19F). This indicates that glp-1 activity
is sufficient to drive self-renewal at the expense of differentiation in gsk-3 mutants.
Together, these data demonstrate that responsiveness to glp-1 signaling was not
affected in gsk-3 mutant GSCs.
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Figure 16: gsk-3 mutants maintain fewer GSCs
(A) Dissected germlines from adult (24 hours past L4) wildtype (top) and
gsk-3(tm2223) (middle), and gsk-3(nr2047) labeled with REC-8 (green, GSCs) and
DAPI (white, DNA). (B) Graph displaying the number of GSCs in wildtype,
gsk-3(tm2223), and gsk-3(nr2047) at 24 hours past L4. (C) Graph displaying the
number of cell diameters between the distal tip cell and the transition zone in wildtype,
gsk-3(tm2223), and gsk-3(nr2047) at 24 hours past L4. (D) Graph displaying the total
number of GSCs in wildtype and gsk-3(nr2047) mutant animals on a time course from
mid-L4 until 60 hours after mid-L4. (E) Graph displaying the number of cell diameters
between the distal tip cell and the transition zone in wildtype and gsk-3(nr2047) mutant
animals on a time course from mid-L4 until 60 hours after mid-L4. In B and C, error
bars indicate mean ± SD. **P<0.001, and n.s., not significant.
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Table 2: gsk-3 promotes developmental germ cell expansion
Whole mount germ cell counts at larval stages in wildtype and two gsk-3 mutant
alleles (nr2047 and tm2223) utilizing a PGL-1::mCherry transgene to identify germ
cells. gsk-3 mutants (nr2047 and tm2223) contain fewer germ cells than wildtype
throughout development. Counts are presented as mean ± SD.
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Figure 17: The gsk-3 mutant GSC defect is germline autonomous
(A, B) Transgenic expression of a germline driven GFP::GSK-3(WT) AUM2026
(vizIs27[Ppie-1::GFP::GSK-3]) is detected by western blot (A) and immunofluorescence
(B). (A) Western blot analysis was performed using an anti-GFP antibody on WT and
gsk-3 (nr2047);vizIs27[Ppie-1::GFP::GSK-3(WT)] whole worm extracts. A 75kDa band
corresponding to GFP::GSK-3 was detected in the gsk-3(nr2047);[Ppie-1::GFP::GSK3(WT)] worms, but not in wildtype (N2). anti-Tubulin was used as an internal control.
(B) Dissected germline from adult (24 hours past L4) GFP::GSK-3(WT) AUM2026
(vizIs27[Ppie-1::GFP::GSK-3]) labeled for GFP (Shah et al.). (C) Dissected germlines
from adult (24 hours past L4) wildtype (top), gsk-3(nr2047) (middle), and gsk3(nr2047);vizIs27[Ppie-1::GFP::GSK-3(WT)] (bottom) labeled with HIM-3 (green,
GSCs) and DAPI (white, DNA). (D) Graph displaying the number of GSCs in wildtype,
gsk-3(nr2047), and gsk-3(nr2047);vizIs27[Ppie-1::GFP::GSK-3(WT)]. (E) Graph
displaying the length of the progenitor zone in wildtype, gsk-3(nr2047), and gsk3(nr2047);vizIs27[Ppie-1::GFP::GSK-3(WT)]. All images are oriented with distal tip
(asterisk) to the left and the end of the progenitor zone marked by a solid line. Scale
bar: 40µm.
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Figure 18: The gsk-3 mutant GSC defect is kinase dependent
(A) Expression of a germline driven kinase dead GFP::GSK-3 transgene
(vizSi20[Pmex-5::GFP::GSK-3(KD)]) at a single copy knock-in localizes to nuclear and
cytoplasmic compartments in the progenitor zone. DAPI (white) labels the DNA, while
GFP (green) labels transgene expression. (B) Wildtype GFP::GSK-3 (vizSi44) rescues
the GSC number (B, middle) while the kinase dead GSP::GSK-3 does not (B, bottom).
DAPI (white) labels the DNA, while HIM-3 (green) labels meiotic cells. Images are
oriented with distal tip (asterisk) to the left and the end of the progenitor zone marked
by a solid line. Scale bars: 40µm.
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Figure 19: Self-renewal through Notch Signaling is unaffected in gsk-3 mutants
Dissected germlines from adult (24 hours past L4) animals of indicated genotypes
labeled with DAPI (white, DNA) and HIM-3 (green, meiotic cells) are oriented from left
(progenitor zone) to right (oocytes). The left panel shows micrographs of germlines
from animals maintained at permissive temperature of 15°C (A, C, E); the right panel
displays adult germlines from animals shifted to the restrictive temperature of 25°C as
embryos (B, D, F). (A, B) N2s and gsk-3(nr2047) mutants are displayed. (C, D) glp1(bn18ts) and gsk-3(nr2047);glp-1(bn18ts) mutants are displayed. (E, F) glp-1(ar202gf)
and gsk-3(nr2047);glp-1(ar202gf) mutants are displayed. Each experiment was
performed three times, and each time an N of 30 germlines was assayed. HIM-3
staining is outlined with a dashed line. All images are oriented with distal tip (asterisk)
to the left and the end of the progenitor zone marked by a solid line. Scale bars: 20µm
(D), and 50µm (A-C,E,F).
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3.3: gsk-3 Mutant GSCs Enter and Progress through S Phase Inefficiently
We had identified the defect in early larval development in gsk-3 mutants as a
failure of GSCs to expand. During early larval development, the GSCs are undergoing
a rapid cell cycle to expand into the niche. As neither differentiation nor self-renewal
was affected in gsk-3 mutant GSCs, we investigated the cell cycle parameters of gsk-3
GSCs. Cell cycle parameters were investigated via immunofluorescence analysis on
dissected germlines using phospho-histone H3 (pH3) labeling to mark M phase and
EdU incorporation to mark S phase. The gsk-3 mutant GSCs labeled with pH3,
indicating that they entered a productive M phase (Figure 20A, B). Mitotic index, which
is the number of pH3 positive cells over the total number of cells, is used to measure
the frequency of germ cell divisions. There was no significant difference in mitotic index
found between wildtype and gsk-3 mutant GSCs (Figure 20C). In contrast, S phase
was markedly altered in gsk-3 mutant GSCs. In wildtype animals, 100% of the
germlines incorporated EdU with an S phase index (assayed by number of GSCs that
are EdU positive divided by the total number of GSCs) of ~ 55% in adults, and ~67% in
L4’s (Figure 20A, 20B, 20D) on a 15-minute EdU pulse. In gsk-3 mutants however,
~90% of gsk-3 mutant germlines failed to incorporate detectable EdU both as adults
(Figure 20A) and L4s (Figure 20B), and of those germlines that did, the S phase index
was only ~6% (Figure 20D). These data suggest that cell cycle progression is affected
in GSCs with a defect in S phase.
These results could potentially be due to the fact that the gsk-3 mutant GSCs has a
longer S phase of the cell cycle, or were more synchronous relative to wildtype. To
determine whether the lack of EdU incorporation was due to increased length of each
cell cycle phase we fed the worms the EdU bacteria for longer times of 1, 3, and 5
hours. Wildtype GSCs incorporate EdU label robustly after 1 hour of feeding with EdU
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bacteria (Figure 21). By 5 hours of continuous labeling, ~90% of the cells in the
progenitor zone are labeled with EdU (Figure 21). Loss of gsk-3, however, results in
extremely poor EdU incorporation even after 1, 3, or 5 hours of continuous feeding,
suggesting a severe defect in S phase entry or replication rate (Figure 21). It is also
likely, however, that the lack of EdU incorporation could be a reflection of low EdU
accessibility itself due to low EdU bacteria uptake, which occurs when mutants cannot
feed well, or decreased bacterial digestion.
To test whether the lack of EdU incorporation was a reflection of S phase defects
or defects in feeding we assayed mutants that have a low pharyngeal pumping rate and
thus feed at a lower rate, eat-2 mutants. The rate of pharyngeal pumping, used as a
measure of feeding, in wildtype animals is ~280 pumps per minute while eat-2 mutants
eat at a rate of ~80 pumps per minute (Figure 22A). Feeding EdU bacteria to eat-2
mutants for 30 minutes resulted in an EdU intensity similar to wildtype (Figure 22B). In
contrast, gsk-3 mutants, which eat at an intermediate rate of ~200 pumps per minute,
had weak EdU intensity (Figure 22). Since the pumping rate of eat-2 mutants was lower
than gsk-3 mutants or wildtype, and they incorporated EdU efficiently, low bacterial
intake was likely not the cause of the EdU incorporation defect.
We next investigated whether the lack of EdU incorporation in gsk-3 mutant GSCs
was due to a decreased rate of bacterial digestion in gsk-3 mutants resulting in rapid
degradation of the EdU label. To test this, I developed a method to incorporate EdU
without using bacteria. Instead of indirect EdU exposure, I soaked the worms in a
200µM solution of EdU for 10 minutes and dissected immediately after EdU incubation.
Upon 10 minutes of EdU soaking, wildtype GSCs incorporated EdU efficiently and
100% of the germlines were labeled at ~67% S phase index (Figure 23). However, EdU
incorporation was still very low in the gsk-3 mutant GSCs (Figure 23). This data
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demonstrates that direct EdU exposure is insufficient to recover EdU incorporation,
suggesting that the EdU incorporation defect is not due to the feeding method of EdU
incorporation. As a majority of gsk-3 mutant germlines failed to incorporate detectable
EdU, it is likely that GSCs in gsk-3 mutants incorporate fewer molecules of EdU per
GSC compared to wildtype GSCs, suggesting a defect in S phase progression. In
addition, the lower S phase index in those gsk-3 mutants with visible incorporation hints
at an S phase entry defect. Therefore, we next tested whether there were any changes
to S phase entry in gsk-3 mutants.
To test whether the GSCs in gsk-3 mutant animals lengthened G1 due to inefficient
S phase entry, we assayed for subcellular GFP::MCM-3 (gtIs64) localization
(Sonneville et al. 2012). Mcm3 is a component of the DNA licensing complex that
accumulates in the nucleus in early-mid G1 in vertebrate cultured cells, and is
phosphorylated by Cdk2 and re-localized to the cytoplasm in late G1 or early S to
prevent re-replication (Li et al. 2011); thus, nuclear localization of Mcm3 indicates
nuclei in G1 (Blow 1993; Chong and Blow 1996). To test whether GFP::MCM-3 had
cellular localization dynamics in C. elegans GSCs similar to vertebrate cultured cells,
we depleted cdk-2 in GFP::MCM-3 animals and determined its localization. As
previously described (Fox et al. 2011), depletion of cdk-2 results in a G1 cell cycle
arrest wherein all cells are negative for EdU (S phase) and pH3 (M phase) (Figure
24A). GFP::MCM-3 localizes to GSC nuclei upon depletion of cdk-2 (Figure 24B)
indicating that GFP::MCM-3 changed cellular localization in GSCs in response to the
loss of cdk-2, and by extension G1 arrest, as would be predicted from the vertebrate
systems. Additionally, GFP::MCM-3 was excluded from meiotic germ cell nuclei in
animals treated with cdk-2 RNAi (Figure 24B), indicating that the reporter changed
localization based on the type of cell cycle. Wildtype germlines displayed cytoplasmic
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GFP::MCM-3 in both GSCs and meiotic cells (Figure 24B) which is consistent with
previous reports that the GSCs have a very short (seemingly absent) G1. In contrast,
GFP::MCM-3 was nuclear in gsk-3 mutant GSCs (Figure 24B) in 56% + 3% of the cells
and was cytoplasmic when the cells entered meiosis (Figure 24B). Taken together,
these data suggest that gsk-3 mutant GSCs are in G1 for a longer period of time
relative to wildtype GSCs due to inefficient entry into S phase in addition to the
inefficient S phase progression found earlier. Furthermore, increased nuclear
GFP::MCM-3 also suggests that CDK-2 activity may be affected in gsk-3 mutants,
which could result in both of these observed defects.
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Figure 20: gsk-3 mutant GSCs cycle but do not incorporate EdU
Dissected germlines from wildtype and gsk-3 mutants at from adult (24 hours past
mid-L4) (A) and mid-L4 (B). The progenitor region is oriented with the DTC (*) on the
left and are labeled for Nuclei (DAPI, white) pH3 (red) and EdU (green). Pictures were
taken at the same gain and exposure, and processed in the same tube to compare the
level of EdU incorporation. (C) Mitotic index of wildtype and gsk-3 mutant GSCs over a
time course from mid-L4 to 60 hours past mid-L4 (B) S phase index of those germlines
in which EdU labeling was detected from wildtype and gsk-3 mutant GSCs. Each
experiment in (A, B) was performed eight times, and 30-40 germlines were assayed
each time. Error bars represent the standard deviation obtained from at least 30
germlines each from three independent experiments. End of each progenitor zone is
labeled with a solid line. Scale bar: 40µm.
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Figure 21: gsk-3 mutant GSCs do not incorporate EdU after long pulses
Wildtype and gsk-3(nr2047) mutant worms were fed with EdU bacteria for 1 hour, 3
hours or 5 hours, and processed for detection of EdU incorporation. DAPI (white) labels
DNA, and EdU (green) labels actively replicating S phase cells. Distal tip of each
germline is labeled with an asterisk. Proximal end of each progenitor zone is labeled
with a solid line. Scale bar: 40μm.
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Figure 22: EdU incorporation is not dependent on the rate of bacterial eating
All microscopy images in this figure represent the progenitor region of a dissected
hermaphroditic adult germline with distal tip on the left of the photograph. DAPI marks
DNA, and EdU labels actively replicating S phase cells. (A) eat-2 mutants are defective
in pharyngeal pumping, and thus a model for dietary restriction. gsk-3 mutants display
pharyngeal pumping rate less than wildtype animals, but significantly higher than eat-2
mutant. Values indicate the mean ± S.D. *P<0.05, **P<0.001. n= number of animals
counted. (B) Dissected germlines from the genotypes listed. DAPI (white) labels DNA,
and EdU (green) labels actively replicating S phase cells. Distal tip of each germline is
labeled with an asterisk. Proximal end of each progenitor zone is labeled with a solid
line. Scale bar: 40 μm.
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Figure 23: EdU soaking does not rescue EdU incorporation in gsk-3 mutants
Dissected germlines from wildtype and gsk-3 mutants after soaking in 200μM EdU
for 15 minutes. DAPI (white) labels DNA, and EdU (green) labels actively replicating S
phase cells. Distal tip of each germline is labeled with an asterisk. Proximal end of each
progenitor zone is labeled with a solid line. Scale bar: 40μm.
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Figure 24: gsk-3 mutant GSCs retain nuclear MCM-3
(A) Dissected germline from a cdk-2 (RNAi) animal with distal end (asterisk)
pointing left. DNA in white (DAPI), EdU in red (S phase), and pH3 in yellow (M phase).
EdU and pH3 labeled channels are outlined with a dashed line. (B) Dissected germline
from wildtype, cdk-2 (RNAi), and a gsk-3(nr2047) mutant with distal end (asterisk)
pointing left. DNA in white (DAPI) and MCM-3 (GFP) in green. The end of the
progenitor zone is labeled with a white line. Scale bar: 40µm.
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3.4: gsk-3 Promotes cdk-2 Transcription to Regulate a Rapid G1/S Transition
To assess whether there were any changes in CDK-2 activity, we assayed
processes and proteins which can inhibit its activity such as DNA licensing and CDK
inhibitor proteins. DNA licensing is required for DNA replication as it provides starting
points for the DNA polymerases. The act of DNA licensing activates Cdk2 in
mammalian cell culture, preventing progress from G1 to S phase in its absence (Nevis,
Cordeiro-Stone, and Cook 2009). Therefore, if C. elegans GSCs are regulated
similarly, loss of a DNA licensing factor may result in difficulty with entry and
progression through the S phase. To test this hypothesis, we reduced the expression of
five DNA licensing factors (Table 3) by RNAi in both wildtype and gsk-3 mutant
germlines and assayed for evidence of an arrest by cellular “fried egg” morphology
(DAPI), characteristic of cell cycle arrest in GSCs. While GSCs in wildtype animals with
control RNAi (GFP) appeared normal and displayed no signs of cell cycle arrest, GSCs
in wildtype animals upon RNAi of components which recognize DNA licensing sites
presented with DNA fragmentation and re-replication defects (Figure 25A). Surprisingly,
however, GSCs from gsk-3 mutants upon RNAi of the licensing complex components
did not result in fragmentation or re-replication defects. If gsk-3 was down-regulating
one of these factors, RNAi of that factor should appear similar to gsk-3 mutants.
However, since the gsk-3 mutants did not show a similar phenotype, and were able to
rescue the DNA fragmentation and re-replication phenotypes of DNA licensing factor
reduction, it is unlikely that gsk-3 mutants reduce DNA licensing factors.
To next determine whether CDK inhibitors and negative regulators were
responsible for the gsk-3 mutant GSC phenotypes, we investigated two negative
regulators of cdk-2, pRb (lin-35) and p57 (cki-2). lin-35 is a negative regulator of midG1 phase of the somatic cell cycles in C. elegans (Boxem and van den Heuvel 2001)
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and negatively regulates transcription of Cdk2 through inhibition of E2Fs in mammalian
cell culture (DeGregori et al. 1997). cki-2 is thought to negatively regulate late G1
phase in proliferative cells of the soma (Buck, Chiu, and Saito 2009; Kalchhauser et al.
2011) and negatively regulates Cdk2-Cyclin E activity in mammalian cell culture (Lee,
Reynisdottir, and Massague 1995). If GSCs are regulated similarly to mammals and C.
elegans somatic cells, increased expression of either inhibitor should decrease cdk-2
activity. To test the hypothesis that lin-35 or cki-2 affects the progression of G1 into S
phase, we depleted lin-35 via RNAi and analyzed gsk-3;cki-2 double mutant germlines.
Neither loss of lin-35 nor loss of cki-2 rescued the gsk-3 mutant GSC phenotype,
although there was a slight decrease in the progenitor region length of wildtype
germline upon of loss of cki-2 (Figure 26). This suggests that the gsk-3 mutant GSC
phenotype is not due to increased expression of lin-35 or cki-2.
Since we did not observe any altered expression of cdk-2 regulators that may
affect gsk-3 GSCs, we assayed expression of the cdk-2 and cye-1 themselves. cdk-2
and cye-1 are expressed in all wildtype GSCs and their loss results in a cell cycle arrest
in all of the GSCs suggesting that CDK-2 and CYE-1 are active in all of the GSCs,
irrespective of the phase of the cell cycle (Fox et al. 2011) (Figure 27, 28). Thus, to
determine whether CDK-2 function was reduced in gsk-3 mutant germlines and thus
responsible for the GSC defects, we assayed for CYE-1 and CDK-2 expression.
We observed that CYE-1 was still expressed in gsk-3 mutant germlines albeit at a
slightly lower in gsk-3 mutant germlines (Figure 27). This suggested that CYE-1 may
not be regulated by gsk-3, or responsible for the gsk-3 GSC phenotype. Since no CDK2 antibody exists, we obtained a transgenic YFP::CDK-2 (Cowan and Hyman 2006)
driven by the germline-specific pie-1 promoter and expressed it in the gsk-3 mutant
background to assess its localization. Surprisingly, the transgenic expression of
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YFP::CDK-2 in gsk-3 mutant background rescued the gsk-3 GSC numbers (Figure
28A-E) and S phase onset and progression (Figure 28A-D, 28F). Additionally, CDK-2 is
expressed throughout the GSCs in both wildtype and gsk-3 mutant cells in this context
(Figure 28G, 28H). Because pie-1 driven YFP::CDK-2 rescued the gsk-3 mutant GSC
defects and localized to the gsk-3 mutant GSCs in a manner similar to wildtype, it
suggested that the defects in gsk-3 mutants are driven by decreased CDK-2 function
and that the relevant regulation of CDK-2 via GSK-3 was not through post-translational
mechanisms, such as regulating CDK-2 protein degradation or activity through
phosphorylation. Together, these data demonstrate that gsk-3 mutant GSCs enter and
progress through S phase slowly due to lower CDK-2 accumulation, likely at the
transcriptional level.
To determine whether GSK-3 regulates CDK-2 levels transcriptionally in the GSCs,
we assayed for CDK-2 mRNA in dissected germlines from gsk-3 and wildtype animals,
using qRT-PCR. CDK-2 mRNA levels were lower by 10-fold in gsk-3 mutant germlines
compared to wildtype (Figure 29A), and were restored in gsk-3 mutant animals carrying
the transgenic YFP::CDK-2 (Figure 29A). To determine whether the lower transcript
level of CDK-2 in gsk-3 mutant germlines was specific to the GSC population, we
performed single molecule hairpin chain reaction FISH (Shah et al. 2016) with CDK-2
mRNA probes in wildtype and gsk-3 mutant germlines. CDK-2 mRNA accumulates
throughout the progenitor zone, predominantly in the cytoplasm, and is specific to cdk-2
(Figure 29B, 29D). However, in gsk-3 mutant germlines cdk-2 mRNA levels are much
lower relative to wildtype germlines (Figure 29A, 29C). These data demonstrate that
GSK-3 promotes cdk-2 mRNA transcription in wildtype GSCs and reduction of CDK-2
expression in gsk-3 mutants leads to defects in S phase entry and progression.
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To directly assess whether gsk-3 regulates the transcription of cdk-2, we designed
a transcriptional reporter for cdk-2. However, a perusal of the cdk-2 gene structure on
Wormbase (ver WS258), revealed that intron 1, rather than the promoter annotated by
Wormbase (ver WS258), contained multiple transcription factor and RNA polymerase II
binding sites as well as SL1 and SL2 splice sites (Wormbase WS258) (Figure 30).
These observations suggested that intron 1, rather than the promoter, may drive cdk-2
expression. Thus, we generated two distinct transgenes: one with the Wormbase
predicted 2Kb promoter driving GFP (cdk-2[Pr]::GFP), and one containing the intron 1
driving GFP (cdk-2[In1]::GFP) (Figure 31A, 31B). As hypothesized, we observed that
cdk-2[Pr]::GFP did not express in the germline, suggesting that the predicted promoter
does not drive cdk-2 expression (vizSi34, data not shown, Wormbase WS258). Instead,
cdk-2[In1]::GFP was expressed throughout the germline (Figure 31C), suggesting that
intron 1 drives cdk-2 expression in the germline. In comparison to wildtype, expression
of cdk-2[In1]::GFP in gsk-3 mutants resulted in lower GFP accumulation of the reporter
in the progenitor zone, but not in oocytes (Figure 13C). Taken together, these data
demonstrate that gsk-3 regulates cdk-2 transcription in the GSCs.
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Table T3: DNA licensing factor homologs in C. elegans
Human DNA licensing factors are listed along with their C. elegans homologs and
a sequence identifier. Highlighted sequences were tested by RNAi.
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Figure 25: DNA licensing factors do not contribute to gsk-3 mutant GSC defects
All microscopy images in this figure display the progenitor region of a dissected
germline after control RNAi (gfp) or RNAi of 5 members of the origin recognition and
licensing complex in wildtype (A) and gsk-3 mutants (B). Distal tip of the germline
(asterisk) is on the left of the photograph. DAPI (white) enables the visualization of
DNA, while HIM-3 (Shah et al.) enables visualization of meiotic cells.
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Figure 26: cdk-2 inhibitors do not contribute to the gsk-3 mutant GSC defects
(A, B) Progenitor regions of a dissected germline after control RNAi and RNAi of
cdk-2 and lin-35 in wildtype (A) and gsk-3 mutants (B). (C, D) Progenitor regions of a
dissected germline from cki-2(ok2105) single and gsk-3(nr2047);cki-2(ok2105) double
mutants. Distal tip of the germline (asterisk) is on the left of the photograph. DAPI
(white) enables the visualization of DNA, while HIM-3 (Shah et al.) enables
visualization of meiotic cells. Scale bar: 40µm
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Figure 27: CYE-1 protein is expressed in gsk-3 mutant GSCs
Dissected germlines from wildtype and gsk-3(nr2047) mutant animals, oriented
with distal end (*) to the left. Anti-cye-1 antibody labels Cyclin E in all the GSCs evenly
in both wildtype and gsk-3 mutant germlines, and is specific to cye-1 RNAi. End of
progenitor zone is labeled with a white line. Scale bar: 40µm.
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Figure 28: CDK-2 overexpression rescues the gsk-3 mutant GSC defect
Dissected germlines displaying the progenitor zone oriented with the DTC to the
left in all photographs in this figure. (A-D) Transgenic expression of YFP::CDK-2
(ddIs30, via Ppie-1 promoter) in gsk-3 mutant germlines results in EdU incorporation
upon a 10 minute EdU pulse (D), gsk-3 single mutants incorporate very low or no EdU
with the same treatment (B). (E-F) pie-1 driven YFP::CDK-2 rescues the S phase index
(E) and the total number of GSCs of gsk-3 mutant germlines (F). (G-H) YFP::CDK-2 is
expressed uniformly in all of the GSCs in wildtype and gsk-3 mutants. (A-H) the
experiments were performed four times, each time 30-35 germlines analyzed. End of
each progenitor zone is labeled with a solid line. Scale bar: 40µm.
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Figure 29: cdk-2 mRNA is downregulated in gsk-3 mutant GSCs
(A) qRT-PCR demonstrates significantly lower levels of cdk-2 mRNA in gsk-3 mutant
germlines relative to wildtype. YFP::CDK-2 has higher cdk-2 mRNA compared to
wildtype, revealing over-expression of CDK-2 in the transgene. (B-D) cdk-2 FISH
analysis on dissected germlines shows cytoplasmic expression of cdk-2 in wildtype (B)
that is absent in cdk-2 depleted germlines (D) and low in gsk-3 mutant germlines (C).
Panel A the experiment was performed three times and each time 100 germlines were
dissected and assayed by qRT-PCR. (B-D) the experiment was performed three times,
each time 12-15 germlines were assayed. All experiments were performed on adult
animals, at 24 hours past L4 stage of development. End of each progenitor zone is
labeled with a solid line. Scale bar: 40µm.
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Figure 30: Intron 1 of cdk-2 is the promoter (WS258)
Screen shot of Wormbase Ver. WS258 depicting the binding of various
transcription factors as well as DNA polymerase II via Chip analysis to the “intron 1” of
cdk-2 along with predicted SL1 and SL2 trans-splicing sites. Regions highlighted in
yellow are predicted binding sites. Transcription factors which did not bind to either the
promoter or the intron were removed from the figure. CHIPs which did not show binding
of DNA polymerase II to either the promoter or the intron were removed from the figure.
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Figure 31: gsk-3 promotes cdk-2 transcription which is driven by intron 1
(A) Gene structure of cdk-2 on Wormbase Ver WS258. (B) Differential interference
contrast (DIC) and GFP live image depicting the expression of the transcriptional
reporter driven by Intron 1 of cdk-2 in the germline and embryos. Dashed line marks
outline of distal germline. (C-D) Dissected germlines for adult (24 hours past L4)
wildtype and gsk-3 mutants carrying the cdk-2 transcriptional reporter driven by Intron 1
reporter, mounted in PLP media on the same slide, reveal expression of the cdk-2
transcriptional reporter in the progenitor zone (C) of wildtype but not gsk-3 mutant (D).
End of each progenitor zone is labeled with a solid line. Scale bars: 50µm.
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3.5: DPL-1 Mediates GSK-3-dependent Regulation of CDK-2 Transcription and S
Phase Progression
To determine the factors that regulate cdk-2 transcription downstream to GSK-3,
we perused the ChIP data for the cdk-2 intron 1 using Wormbase, and identified
several transcription factors that bind to it, most notably, efl-1 and dpl-1, homologs of
the E2F transcription factor family and the Dp1 transcription factor (Chapter 1.2.2,
Figure 32), which promote S phase entry in vertebrate systems (Almasan et al. 1995;
Muller et al. 1997). Because loss of efl-1 or dpl-1 individually does not inhibit S phase in
C. elegans (Ceol and Horvitz 2001; Chi and Reinke 2006, 2009), suggesting that they
do not promote S phase in C. elegans, we wondered whether they repress rather than
promote S phase in the context of gsk-3 mutants. To determine whether these factors
regulate S phase entry and progression downstream to gsk-3, we assayed them via
RNAi-mediated depletion in the gsk-3 background. Depletion of dpl-1 in L4 animals
from wildtype or gsk-3 heterozygous animals resulted in strong embryonic lethality in
F1 progeny, as did the double mutants between dpl-1 and gsk-3 (not shown). Thus, we
depleted dpl-1 starting at L4 in wildtype and gsk-3 mutant animals for 48 hours and
assayed for EdU incorporation in the germlines (Figure 33). Wildtype GSCs from
control (luciferase) RNAi and dpl-1 RNAi exhibited normal EdU incorporation with S
phase indices of ~55% and ~67% respectively (Figure 33A, 33C, 33F), as well as
endomitotic oocytes in the proximal germlines, as described previously (Chi and Reinke
2006, 2009). dpl-1 RNAi in gsk-3 mutant animals restored EdU incorporation in GSCs
in all the germlines with an S phase index of ~35% (Figure 33B, 33D, 33F), partially
rescuing the S phase progression defect. These data suggest that gsk-3 normally
inhibits dpl-1 in the GSCs to promote S phase progression.
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To determine whether dpl-1 regulated cdk-2 mRNA levels, we performed FISH
analysis on gsk-3(nr2047);dpl-1(RNAi) dissected germlines. We found that the cdk-2
mRNA was restored in the gsk-3(nr2047);dpl-1(RNAi) double mutant germlines and
was equivalent to dpl-1 RNAi alone (Figure 34). In summary, these data demonstrate
that gsk-3 inhibits dpl-1 to maintain persistent high levels (and thus activity) of CDK-2
mRNA expression in wildtype GSCs, resulting in rapid S phase entry and progression.
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Figure 32: DPL-1 binds to the cdk-2 intron1
Screen shot of Wormbase Ver. WS258 depicting the binding of DPL-1 via ChIP
analysis to the “intron 1” of cdk-2.
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Figure 33: dpl-1 RNAi rescues the gsk-3 mutant GSC proliferation defect
Dissected adult (24 hours past L4) germlines displaying the progenitor zone
oriented with the DTC to the left in all photographs in this figure. (A-D) RNAi-mediated
depletion of dpl-1 in gsk-3 mutant animals results in restoration of EdU incorporation,
assayed by a 10-minute EdU pulse (D), gsk-3 single mutant germlines incorporate very
low EdU (B). (B) RNAi mediated depletion of dpl-1 in wildtype and gsk-3 mutant
germlines results in a strong reduction of dpl-1 mRNA abundance. (C) RNAi mediated
depletion rescues the EdU incorporation and restores the S phase index to ~35% in
gsk-3 mutant GSCs. The RNAi experiments were performed five times, and for A-D 2022 germlines were imaged each time. Scale bar: 40µm.
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Figure 34: dpl-1 RNAi rescues cdk-2 transcription in gsk-3 mutants
(A-D) RNAi-mediated depletion of dpl-1 in gsk-3 mutant animals results in accumulation
of cdk-2 mRNA (D), gsk-3 single mutant germlines exhibit very low accumulation of
cdk-2 mRNA (B). The photographs for cdk-2 FISH were captured at 220ms each. A-D,
10-12 germlines were imaged each time. Scale bar: 40µm.
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3.6 Conclusion and Model
We report on a novel mechanism through which C. elegans germline stem cells
maintain their unique cell cycle structure with an abbreviated G1 phase (Figure 35). We
find that gsk-3 promotes S phase entry and progression in a metabolically rich
environment to mediate rapid expansion during the larval stages. GSK-3 function does
not impact the balance between differentiation and self-renewal of the stem cells,
revealing a specific function of this physiological regulator in maintaining the pool of
GSC. The observed lack of EdU incorporation in gsk-3 mutants is likely not due to EdU
accessibility to the germline, but rather points to difficulty of S phase entry and
progression. We find that it is not due to aberrant DNA licensing or CDK-2 inhibition,
but rather due to low expression of CDK-2 itself. We next find that CDK-2 is inhibited
transcriptionally in gsk-3 mutants, which is rescued by RNAi of the cell cycle regulator
dpl-1. This results in a situation where cdk-2 mRNA expression is regulated by gsk-3 to
maintain a continuously high expression in the GSCs, resulting in high CDK-2 protein
levels, so that when the cells reach the end of mitotic M phase they can transition into
S phase with minimal time spent in G1. This results in an abbreviated G1 phase of the
cell cycle thus allowing GSCs to proliferate rapidly to meet the tissue demands
imposed by continuous production of embryos. Additionally, since gsk-3 is a metabolic
regulator, GSCs may respond to chronic metabolic stress to control cell cycle
progression through gsk-3.
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Figure 35: gsk-3 Model
GSK-3 beta inhibits DP1 transcriptional repressor to maintain persistent high levels of
CDK-2 and mediate a short G1 coupled with rapid S phase entry and progression in C.
elegans germline stem cells.
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CHAPTER 4: ACUTE NUTRITIONAL DEPRIVATION AND GERMLINE STEM CELL
PLASTICITY
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Chapter 4: Acute Nutritional Deprivation and Germline Stem Cell Plasticity
4.1: Introduction
Cell cycle control is integral to the plasticity of a constantly dividing population of
stem cells such as the C. elegans GSCs. In conditions such as acute starvation or lack
of nutrients, the inability to halt the cell cycle would result in an exhaustion of energy
and nutrients. C. elegans PGCs and GSCs also arrest in conditions of acute starvation,
likely to cope with the hostile environment. PGCs arrest at G2 when the larva hatches
in the absence of food. This arrest is abrogated by loss of PTEN (daf-18) and PI3K
(age-1) or AKT (akt-1) (Fukuyama, Rougvie, and Rothman 2006). Thus, signaling
through the PI3K-AKT axis regulates the PGC arrest in hostile environmental
conditions.
GSC arrest appears in response to acute starvation in both L4 and adult animals
as well. Acute starvation of L4 worms results in shrinkage of the germline and gamete
production halts (Angelo and Van Gilst 2009). Return of the animal to replete nutrition
results in regeneration of the germline and gamete production resumes. These data
suggested that GSCs display plasticity an ability to adapt to environmental conditions.
Seidel and Kimble 2015, discovered that the GSCs undergo cell cycle arrest during this
time, though the nature and regulation of the arrest remain unknown (Seidel and
Kimble 2015). In this chapter, I investigated the nature of the GSC arrest and
uncovered its regulation through nutritional signaling.
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4.2: The Adult C. elegans GSCs Reversibly Arrest at G2 during Starvation
Acute starvation of adult C. elegans causes all the GSCs to stop cell divisions and
enter cell cycle arrest. This arrest is completely in place as early as 4 hours of
starvation (Figure 36A, B) (Seidel and Kimble 2015). To determine the cause of this
arrest, I characterized the cell cycle state of GSCs and assayed for M and S phase
using pH3 and EdU labeling respectively. Current methods in the field for EdU
incorporation use feeding of the EdU analog through thymidine deficient bacteria grown
in the presence of the EdU analog (Fox et al. 2011). Since feeding is incompatible with
acute starvation, I devised a method to incorporate EdU by soaking the animal in an
EdU solution for 10 minutes (described in detail in Materials and Methods). In this
chapter, all EdU incorporation and S phase indices in GSCs from starved or fed control
animals were labeled with the soaking EdU method. GSCs from fed animals
demonstrated an average of ~4 dividing cells with ~ 60% S phase index (Figure 36B,
36C). However, GSCs from animals without food for more than 4 hours displayed a
distinct lack of pH3 labeled cells. These data suggest that the GSCs may be blocked
from entering the M phase. To determine whether the S phase would alter with longer
starvation times, I assayed GSC starvation for 4, 8, 12, and 18 hours, and observed
that the S phase index does not change significantly upon extended starvation times
(Figure 36C). Even in GSCs from animals without food for 18 hours, which is ~3 times
longer than normal S phase length, I observed that the percentage of cells in S phase
had not altered significantly. Since the GSCs are not actively entering M phase (as they
do not display any pH3 positive nuclei), they are not transitioning into G1. Therefore,
there are no new cells to enter S phase during starvation. With no new input into S
phase, and no apparent output from S phase, these data suggest that the cells which
were in S phase at the beginning of starvation remain in S phase for at least 3 times
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longer than expected, leading to the model that starvation causes an extended S phase
in the GSCs along with a cell cycle arrest. This cell cycle arrest is reversible since
refeeding the animals after twelve hours of starvation causes pH3 positive cells to
reappear (Figure 36A).
Together, these data reveal that the C. elegans GSCs undergo a reversible cell
cycle arrest with an extended S phase. The finding that a cell cycle arrest is imposed in
GSCs in C. elegans was also demonstrated by the Kimble lab during the course of this
work (Seidel and Kimble 2015). What remains unknown is the nature of the arrest and
the underlying mechanism.
I hypothesized that the arrest was most likely in the G2 phase of the cell cycle,
which until now the field has only assayed using nuclear size as an assay. However, if
cell cycle arrest is induced via cdk-1 or cdk-2 depletion, the GSC nuclei expand into a
“fried egg” morphology. Therefore, nuclear size is an imprecise measure of cell cycle
phase during cell cycle arrest. Therefore, to determine whether the GSCs arrested at
G2, I performed an EdU pulse-chase experiment and assayed the various stages of the
cell cycle upon starvation and refeeding (Figure 37).
Since starved germlines incorporate EdU, cells in S phase can be labeled at any
point during starvation. Therefore, I reasoned that if starved germlines are pulsed with
EdU and released from starvation the S phase labeled cells would also label with pH3
when the cells divide after re-entering the cell cycle (Figure 37). Such cells would be
double positive – S phase and M phase labeled. However, if there are cells which
arrest in the G2 phase of the cell cycle, then they would not incorporate the EdU label.
Once these cells divide upon release of the arrest, they would only be labeled for pH3
and be single label positive. Since G2 is after S phase, any EdU negative cells
observed dividing before EdU positive cells would have been from G2 (Figure 37).
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To determine the stage at which the cells were arrested during starvation I pulsed
the animals with EdU after a 12 hour starvation, then refed them for 1 hour, 2 hours
and 4 hours. As expected the control starved germlines displayed no pH3 positive cells.
Upon 1 hour of refeeding, a majority of the germlines displayed no pH3 staining in the
GSC population suggesting that the cells were in an arrested state, likely because the
nutritional trigger had not been detected (Figure 38B). However, ~30% of the animals
displayed pH3 positive cells suggesting that in these animals, the nutritional cues had
triggered re-entry into the cell cycle (Figure 38A, 38B). A majority of these pH3 positive
cells were EdU negative (Figure 38B) suggesting that the first set of cells to renter the
cell cycle upon refeeding had arrested at the G2 stage. By 4 hours of refeeding, a
significant proportion of the GSCs were both pH3 and EdU positive. The spike of
divisions observed in some animals at 1 hour of refeeding is consistent with a cell cycle
arrest and a piling up of germ cells at that point of the cell cycle. Upon the release of
that arrest, this synchronized portion of cells enter mitosis together, and with most of
them being EdU negative, these cells were most likely released from a G2 arrest.

116

117

Figure 36: Starvation induces a reversible cell cycle arrest
(A) Dissected germlines with distal tips outlined with a dashed line and oriented to
the left. Stained with DAPI (white), EdU (green) pH3 (red), and HIM-3 (blue). Last
germline does not have HIM-3. From top to bottom, animals were: (1) Fed for 4 hours
after reaching 24 hours past L4; (2) Starved for 4 hours after reaching 24 hours past
L4; (3) Starved for 18 hours after reaching 24 hours past L4; (4) Starved for 12 hours
after reaching 24 hours past mid L4 followed by recovery to replete conditions (NGM
plate with OP50) for 4 hours. (B) Dividing cells were counted in fed and starved
germlines. Time point listed is the duration of feeding or starvation after reaching 24
hours past mid L4. (C) S phase index of germlines from fed and starved animals. Time
point listed is the duration of feeding or starvation after reaching 24 hours past mid.
Scale bar: 20µm.
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Figure 37: Detecting G2 cells after releasing the reversible arrest
Experimental plan for detecting G2 cells by pulsing EdU and releasing the
reversible starvation-induced arrest. Time is on the y-axis. Circles represent cells. Solid
line next to circles represents an arrest. Cells can be unlabeled (white) or labeled for
EdU (green), pH3 (red), or both (yellow).
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Figure 38: Starvation induces a G2 arrest.
(A) Dissected wildtype germlines after starvation (left) and refeeding (middle and right)
with distal tips outlined with a dashed line and oriented to the left. Stained with DAPI
(white), EdU (green) pH3 (red). (B) Analysis of EdU colabeling after an EdU pulsechase experiment. Circles represent individual germlines. Height on the y-axis
represents the number of dividing cells in that germline. Color depicts the percent of
dividing cells which are co-labeled with EdU. Circles below the X-axis had no dividing
cells. Scale bar: 20µm.
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4.3: The Starvation-induced G2 Arrest is Independent of DNA Damage Signaling
Since the reversible starvation-induced arrest occurred at the G2 stage, I
investigated the role of the DNA damage signaling pathway, which is known to induce a
G2 arrest. Starvation has the potential to induce DNA damage through replication
stress. If replication continues during starvation, nucleotide depletion is possible due to
the lack of an external source of precursors. This replication stress activates Atm
and/or Atr kinase which can result in a cell cycle arrest by inhibiting CDK-1 (Zeng et al.
1998). As discussed previously Atm and Atr kinases inhibit Cdk1 through a kinase
cascade which leads to a G2 arrest through inhibition of Cdk1-Cyclin B complexes
(Chapter 1.2.4). Since atl-1 has been implicated in regulating cell cycle arrest in GSCs
in response to DNA damage, I assayed the activation state of the chk-1 kinase in GSCs
with and without starvation.
In response to Atr activation, Chk1 is phosphorylated at Ser345 and activated. In
C. elegans, CHK-1 is phosphorylated in response to replication stress from
hydroxyurea treatment but not double strand breaks (Lee et al. 2010). I assayed for
phospho-CHK-1 status using Hydroxyurea as a positive control. Hydroxyurea treated
control GSCs displayed a high level of phospho-CHK-1 staining, suggesting that the
atl-1 pathway activated in response to replication stress in the GSCs (Figure 39).
Comparison of GSCs from fed vs starved germlines revealed only a low level of pCHK1 label, suggesting replication stress may not occur during starvation to induce a cell
cycle arrest.
While there was no observable replication stress during starvation, it is possible
that other forms of DNA damage were incurred. Therefore, I next investigated whether
the DNA damage response played a role in mediating the starvation-induced G2 arrest.
atm-1 and atl-1 are the major signaling modules through which DNA damage signals in
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GSCs. I reasoned that if DNA damage was responsible for the starvation arrest,
removal of these kinases would abrogate that arrest. I assayed atm-1 and atl-1 single
and double mutant GSCs at 24 hours past L4 upon fed and starved treatment for 12
hours. Under fed conditions, wildtype, atm-1 and atl-1 GSCs displayed pH3 positive
cells, and upon starvation, all genotypes lacked pH3 positive cells, suggesting that the
cell cycle arrest was induced (Figure 40). However, while atm-1 and atl-1 are thought to
be sufficient to mediate the cell cycle arrest due to DNA damage, atl-1 can compensate
for atm-1 in response to DSBs (Lee et al. 2010). To test whether atm-1 and atl-1 were
redundant with each other, I assayed the atm-1;atl-1 double mutant. As before, fed
wildtype and atm-1;atl-1 double mutant GSCs displayed pH3 positive cells (Figure 41).
Upon starvation, wildtype GSCs displayed the G2 arrest and did not label with pH3.
However, the atm-1;atl-1 double mutant germlines displayed pH3 positive GSCs that
were seemingly undergoing mitotic catastrophe, with extreme DNA damage (Figure 41,
arrowhead). Mitotic catastrophe occurs when a cell attempts to divide with high levels
of DNA damage, eventually resulting in cell death. Considering that there is no
evidence for programmed cell death or clearance of cell corpses in the progenitor zone
of the C. elegans GSCs, it is likely that a mitotic catastrophe event perdures for a long
time after initiating. Since mitotic catastrophe is a result of extreme DNA damage, their
presence in the atm-1;atl-1 double was not surprising; the mitotic catastrophe likely
occurred from lack of atm-1;atl-1 irrespective of starvation state (as is obvious to a
lower extent in GSCs from fed animals). Since I was unable to assess the role of atm-1
and atl-1 in regulating the starvation-induced G2 arrest in these experiments, I
performed the pulse-chase experiments as described above to assess whether the
GSCs arrest in G2 at all in the absence of atm-1 and atl-1 upon starvation.

122

In wildtype GSCs, the EdU pulse-chase experiment revealed an increase in EdU
negative pH3 positive cells upon 1 hour of refeeding (Figure 38). I hypothesize that this
increase in pH3 positive, EdU negative cells was likely due to a build-up of cells in G2.
If a similar build-up were to occur in the absence of the atm-1 and atl-1 kinases, there
is likely a portion of the G2 arrest which is independent of the DNA damage response.
Therefore, I starved atm-1;atl-1 animals at 12 hours past L4 for 18 hours. I then pulsed
the starved animals with EdU for 15 minutes and performed a refeeding time course for
1, 1.5, 2, and 4 hours. As before, the refeeding led to a sharp increase in pH3 positive,
EdU negative cells around the 1-1.5 hour mark (Figure 42). At the 4 hour mark, all the
germlines contained pH3 cells, although the numbers were lower than those seen at 11.5 hours; most of the pH3 positive cells are EdU positive (Figure 42). The similarity in
the emergence of EdU negative, pH3 positive cells at 1-1.5 hour of refeeding upon long
starvation in wildtype and atm-1;atl-1 double mutant germlines suggests that starvation
induces a G2 arrest even in the absence of the atm-1 and atl-1 kinases, and therefore
in the absence of DNA damage signaling. These data demonstrate that the starvationinduced G2 arrest is independent of the DNA Damage signaling pathway. I next
investigated the mechanism that may regulate the starvation-induced reversible G2
checkpoint.
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Figure 39: Starvation does not activate CHK-1
Dissected germlines from wildtype animals which were either fed (top), starved
(middle), or fed and hydroxyurea treated (bottom). Distal tip is outlined with a dashed
line and germlines are oriented with the distal tip to the left. Germlines are stained for
DAPI (white), (pSer345)CHK-1 (green) and pH3 (red). Scale bar is 20µm.
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Figure 40: The starvation arrest does not require individual DNA damage kinases
Dissected germlines from atm-1 and atl-1 single mutants with wildtype control
which were either fed or starved. Distal tip is outlined by a dashed line and is oriented
to the left. Germlines are stained with DAPI (white), EdU (green), and pH3 (red). Scale
bar: 20µm.
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Figure 41: Starvation induces mitotic catastrophe in atm-1;atl-1 double mutants
Dissected germlines from atm-1;atl-1 double mutants along with wildtype controls
which were either fed or starved. Distal tip is outlined by a dashed line and is oriented
to the left. Germlines are stained with DAPI (white), EdU (green), and pH3 (red).
Arrowhead depicts a mitotic catastrophe event during starvation which is pH3 positive.
Scale bar: 20µm.
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Figure 42: DNA damage kinases are not necessary for the starvation-induced G2
arrest.
(A) Dissected atm-1;atl-1 double mutant germlines after starvation (top left) and
refeeding (top right, bottom left, bottom right) with distal tips outlined with a dashed line
and oriented to the left. Stained with DAPI (white), EdU (green) pH3 (red). Scale bar:
20µm. (B) Analysis of EdU colabeling after an EdU pulse-chase experiment. Circles
represent individual germlines. Height on the y-axis represents the number of dividing
cells in that germline. Color depicts the percent of dividing cells which are co-labeled
with EdU. Circles below the X-axis are germlines with zero dividing cells.
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4.4: The Starvation-induced G2 Arrest is Mediated by Nutritional Signaling
The two major nutritional signaling pathways in the C. elegans germline are Insulin
signaling and TOR signaling (Chapter 1.3.7). Previous studies in the field suggest that
both of these pathways play an important role in GSC proliferation in larval animals
during the expansion phase (Fukuyama, Rougvie, and Rothman 2006; Michaelson et
al. 2010; Korta, Tuck, and Hubbard 2012). To determine whether these two signaling
pathways were important for adult GSC arrest I assayed daf-2(e1370) mutants to
assess the contribution of Insulin signaling and rsks-1(ok1255), a downstream effector
of TOR signaling, to assess the contribution of TOR signaling. To rule out any
compensation between the two pathways, I also assessed the impact of a loss of both
daf-2 and rsks-1 with a daf-2(e1370)rsks-1(ok1255) double mutant. daf-2(e1370)
contains a missense mutation in the kinase domain which results in a temperaturesensitive loss of kinase activity at the restrictive temperature of 25°C, while the animal
is relatively wildtype at 15°C. Therefore, I used daf-2(e1370), rsks-1(ok1255), and
daf-2(e1370)rsks-1(ok1255) double mutants at 15°C until 6 hours past mid L4, then
shifted for 18 hours to either 25°C or 15°C (Figure 43). In all mutants at either
temperature, I observed germlines with dividing cells indicating that a G2 arrest did not
occur (Figure 43). However, even a transient arrest or lengthening of G2 would result in
a drop in proliferation.
To determine whether there was any evidence of a transient G2 arrest, I counted
the pH3 positive cells for each genotype. I reasoned that a lower number of pH3
positive cells would signal either extension of the cell cycle or a transient arrest.
However, the length of the progenitor zone can change depending on the degree of
differentiation within the germline. Genotypes that result in alteration of the balance
between proliferation and differentiation provide less area for GSCs to proliferate, and
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thus fewer dividing cells would be observed solely due to a smaller available
population. Therefore, I normalized the number of dividing cells by the length of the
progenitor region in cell diameters to calculate an adjusted division index (ADI).
I determined the ADI for wildtype at 15°C and 25°C and found that they were
similar. In daf-2 mutants, I observed that at 15°C, the ADI was similar to wildtype, but at
the restrictive temperature, the ADI dropped significantly (p<0.0001) (Figure 44).
However, in rsks-1 mutants, the ADI was similar to wildtype at either temperature
suggesting that rsks-1 does not contribute to cell cycle progression in adult GSCs
(Figure 44). Additionally, in the double mutant, the ADI dropped a similar amount to that
in the daf-2 single mutant at the restrictive temperature, suggesting that daf-2, and
therefore Insulin signaling, regulates G2/M progression downstream to nutritional input
(Figure 44). However, since rsks-1 is only one of the many downstream effectors of
TOR signaling, I chose to investigate TOR itself and assess the contribution of the TOR
signaling pathway.
In C. elegans, the TOR homolog is let-363. Deletions in let-363 result in a larval
arrest at L3, prohibiting investigation into any adult phenotypes (Long et al. 2002).
Therefore, to investigate the role of let-363 in adult GSCs, I depleted let-363 via RNAi
and assayed adult GSCs. Since Mtor kinase is activated in the presence of nutrition, I
reasoned that let-363 RNAi should phenocopy the nutritional arrest. I performed the
RNAi at two conditions, a milder condition, where the RNAi was performed in adults for
24 hours followed by assaying the GSCs; and a long term RNAi, where the larvae were
subjected to RNAi from hatching with GSCs assayed in the adult (24 hours past L4).
The milder 24 hour depletion of let-363 did not reveal much impact on pH3 positive
cells and the RNAi germlines were similar to wildtype germlines (Figure 45). However,
with the longer RNAi, I observed that ~30% of germlines were pH3 negative and the
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ADI observed was significantly lower than wildtype (p<0.0001) (Figure 45). These data
suggest that TOR signaling may contribute to G2/M progression in addition to the
Insulin signaling. However, due to the inherent variability of RNAi experiments, I
generated a loss of function allele in let-363 and verified these phenotypes.
While LET-363 has not been crystallized, its domain structure is very similar to the
human homolog, mTOR, which has been well characterized and crystallized (Yang et
al. 2013; Long et al. 2002). I used the homology between the two proteins to design a
deletion for let-363. The N-terminal portion of LET-363 contains the heat domains to
which Rptor (daf-15) and Rictor (rict-1) bind. The C-terminal portion harbors the Mtor
kinase domain which is split in half by the Fkbp12-Rapamycin binding domain (FRB),
which protrudes from the kinase domain and partially occludes the substrate cleft
(Yang et al. 2013) (Figure 46A, B). The FRB has been found to assist in recruiting
p70s6k in mammals. While rsks-1 does not affect proliferation in adult GSCs, the FRB
may recruit other downstream effectors of let-363. Therefore, I used CRISPR to
remove this domain in an attempt to create a partial loss of function allele.
The FRB bridges exons 26 to 28, so I identified two crRNAs which bordered the
domain (Figure 46C). After designing the repair template to contain 5xGly as a flexible
linker, I performed the CRISPR injections (Figure 46C). I identified 6 candidates from
the injections corresponding to the homology repair using a PCR-based screening
method (Figure 46D) (Chapter 2.1.6). Sequencing of the lesion revealed that five of the
six candidates contained the desired sequence. The resultant allele, let-363(viz27)
(Hereafter designated let-363(ΔFRB)) is viable and does not arrest at L3 as null alleles
of let-363 do. However, let-363(ΔFRB) animals are smaller in size than wildtype (data
not shown), and while their brood size is the same as wildtype, their rate of egg laying
is decreased (Figure 47). To determine whether deletion of the FRB in let-363 led to an
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impact on GSC proliferation, I assayed let-363(ΔFRB) germlines. I observed that
let-363(ΔFRB) germlines appeared skinnier than wildtype (Figure 48A). Additionally, in
~30% of germlines there were no pH3 positive cells (Figure 48B). Upon assaying for
ADI, I found that let-363 had a significantly lower ADI (p<0.0001) than wildtype
suggesting that loss of TOR signaling leads to a partial cell cycle arrest in adult GSCs
(Figure 48C). These data suggest that both Insulin signaling and Tor signaling regulate
G2/M progression. Current experiments in the lab are ongoing to assess whether these
two pathways function in a redundant manner. More importantly, I wondered how LET363 may control the cell cycle.
Studies from yeast, also suggest a role for TOR signaling in regulating the cell
cycle. I surmised that let-363 does not function through the canonical TOR signaling
pathway and lysosomes since there was anecdotal evidence in the lab and from the
field on lack of lysosomes in germ cells. To determine whether germ cells contain
lysosomes, I utilized the High Resolution Electron Microscopy Facility at MD Anderson
Cancer Center to perform Transmission Electron Microscopy. Lysosomes were
identified as circular membrane-bound vesicles approximately 0.5 micron in size
(Sigmond et al. 2008). While the gut contains lysosomes, I did not find any in the GSCs
(Figure 49). Thus, I assayed for distinct pathways that may mediate the role of TOR
signaling in regulating G2/M progression. Since fission yeast does not regulate TOR
signaling through lysosomal signaling either, I wondered whether there were parallels
in the cell cycle regulation between yeast and C. elegans GSCs.
In fission yeast, Tor can regulate p38 stress kinases to regulate Cdc25 (LopezAviles et al. 2008; Lopez-Aviles et al. 2005). Since Cdc25 directly regulates Cdk1, this
would provide a link between TOR signaling and cell cycle regulation. To test this, I
assayed for the effect of stress kinases in regulating the GSC arrest in C. elegans.
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There are three p38-like (pmk-1, pmk-2, pmk-3) and four JNK-like (jnk-1, kgb-1, kgb-2,
C49C3.10) stress kinases in C. elegans which respond to a variety of different
stressors from infection to injury (Reviewed in Andrusiak and Jin 2016). To determine
whether stress kinases function downstream of let-363 in GSC response to starvation, I
assayed four of these kinases, pmk-1, pmk-2, jnk-1, and kgb-1. I did not pursue pmk-3
because it does not contain the canonical TGY motif through which the p38 family is
activated, and so it is likely not activated by an upstream map kinase cascade. I
depleted each kinase via an F1 RNAi (the RNA was depleted in the mothers and
progeny) and observed changes in the germlines of the F1 progeny. I observed that
under fed conditions, all genotypes had ADIs similar to the luciferase control (Figure
50). However, loss of pmk-2 and kgb-1 individually displayed an increase in ADI,
raising the possibility that they could each partially abrogate the starvation arrest. To
investigate their effect on mediating the G2/ M arrest, I assayed for their necessity to
induce the arrest. I performed an F1 RNAi of each kinase and starved animals at 24
hours past mid L4. The germlines contained dividing cells which would indicate an
incomplete arrest. The luciferase control RNAi, as expected, had zero germlines with
pH3 positive cells. Similarly, the germlines from jnk-1, pmk-1, and pmk-2 RNAi did not
display pH3 positive cells, suggesting that their loss did not abrogate the G2 arrest.
However, loss of kgb-1 by RNAi leads to ~5% of germlines with pH3 positive cells.
While this number is small, the data suggests kgb-1 activity may be necessary for
initiating a complete G2 arrest upon starvation. Because RNAi only depletes the RNA
and may not affect protein function, which could account for the small effect observed, I
obtained a kgb-1(um3) mutant allele and performed the analysis. The um3 allele
deletes a large portion of the KGB-1 kinase domain (Smith et al. 2002). Previous
studies describe this allele as temperature-sensitive. While it is relatively wildtype at
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20°C, the strain is sub-fertile at 15°C. Therefore kgb-1(um3) was cultured at 20°C and
shifted at mid L4 for 24 hours to 15°C, followed by a 4 hour starvation. As previously
shown, wildtype animals underwent complete G2 arrest at 20°C, but at 15°C the G2
arrest in wildtype animals is evident only in 80% of the animals, with the remaining
~20% of germlines displaying pH3 positive cells. These data suggest that temperature
enhances the starvation-induced G2 arrest in wildtype. It was interesting however that
in the kgb-1(um3) mutants at 15°C, ~80% of germlines displayed pH3 positive cells,
and at 20°C the kgb-1(um3) mutants maintained ~5% of germlines with pH3 positive
cells, further suggesting that kgb-1 assists in the starvation-induced G2 arrest. Since
there are reports that active p38 genetically interacts with Cdk1 regulator to inhibit cell
cycle progression, I next investigated CDK-1 regulation during starvation.
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Figure 43: daf-2 and rsks-1 mutants do not completely arrest
Dissected germlines from the listed genotypes with the distal tip outlined with a
dashed line and oriented to the left. Left panel are animals raised at 15°C, Right panel
are animals which were shifted to 25°C for 18 hours prior to dissection. All animals
were dissected at 24 hours past mid L4. Stained for DAPI (white), EdU (green), and
pH3 (red). Scale bar: 20µm.
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Figure 44: ADI analysis of daf-2 and rsks-1 mutants
ADI analysis is measured as the number of pH3 positive cells divided by the
number of cell rows in the progenitor region. (**) p < 0.005, (****) P < 0.0001.
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Figure 45: RNAi of let-363 results in decreased proliferation
(A) Dissected germlines form the listed genotypes with the distal tip outlined with a
dashed line and oriented to the left. Stained for DAPI (white) and pH3 (red). Scale bar:
20µm. (B) ADI analysis is measured as the number of pH3 positive cells divided by the
number of cell rows in the progenitor region. Displayed is the ADI for the long-term (F1)
RNAi. (**) p < 0.005, (****) P < 0.0001.
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Figure 46: let-363(ΔFRB) mutagenesis
(A) 3D model of a c-terminal portion of let-363 kinase (pink and green) threaded
onto the structure of a c-terminal portion of human mTOR (4JSP) (blue and red) using
the ITASSER suite. The FRB domain is labeled in green (let-363) or red (mTOR).
Square denotes the region magnified in (B). (B) Increased magnification of the FRB
domain. The amino acids bordering each breakpoint for the FRB allele are labeled. (C)
CRISPR design for replacing the FRB domain with a 5xGly flexible linker. Green and
pink flags represent PCR primers used for allele detection as well as sequencing (not
to scale). (D) Sequencing result from 6 clones generated from CRISPR injections using
the above scheme. 5 of the 6 contain the desired edit, while the other one has a 3 base
pair deletion (dashes) resulting in a missense mutation.
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Figure 47: let-363(ΔFRB) has a decreased rate of progeny lay
(A) Analysis of the total progeny laid by wildtype and let-363(ΔFRB). (B) Break
down of the analysis in (A) by day. (**) p < 0.005, (****) P < 0.0001.
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Figure 48: let-363(ΔFRB) has a proliferation defect
Dissected germlines from wildtype and let-363(ΔFRB) oriented with distal tip to the
left. (A) Full germlines displayed with the progenitor region outlined. Loop region and
the region with developing oocytes are defined by solid lines. Oocytes are labeled up to
the -3 oocyte with regards to birth order. Asterisks define regions of increased
background due to an adjacent germline. Stained for DAPI (blue), EdU (green), and
pH3 (red). Scale bar: 100µm. (B) Progenitor region is displayed with the distal tip
outlined with a dashed line and oriented to the left. Stained for DAPI (white), EdU
(green), and pH3 (red). (C) ADI analysis is measured as the number of pH3 positive
cells divided by the number of cell rows in the progenitor region. (****) p < 0.0001.
Scale bar: 20µm.
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Figure 49: Lysosomes are absent from GSCs
Samples were dissected and fixed in 3% glutaraldehyde plus 2%
paraformaldehyde in 0.1 M cacodylate buffer, pH 7.3 prior to submission to the High
Resolution Electron Microscopy Facility at MD Anderson Cancer Center where they
were prepared by Kenneth Dunner. (A,B) TEM image from the germline. Square
denotes magnified region shown in (B). (C,D) TEM image from the gut. Square
denotes magnified region shown in (D). Scale bar is: 2 µm(A,C), 0.5 µm(B,D).
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Figure 50: Stress kinases may contribute to the starvation-induced G2 arrest
(A) Dissected germlines of animals after RNAi of stress kinases (jnk-1, pmk-1,
pmk-2, and kgb-1) and a luciferase control with or without starvation. Germlines have
the distal tip outlined with a dashed line and are oriented with distal tip to the left.
Stained for DAPI (white) and pH3 (red). Scale bar: 20µm. (B) ADI analysis is measured
as the number of pH3 positive cells divided by the number of cell rows in the progenitor
region. (n.s.) not significant.
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4.5: CDK-1 activity is Modulated by Nutritional and MAPK Pathways to Regulate
the Reversible Starvation-induced G2 Arrest
Entry into M phase from G2 is controlled by cdk-1 and cyb-1 in C elegans. cdk-1 is
inhibited by wee-1, so to investigate the role of cdk-1 signaling during starvation, I
depleted wee-1.3 by RNAi. wee-1.3 is one of the Wee1 homologs in C. elegans and is
expressed in the germline. After 4 hours of starvation, wee-1.3 RNAi resulted in ~40%
of germlines with pH3 positive cells (Figure 51). This suggested that wee-1.3 plays a
role in either entry or maintenance of the G2 arrest.
To determine whether wee-1.3 mediated CDK-1 phosphorylation is regulated in
response to starvation. I used antibodies to detect (pT14pY15)CDK-1, the inhibitory
mark generated by WEE-1 and MYT-1 kinases; and a total CDK-1 antibody to observe
overall changes in protein expression. The total CDK-1 antibody was raised by Dr.
Andy Golden (NIH/NIDDK) and kindly provided by Jill Schumacher (MD Anderson
Cancer Center). Both antibodies are specific to CDK-1 as they are depleted upon cdk-1
RNAi (Figure 52). Additionally, the (pT14pY15)CDK-1 antibody is responsive to
replication stress and DNA damage signaling since it increases in intensity after
hydroxyurea treatment (Figure 52). Therefore, using these antibodies, I could assay the
inhibitory state of CDK-1 during starvation. I assayed animals at 24 hours past mid L4
in either fed or starved conditions. The starvation was performed for 4 hours. The
germlines were then stained with either (pT14pY15)CDK-1 or total CDK-1 as well as
pH3. In fed worms, there was noticeable accumulation of both the total CDK-1 as well
as the (pT14pY15)CDK-1 in cells that were pH3 negative. This suggested that when
the GSCs were not in M phase, CDK-1 was maintained in the nucleus in an inhibited
state. In GSCs from starved germlines, the signal for (pT14pY15)CDK-1 was similar to
GSCs from fed germlines. However, there was a decrease in total CDK-1 expression
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level, and the low-level signal was not nuclear but rather cytoplasmic (Figure 53). To
better understand this expression dynamic, the experiment was repeated and analyzed
using confocal microscopy. I observed that the fed animals had clear nuclear
localization of both total CDK-1 and the inhibitory (pT14pY15)CDK-1 (Figure 53). In
starved animals, while the (pT14pY15)CDK-1 signal remained, the nuclear, total CDK-1
signal was not visible (Figure 53). In addition, the overall accumulation of CDK-1 was
decreased in starved animals. These data demonstrate two things: 1) total CDK-1
levels are decreased upon starvation and (2) the phosphorylated nuclear signal of
CDK-1 does not change upon starvation. At first sight these data seem confusing,
however it led me to posit that CDK-1 was regulated at several levels simultaneously
during starvation. One process would be responsible for decreasing the overall
expression of CDK-1 as was observed. However, for the accumulation of inhibited
CDK-1 to remain the same in fed and starved animals, the proportion of inhibited
CDK-1 must increase. Therefore, another process would be responsible for this
increase in inhibited CDK-1. Combining both processes may cause the strong G2
arrest observed.
I then reasoned that if the proportion of inhibited CDK-1 were high enough in the
fed condition, it might be possible to watch the inhibited CDK-1 drop during starvation
along with the total CDK-1 signal. To test this, I attempted to saturate the
(pT14pY15)CDK-1 signal using hydroxyurea treatment. As seen before, hydroxyurea
treatment leads to an increase in the (pT14Y15)CDK-1 signal (Figure 52). If the
hydroxyurea treated germlines are then starved and the total CDK-1 levels drop, I
would also be able to compare the levels of phospho-CDK-1, and a change in
phospho-CDK-1 level should be easily detectable. Therefore, I treated wildtype animals
with hydroxyurea for 12 hours and either starved or fed them for 4 hours. After
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dissection, the germlines from fed animals were labeled with anti-NOP-1, a nucleolar
marker, and combined with the starved samples for each condition. The combined
samples were then split into two equal portions and stained with either
(pT14pY15)CDK-1 or total CDK-1 antibodies. By staining both fed and starved in the
same tube, I was able to rule out any intensity differences due to differences in
antibody treatment or exposure. As expected, fed hydroxyurea-treated animals had
high (pT14pY15)CDK-1 expression in the GSCs when compared to their control
counterparts (Figure 54). However, even with increased signal, there was no change in
(pT14pY15)CDK-1 intensity between the fed and starved conditions in hydroxyureatreated animals (Figure 54). This is in contrast to the drop in total CDK-1 levels, which
can be seen in both the hydroxyurea-treated and control animals. In order for the
(pT14pY15)CDK-1 intensity to remain the same in control animals, the drop in total
CDK-1 levels must be accompanied by an increase in (pT14pY15)CDK-1 levels.
Therefore, I posit that the increase in (pT14pY15)CDK-1 may be due to the role of
kgb-1 during starvation. Additionally, I was intrigued by the drop in total CDK-1 levels
upon starvation since that seemed like a key mechanism underlying the onset of G2
arrest upon starvation. Thus, I investigated how cdk-1 expression was regulated during
starvation.
To determine if cdk-1 was being transcriptionally repressed I assayed for CDK-1
mRNA, using PGL-1 mRNA as an internal control. I fed adult animals (24 hours past
L4) and performed FISH using the above probes. I observed that both fed and starved
conditions contained comparable fluorescence intensity for CDK-1 mRNA and PGL-1
mRNA. This suggested that cdk-1 was not being transcriptionally regulated.
Since TOR signaling regulated the G2 arrest, at least in part, it is likely that cdk-1
expression is translationally regulated. Two downstream effectors of TOR signaling that
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regulate translation are rsks-1 and Eif4ebp1. As observed earlier, rsks-1 does not play
a role in the proliferation of adult GSCs, therefore I investigated the role of Eif4ebp1 in
regulating CDK-1 expression. Eif4ebp1 is a negative regulator of 5’ cap-dependent
mRNA translation which functions by binding Eif4e (Eukaryotic translation initiation
factor 4E). Active TORC1 phosphorylates Eif4ebp1, dissociating it from Eif4e. This
allows Eif4e to form a complex with Eif4g (Eukaryotic translation initiation factor 4G) to
promote translation initiation. In C. elegans there is no known homolog of Eif4ebp1.
However, while there are multiple genes with homology to regulatory subunit Eif4e, the
structural subunit Eif4g has only one homolog (ifg-1). Since this complex regulates
translation, and some of its components have larval GSC proliferation defects as well
as suboptimal fertility, I used RNAi to investigate the function of ifg-1 (Korta, Tuck, and
Hubbard 2012; Long et al. 2002). After a 24 hour RNAi treatment, I dissected and
analyzed ifg-1 RNAi germlines. When compared to luciferase RNAi controls, ifg-1 RNAi
germlines displayed significantly lower ADI (Figure 55). This suggests that ifg-1
depletion, and translational inhibition in general, affects adult GSC proliferation.
Therefore, I hypothesize that a decrease in TOR signaling results in lower IFG-1
mediated protein translation which in turn lowers the level of CDK-1, and together with
phosphorylation mediated inhibition of CDK-1, the overall lower levels of CDK-1 upon
starvation induce the G2 arrest.
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Figure 51: wee-1.3 regulates the starvation-induced G2 arrest
Dissected germlines of animals after RNAi of wee-1.3 and a luciferase control with
or without starvation. Germlines have the distal tip outlined with a dashed line and are
oriented with distal tip to the left. Stained for DAPI (white) and pH3 (red). Scale bar:
20µm.
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Figure 52: CDK-1 and (pT14pY15)CDK-1 antibodies respond as expected
Dissected wildtype germlines under normal conditions (top), after cdk-1 depletion
(middle), or after Hydroxyurea treatment for 18 hours (bottom). Left panel was stained
for total CDK-1, right panel was stained for (pT14pY15)CDK-1. Both panels were
stained for DAPI (white) and pH3 (red). Germlines have the distal tip outlined with a
dashed line and are oriented with the distal tip to the left. Scale bar: 20µm.
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Figure 53: CDK-1 expression decreases as pCDK-1 remains unchanged
Dissected wildtype germlines with or without starvation. Left panel was stained for
total CDK-1, right panel was stained for (pT14Y15)CDK-1. Both panels were stained for
DAPI (white). Germlines have the distal tip outlined with a dashed line and are oriented
with the distal tip to the left. Germlines were either imaged using an epifluorescence (A)
or confocal (B) microscope. Scale bar: 20µm.
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Figure 54: Hydroxyurea exacerbates the regulation of CDK-1 during starvation
Dissected wildtype germlines with or without starvation. Left panel was stained for
total CDK-1, right panel was stained for (pT14Y15)CDK-1. After staining fed animals
with NOP-1 (red), a nucleolar marker, fed and starved groups were combined and
stained in the same tube for DAPI (white) and CDK-1 or (p124Y15)CDK-1 antibody
Germlines have the distal tip outlined with a dashed line and are oriented with the distal
tip to the left. Animals were either treated with Hydroxyurea (A), or with M9 vehicle
control (B). Scale bar: 20µm.

157

Figure 55: RNAi of the translational regulator ifg-1 inhibits proliferation
Dissected germlines from animals treated with RNAi for ifg-1 or luciferase control.
Stained for DAPI (white), pH3, and HIM-3. Germlines have the distal tip outlined with a
dashed line and are oriented with the distal tip to the left. Germlines were either imaged
in an epifluorescence (A) or confocal (B) microscope. Scale bar: 20µm.

158

4.6: Conclusion and model
Starvation is detrimental to organisms. Therefore, being able to respond to
starvation in a way that preserves cellular integrity is important. In this chapter, I
uncovered that C. elegans GSCs respond to acute starvation with a reversible G2
arrest which is released upon return to replete conditions (Figure 56). I found no
evidence of DNA damage due to replication stress during this arrest, and the arrest
appears to be independent of DNA damage signaling all together. Instead, this arrest is
mediated by nutritional signaling pathways. Loss of Insulin signaling (daf-2) or TOR
signaling (let-363) results in an induction of the G2 arrest, with each contributing
partially to the phenotype. Mechanistically, the arrest is partially mediated by stress
signaling through kgb-1 which in turn leads to cdk-1 inhibition. Consistent with this
model, depletion of the negative regulator wee-1.3 abrogates the G2 arrest, although
loss of wee-1.3 results in a stronger abrogation of the G2 arrest than evidenced in kgb1 mutants, suggesting that cdk-1 is regulated by signals or mechanisms in addition to
the one mediated by kgb-1. Furthermore, starvation resulted in a reduction of total
CDK-1 protein, in addition to the phosphorylation mediated inhibition imposed by
wee-1.3. The decrease in CDK-1 protein levels was not regulated transcriptionally in
response to starvation, but rather may be under translational regulation, as transient
depletion of ifg-1, which functions downstream of let-363 to promote translation, causes
the onset of G2 arrest. Together, these data put forward the model that Insulin and
TOR signaling regulate the G2 arrest in parallel. TOR signaling functions independent
of the lysosomes, and via the stress activated kinase kgb-1 and ifg-1 to regulate CDK-1
both at the post-translational level and at the translational level to efficiently respond to
lack of nutrients in the environment and protect germ cell integrity.
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Figure 56: Starvation Model
Starvation inhibits both the let-363 and daf-2 signaling pathways to inhibit G2
progression. let-363 mediates this response by inhibition of cdk-1 translationally,
through ifg-1, and post-translationally, by increased inhibitory phosphorylation mediated
by kgb-1.
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5.1: Discussion
Stem cells play a critical role in maintaining tissue homeostasis, during tissue
repair and regeneration. To faithfully execute these functions stem cells respond to
extracellular cues and intrinsic signals to protect the progenitors from environmental or
tissue based insult. In this thesis, I identified two cellular mechanisms which regulate
the cell cycle in GSCs in response to adverse environmental or metabolic conditions.
First: In GSCs, gsk-3 works to promote proliferation through regulation of the G1 phase
of the cell cycle, without affecting the differentiation/self-renewal decision. I find that
gsk-3 promotes EdU incorporation along with promoting a short G1 phase by promoting
cdk-2 transcription. Second: I find that starvation induces a cell cycle arrest at G2 which
is independent of the DNA damage G2 arrest. This starvation-induced arrest is
mediated by Insulin and TOR signaling. The TOR signaling axis is mediated by the
stress kinase kgb-1 and the translation initiation factor ifg-1, culminating in translational
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and post-translational regulation of cdk-1. Combined, these regulatory components
provide plasticity to GSCs in times of adverse environmental or metabolic conditions.

5.1.1: GSCs may lack a DNA licensing checkpoint
In mammalian systems, DNA licensing actively promotes Cdk2 activation,
suggesting that the licensing checkpoint is essential for progression into S phase. In
fact, depletion of licensing components results in cell cycle arrest in a p53 dependent
manner further supporting a DNA licensing checkpoint. During our investigations into
the nature of the gsk-3 mutant GSC phenotype, we found that depletion of the ORC
complex members or Cdc6 resulted in DNA fragmentation and re-replication. Since the
DNA licensing members were depleted by RNAi, it is likely that they were not
completely removed, and so it is possible that some level of DNA licensing occurred,
but that the licensing was not extensive enough to cover the entire genome.
Surprisingly, in gsk-3 mutants, this phenotype is rescued. I propose that the extended
G1 in gsk-3 mutants is in part responsible for this rescue. Extension of G1 in gsk-3
mutants may allow DNA licensing components to complete licensing even if their
expression level is reduced. However, that DNA licensing can be incomplete in wildtype
supports the idea that there is no obvious DNA licensing checkpoint in C. elegans
GSCs in addition to the cells displaying a distinct S phase entry regulation as a whole.
However, if a p53-dependent DNA licensing checkpoint is in place in C. elegans GSCs,
co-depletion of the p53 homolog cep-1 along with DNA licensing factors should appear
worse than depletion of DNA licensing factors alone, providing one avenue of
determining the presence of this checkpoint.

5.1.2: How does constitutively high expression of CDK-2 regulate G1/S switch?
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I find that the cdk-2 mRNA maintains a constitutively high level of expression in the
GSCs, which is necessary for the abbreviated cell cycle structure. The expression of
CDK-2 also reflects its activity, as shown previously by phospho-CDC-6 expression, and
functional analysis (Fox et al. 2011), and from this study. Using the nuclear to
cytoplasmic shuttling of MCM-3 as a dynamic readout of CDK-2 function, we found that
MCM-3 is nuclear when CDK-2 function is lower, and cytoplasmic when CDK-2 function
(or expression) is high. Interestingly, in gsk-3 mutant GSCs, MCM-3 is nuclear in about
56% of the cells, the levels of cdk-2 mRNA are significantly reduced, and the cells
incorporate EdU very inefficiently. Further, over-expression of CDK-2 in the gsk-3
mutants completely rescues the GSC defects. Together, these data suggest that in
GSCs, the cell cycle at the G1/S boundary is largely regulated by the accumulation of
CDK-2. Consistent with this is the observation that depletion (via RNAi) and reduction of
cdk-2 mRNA result in two distinct phenotypes: cell cycle arrest in the former (Fox et al.
2011) and slow S phase entry and progression in the latter (this study).
That Cdk2 expression levels regulate the G1/S switch may be unique to cells that
have a short G1. To put this in the context of canonical mammalian cell cycle progression
which is regulated via low Cdk2 activity in G1 to enable pre-replication complexes to
assemble at origins (Blow and Hodgson 2002), I propose the following model.
Canonically, inactive Cdk2 enables the loading of the pre-replication complex into the
nucleus at the end of G1, and active Cdk2 then initiates S phase, both of which are
regulated through post-translational mechanisms such as phosphorylation. In the context
of GSCs, it is likely that different thresholds of activation form distinct complexes of
CDK-2 that mediate its differing roles in G1 and S. For example, it is likely that the prereplication complex can form at a lower threshold of CDK-2 activity (mimicking an
‘inactive” pool of Cdk2) than a threshold of CDK2 that drives entry and progression
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through S phase. Observations from mESCs support this model. In mESCs despite
continuous high expression of Cdk2 and Cyclin E, a subset of Cdk2 complexes are in
fact “inactivated” at G1, allowing pre-replication complexes to assemble transiently and
allow S phase entry (Ohtsuka and Dalton 2008). Additionally, these complexes are
thought to be undetectable above the elevated Cdk2 expression (Ohtsuka and Dalton
2008). Therefore, one possible hypothesis is that much like in mESCs, different
complexes of CDK-2 exist, and some of these are inactivated at late G1 (despite the high
expression of CDK-2) in GSCs coupled with a very transient loading of the pre-replication
complex. This notion of a very transient loading of the licensing complex may account
for the inability to visualize the nuclear pre-replication complex in wildtype GSCs.
Together, this leads to the model that a pool of CDK-2 is inactive, which enables loading
of the pre-replication complex, but the high CDK-2/CYE-1 levels throughout GSCs result
in the loading being transient thus facilitating an accelerated entry into S phase,
effectively coupling the high expression of CDK-2 with the G1/S switch, and abbreviation
of G1.

5.1.3: DPL-1 as a transcriptional repressor of CDK-2 to regulate G1 and S phase
progression.
Dp1/E2F proteins are canonical G1/S phase regulators across multiple systems, where
they promote G1/S phase progression through activation of S phase target genes.
However, in C. elegans loss of dpl-1 had not previously revealed any loss of G1/S phase
either in the soma (Ceol and Horvitz 2001; Chi and Reinke 2006; Reddien et al. 2007) or
the germline (Figure 33, Chapter 3.5). These data suggested that Dp1/E2F may not
function canonically to promote S phase in C. elegans. Instead, in this study, we made
the discovery that DPL-1 represses S phase transcription. EFL-1, the partner of DPL-1,
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is closest in homology to E2F4 family of E2F transcription factors (Smith et al. 1996), and
in vertebrates E2F4 family members have been implicated in repression of S phase
target genes rather than activation (Dominguez-Brauer et al. 2009; Pilkinton, Sandoval,
and Colamonici 2007; Popov, Chang, and Serikov 2005). Thus, it is possible, that in C.
elegans, the DPL-1/EFL-1 complex function more like the Dp1/E2F4 complex in
vertebrates and repress G1/S phase target genes. Together, these data reveal a novel
mode of cell cycle regulation via transcriptional control of cyclin dependent kinases.

5.1.4: A G2 nutritional checkpoint
Checkpoints are necessary to ensure that the cell cycle completes with fidelity. The
well-established DNA damage checkpoint protects against mitotic catastrophe and
DNA fragmentation (Vakifahmetoglu, Olsson, and Zhivotovsky 2008). This checkpoint
can be triggered in any of G1, S and G2 phases to halt cell cycle progression until the
DNA damage has been repaired, and can trigger cell death if the DNA damage is too
extensive. The starvation-induced G2 arrest may be reminiscent of a checkpoint as
well.
There are reports of nutritional signaling governing the G2/M transition in
D. melanogaster (Hsu, LaFever, and Drummond-Barbosa 2008). Additionally, I have
found that nutritional signaling may be responsible for an arrest at G2. Due to the GSC
cell cycle structure, it is likely that a G2 checkpoint would be optimal. Constant
expression of cye-1 and cdk-2 lead to active CDK-2 in all nuclei. During starvation, it is
likely that cdk-2 remains active, since continuous replication requires active cdk-2, as
we showed using gsk-3 mutants. With continuous active CDK-2, it is unlikely that GSCs
would enter a quiescent state, which prohibits the known G1 checkpoint. Therefore, the
next safest point for the cell to arrest is at G2, when the cell has safely replicated its
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DNA and is growing in order to divide. A nutritional checkpoint at the boundary between
G2 and mitosis would protect against entry into an energy-intensive process when
resources are limited.

5.1.5: Cell cycle plasticity in response to nutrient and metabolic stresses.
The ability to arrest the cell cycle at any phase in the face of metabolic or nutrient
stresses gives the C. elegans GSCs an ability to adapt to adverse conditions, or
plasticity. The regulation of this plasticity described herein may be important for other
populations of rapidly dividing cells. Early embryonic populations of stem cells in
humans and mice share a similar cell cycle structure with cells in S phase for 50-60%
of the cell cycle, leading to relatively short gap phases (White and Dalton 2005).
mESCs, in particular, have constitutive Cdk2 activity throughout the cell cycle, resulting
in the lack of a restriction point and an inability to enter the canonical quiescence at G0
(Stead et al. 2002). Since G1 is a major arrest point in response to nutritional signaling
in many cell types, this altered G1 regulation suggests that mESCs may not retain
plasticity to nutrient availability. However, similar to the proliferation defect found due to
downregulation of let-363 found in this study, Mtor is required for proliferation of the
inner cell mass from which mESCs are isolated (Gangloff et al. 2004). This appears to
mirror the regulation found in C. elegans germline stem cells, raising the possibility that
mESCs respond to acute starvation with a G2 arrest. Further research into the
regulation of the acute starvation-induced arrest of C. elegans GSCs, therefore, may
provide insights into cell cycle plasticity during early embryonic divisions in mammals,
as well as other rapidly dividing populations of cells, including disease states such as
cancer.

167

5.2: Future Directions
5.2.1: gsk-3 in response to external signaling
As stated previously, the adult C. elegans GSCs have a short G1. Here, we
provide evidence of a mutant in gsk-3 which slows S phase entry, effectively
lengthening G1. Additionally, this phenotype occurs due to a lack of gsk-3 kinase
activity. However, gsk-3 can receive signals from multiple pathways. In mammals, gsk3 is inactivated in response to Wnt and Insulin signaling. However, if gsk-3 were to be
inactivated similarly in C. elegans GSCs, normal fed conditions and/or developmental
signaling would result in down-regulation of cdk-2, potentially halting the cell cycle. A
few possibilities exist to reconcile this. Most inhibitory signals rely on the production of
a bait phosphorylation on the N-terminal of gsk-3 (Jope and Johnson 2004). Therefore,
one option is that gsk-3 has lower affinity towards the bait phosphorylation than
towards the substrate mediating cdk-2 expression. A second option would be that gsk-3
is not regulated by nutritional signaling in C. elegans. Regardless, it is still unknown
whether and/or how gsk-3 is regulated in response to nutritional signaling in GSCs.

5.2.2: Insulin signaling in the starvation arrest regulation
Since starvation halts nutritional signaling, it is no surprise that the insulin receptor
homolog daf-2 shows a proliferation defect in adult GSCs. By utilizing a temperaturesensitive daf-2 mutant, I found that the ADI in GSCs was significantly lower than in
wildtype (Figure 43, Chapter 4.4). How the signal is propagated to control the cell cycle
is yet to be determined. There is evidence that the FOXO homolog (daf-16), which
functions downstream of daf-2, can inhibit tumor formation due to increased Notch
signaling providing one possibility (Qi et al. 2012; Pinkston-Gosse and Kenyon 2007).
Another is that the signal goes through TOR signaling. In mammals Insulin signaling
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and TOR signaling are linked by the TSC1/2 complex. To date there is no known
homolog for either protein, suggesting that there may be no link between these two
pathways in C. elegans. However, there is evidence that daf-16, in response to TGFβ
but not Insulin signaling, can regulate the transcription of the Raptor homolog daf-15,
providing an alternate link between the pathways (Qi et al. 2017). Whether they are
independent in regulating the adult starvation-induced arrest remains to be
investigated.

5.2.3: An Extended S phase During Starvation
Sustaining DNA replication for long periods of time can be dangerous. In addition
to replication fork stalling and collapse, large swaths of ssDNA can be generated if the
replicative helicase uncouples from the DNA polymerase all of which can lead to DNA
damage and cell death (Zeman and Cimprich 2014). However, during the GSC
starvation arrest, I observe an extended S phase of at least 18 hours, 3 times longer
than normal S phase. Therefore, GSCs may be incurring DNA damage and mutations
over time.
In addition, there is EdU incorporation at potentially any point during the extended
S phase. This is in contrast to hydroxyurea treatment which does not incorporate EdU
and suggests that there are nucleotides available during the starvation arrest. In acute
starvation, there would be no external source for these nucleotides and the internal
source of these nucleotides remains unknown. The apoptotic cells which are in
pachytene, more proximal in the germline, could provide these nucleotides. Since there
is no sign of re-replication, the GSCs could be undergoing a very slow DNA replication.

169

BIBLIOGRAPHY

Abraham, R. T., and G. J. Wiederrecht. 1996. 'Immunopharmacology of rapamycin',
Annu Rev Immunol, 14: 483-510.
Alessi, D. R., S. R. James, C. P. Downes, A. B. Holmes, P. R. Gaffney, C. B. Reese,
and P. Cohen. 1997. 'Characterization of a 3-phosphoinositide-dependent protein
kinase which phosphorylates and activates protein kinase Balpha', Curr Biol, 7: 261-9.
Almasan, A., Y. Yin, R. E. Kelly, E. Y. Lee, A. Bradley, W. Li, J. R. Bertino, and G. M.
Wahl. 1995. 'Deficiency of retinoblastoma protein leads to inappropriate S-phase
entry, activation of E2F-responsive genes, and apoptosis', Proc Natl Acad Sci U S A,
92: 5436-40.
Andrusiak, M. G., and Y. Jin. 2016. 'Context Specificity of Stress-activated Mitogenactivated Protein (MAP) Kinase Signaling: The Story as Told by Caenorhabditis
elegans', J Biol Chem, 291: 7796-804.
Angelo, G., and M. R. Van Gilst. 2009. 'Starvation protects germline stem cells and
extends reproductive longevity in C. elegans', Science, 326: 954-8.
Arellano, M., and S. Moreno. 1997. 'Regulation of CDK/cyclin complexes during the cell
cycle', Int J Biochem Cell Biol, 29: 559-73.
Arur, S., M. Ohmachi, M. Berkseth, S. Nayak, D. Hansen, D. Zarkower, and T. Schedl.
2011. 'MPK-1 ERK controls membrane organization in C. elegans oogenesis via a
sex-determination module', Dev Cell, 20: 677-88.
Arur, S., M. Ohmachi, S. Nayak, M. Hayes, A. Miranda, A. Hay, A. Golden, and T.
Schedl. 2009. 'Multiple ERK substrates execute single biological processes in
Caenorhabditis elegans germ-line development', Proc Natl Acad Sci U S A, 106:
4776-81.
170

Audry, J., L. Maestroni, E. Delagoutte, T. Gauthier, T. M. Nakamura, Y. Gachet, C.
Saintome, V. Geli, and S. Coulon. 2015. 'RPA prevents G-rich structure formation at
lagging-strand telomeres to allow maintenance of chromosome ends', EMBO J, 34:
1942-58.
Austin, J., and J. Kimble. 1987. 'glp-1 is required in the germ line for regulation of the
decision between mitosis and meiosis in C. elegans', Cell, 51: 589-99.
Bagley, B. N., T. M. Keane, V. I. Maklakova, J. G. Marshall, R. A. Lester, M. M. Cancel,
A. R. Paulsen, L. E. Bendzick, R. A. Been, S. C. Kogan, R. T. Cormier, C.
Kendziorski, D. J. Adams, and L. S. Collier. 2012. 'A dominantly acting murine allele
of Mcm4 causes chromosomal abnormalities and promotes tumorigenesis', PLoS
Genet, 8: e1003034.
Banin, S., L. Moyal, S. Shieh, Y. Taya, C. W. Anderson, L. Chessa, N. I. Smorodinsky,
C. Prives, Y. Reiss, Y. Shiloh, and Y. Ziv. 1998. 'Enhanced phosphorylation of p53 by
ATM in response to DNA damage', Science, 281: 1674-7.
Berry, L. W., B. Westlund, and T. Schedl. 1997. 'Germ-line tumor formation caused by
activation of glp-1, a Caenorhabditis elegans member of the Notch family of
receptors', Development, 124: 925-36.
Berti, M., and A. Vindigni. 2016. 'Replication stress: getting back on track', Nat Struct
Mol Biol, 23: 103-9.
Besson, A., S. F. Dowdy, and J. M. Roberts. 2008. 'CDK inhibitors: cell cycle regulators
and beyond', Dev Cell, 14: 159-69.
Betschinger, J., and J. A. Knoblich. 2004. 'Dare to be different: asymmetric cell division
in Drosophila, C. elegans and vertebrates', Curr Biol, 14: R674-85.
Blow, J. J. 1993. 'Preventing re-replication of DNA in a single cell cycle: evidence for a
replication licensing factor', J Cell Biol, 122: 993-1002.
171

Blow, J. J., and B. Hodgson. 2002. 'Replication licensing--defining the proliferative
state?', Trends Cell Biol, 12: 72-8.
Borgne, A., A. C. Ostvold, S. Flament, and L. Meijer. 1999. 'Intra-M phase-promoting
factor phosphorylation of cyclin B at the prophase/metaphase transition', J Biol Chem,
274: 11977-86.
Bouskila, M., M. F. Hirshman, J. Jensen, L. J. Goodyear, and K. Sakamoto. 2008.
'Insulin promotes glycogen synthesis in the absence of GSK3 phosphorylation in
skeletal muscle', Am J Physiol Endocrinol Metab, 294: E28-35.
Boxem, M., D. G. Srinivasan, and S. van den Heuvel. 1999. 'The Caenorhabditis
elegans gene ncc-1 encodes a cdc2-related kinase required for M phase in meiotic
and mitotic cell divisions, but not for S phase', Development, 126: 2227-39.
Boxem, M., and S. van den Heuvel. 2001. 'lin-35 Rb and cki-1 Cip/Kip cooperate in
developmental regulation of G1 progression in C. elegans', Development, 128: 434959.
Bracken, A. P., M. Ciro, A. Cocito, and K. Helin. 2004. 'E2F target genes: unraveling
the biology', Trends Biochem Sci, 29: 409-17.
Bradford, G. B., B. Williams, R. Rossi, and I. Bertoncello. 1997. 'Quiescence, cycling,
and turnover in the primitive hematopoietic stem cell compartment', Exp Hematol, 25:
445-53.
Brehm, A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and T. Kouzarides.
1998. 'Retinoblastoma protein recruits histone deacetylase to repress transcription',
Nature, 391: 597-601.
Brenner, S. 1974. 'The genetics of Caenorhabditis elegans', Genetics, 77: 71-94.
Brodigan, T. M., Ji Liu, M. Park, E. T. Kipreos, and M. Krause. 2003. 'Cyclin E
expression during development in Caenorhabditis elegans', Dev Biol, 254: 102-15.
172

Brugarolas, J., K. Lei, R. L. Hurley, B. D. Manning, J. H. Reiling, E. Hafen, L. A. Witters,
L. W. Ellisen, and W. G. Kaelin, Jr. 2004. 'Regulation of mTOR function in response to
hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex', Genes Dev, 18:
2893-904.
Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. 'The retinoblastoma protein is
phosphorylated during specific phases of the cell cycle', Cell, 58: 1097-105.
Buck, S. H., D. Chiu, and R. M. Saito. 2009. 'The cyclin-dependent kinase inhibitors,
cki-1 and cki-2, act in overlapping but distinct pathways to control cell cycle
quiescence during C. elegans development', Cell Cycle, 8: 2613-20.
Byun, T. S., M. Pacek, M. C. Yee, J. C. Walter, and K. A. Cimprich. 2005. 'Functional
uncoupling of MCM helicase and DNA polymerase activities activates the ATRdependent checkpoint', Genes Dev, 19: 1040-52.
Campbell, J. M., M. B. Nottle, I. Vassiliev, M. Mitchell, and M. Lane. 2012. 'Insulin
increases epiblast cell number of in vitro cultured mouse embryos via the
PI3K/GSK3/p53 pathway', Stem Cells Dev, 21: 2430-41.
Ceol, C. J., and H. R. Horvitz. 2001. 'dpl-1 DP and efl-1 E2F act with lin-35 Rb to
antagonize Ras signaling in C. elegans vulval development', Mol Cell, 7: 461-73.
Chan, F. K., J. Zhang, L. Cheng, D. N. Shapiro, and A. Winoto. 1995. 'Identification of
human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4',
Mol Cell Biol, 15: 2682-8.
Cheeks, R. J., J. C. Canman, W. N. Gabriel, N. Meyer, S. Strome, and B. Goldstein.
2004. 'C. elegans PAR proteins function by mobilizing and stabilizing asymmetrically
localized protein complexes', Curr Biol, 14: 851-62.

173

Chen, Y. H., S. Keegan, M. Kahli, P. Tonzi, D. Fenyo, T. T. Huang, and D. J. Smith.
2019. 'Transcription shapes DNA replication initiation and termination in human cells',
Nat Struct Mol Biol, 26: 67-77.
Cheng, T., N. Rodrigues, H. Shen, Y. Yang, D. Dombkowski, M. Sykes, and D. T.
Scadden. 2000. 'Hematopoietic stem cell quiescence maintained by p21cip1/waf1',
Science, 287: 1804-8.
Chi, W., and V. Reinke. 2006. 'Promotion of oogenesis and embryogenesis in the C.
elegans gonad by EFL-1/DPL-1 (E2F) does not require LIN-35 (pRB)', Development,
133: 3147-57.
———. 2009. 'DPL-1 (DP) acts in the germ line to coordinate ovulation and fertilization
in C. elegans', Mech Dev, 126: 406-16.
Choi, H. M., C. R. Calvert, N. Husain, D. Huss, J. C. Barsi, B. E. Deverman, R. C.
Hunter, M. Kato, S. M. Lee, A. C. Abelin, A. Z. Rosenthal, O. S. Akbari, Y. Li, B. A.
Hay, P. W. Sternberg, P. H. Patterson, E. H. Davidson, S. K. Mazmanian, D. A.
Prober, M. van de Rijn, J. R. Leadbetter, D. K. Newman, C. Readhead, M. E. Bronner,
B. Wold, R. Lansford, T. Sauka-Spengler, S. E. Fraser, and N. A. Pierce. 2016.
'Mapping a multiplexed zoo of mRNA expression', Development, 143: 3632-37.
Chong, J. P., and J. J. Blow. 1996. 'DNA replication licensing factor', Prog Cell Cycle
Res, 2: 83-90.
Chung, E., P. Deacon, S. Marable, J. Shin, and J. S. Park. 2016. 'Notch signaling
promotes nephrogenesis by downregulating Six2', Development, 143: 3907-13.
Chuykin, I. A., M. S. Lianguzova, T. V. Pospelova, and V. A. Pospelov. 2008.
'Activation of DNA damage response signaling in mouse embryonic stem cells', Cell
Cycle, 7: 2922-8.

174

Copeland, N. A., H. E. Sercombe, J. F. Ainscough, and D. Coverley. 2010. 'Ciz1
cooperates with cyclin-A-CDK2 to activate mammalian DNA replication in vitro', J Cell
Sci, 123: 1108-15.
Cotsarelis, G., T. T. Sun, and R. M. Lavker. 1990. 'Label-retaining cells reside in the
bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and
skin carcinogenesis', Cell, 61: 1329-37.
Coverley, D., H. Laman, and R. A. Laskey. 2002. 'Distinct roles for cyclins E and A
during DNA replication complex assembly and activation', Nat Cell Biol, 4: 523-8.
Cowan, C. R., and A. A. Hyman. 2006. 'Cyclin E-Cdk2 temporally regulates
centrosome assembly and establishment of polarity in Caenorhabditis elegans
embryos', Nat Cell Biol, 8: 1441-7.
Crittenden, S. L., K. A. Leonhard, D. T. Byrd, and J. Kimble. 2006. 'Cellular analyses of
the mitotic region in the Caenorhabditis elegans adult germ line', Mol Biol Cell, 17:
3051-61.
De Meyts, P. 2000. 'The Insulin Receptor and Its Signal Transduction Network.' in K. R.
Feingold, B. Anawalt, A. Boyce, G. Chrousos, K. Dungan, A. Grossman, J. M.
Hershman, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, R. McLachlan, J. E. Morley,
M. New, L. Perreault, J. Purnell, R. Rebar, F. Singer, D. L. Trence, A. Vinik and D. P.
Wilson (eds.), Endotext (South Dartmouth (MA)).
DeGregori, J., G. Leone, A. Miron, L. Jakoi, and J. R. Nevins. 1997. 'Distinct roles for
E2F proteins in cell growth control and apoptosis', Proc Natl Acad Sci U S A, 94:
7245-50.
Den Haese, G. J., N. Walworth, A. M. Carr, and K. L. Gould. 1995. 'The Wee1 protein
kinase regulates T14 phosphorylation of fission yeast Cdc2', Mol Biol Cell, 6: 371-85.

175

Deutsch, P. J., C. F. Wan, O. M. Rosen, and C. S. Rubin. 1983. 'Latent insulin
receptors and possible receptor precursors in 3T3-L1 adipocytes', Proc Natl Acad Sci
U S A, 80: 133-6.
Doble, B. W., and J. R. Woodgett. 2003. 'GSK-3: tricks of the trade for a multi-tasking
kinase', J Cell Sci, 116: 1175-86.
Dominguez-Brauer, C., Y. J. Chen, P. M. Brauer, J. Pimkina, and P. Raychaudhuri.
2009. 'ARF stimulates XPC to trigger nucleotide excision repair by regulating the
repressor complex of E2F4', EMBO Rep, 10: 1036-42.
Dorsett, M., B. Westlund, and T. Schedl. 2009. 'METT-10, a putative methyltransferase,
inhibits germ cell proliferative fate in Caenorhabditis elegans', Genetics, 183: 233-47.
Drake, M., T. Furuta, K. M. Suen, G. Gonzalez, B. Liu, A. Kalia, J. E. Ladbury, A. Z.
Fire, J. B. Skeath, and S. Arur. 2014. 'A requirement for ERK-dependent Dicer
phosphorylation in coordinating oocyte-to-embryo transition in C. elegans', Dev Cell,
31: 614-28.
Duret, L., N. Guex, M. C. Peitsch, and A. Bairoch. 1998. 'New insulin-like proteins with
atypical disulfide bond pattern characterized in Caenorhabditis elegans by
comparative sequence analysis and homology modeling', Genome Res, 8: 348-53.
Eckmann, C. R., S. L. Crittenden, N. Suh, and J. Kimble. 2004. 'GLD-3 and control of
the mitosis/meiosis decision in the germline of Caenorhabditis elegans', Genetics,
168: 147-60.
Edgar, L. G., and J. D. McGhee. 1988. 'DNA synthesis and the control of embryonic
gene expression in C. elegans', Cell, 53: 589-99.
Evans, M. J., and M. H. Kaufman. 1981. 'Establishment in culture of pluripotential cells
from mouse embryos', Nature, 292: 154-6.

176

Evans, T. C., S. L. Crittenden, V. Kodoyianni, and J. Kimble. 1994. 'Translational
control of maternal glp-1 mRNA establishes an asymmetry in the C. elegans embryo',
Cell, 77: 183-94.
Evans, T., E. T. Rosenthal, J. Youngblom, D. Distel, and T. Hunt. 1983. 'Cyclin: a
protein specified by maternal mRNA in sea urchin eggs that is destroyed at each
cleavage division', Cell, 33: 389-96.
Fairman, M. P., and B. Stillman. 1988. 'Cellular factors required for multiple stages of
SV40 DNA replication in vitro', EMBO J, 7: 1211-8.
Falck, J., N. Mailand, R. G. Syljuasen, J. Bartek, and J. Lukas. 2001. 'The ATM-Chk2Cdc25A checkpoint pathway guards against radioresistant DNA synthesis', Nature,
410: 842-7.
Fay, D. S., and M. Han. 2000. 'Mutations in cye-1, a Caenorhabditis elegans cyclin E
homolog, reveal coordination between cell-cycle control and vulval development',
Development, 127: 4049-60.
Feng, Z., W. Hu, E. de Stanchina, A. K. Teresky, S. Jin, S. Lowe, and A. J. Levine.
2007. 'The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress,
cell and tissue specificity, and the role of these gene products in modulating the IGF1-AKT-mTOR pathways', Cancer Res, 67: 3043-53.
Ferraro, F., C. L. Celso, and D. Scadden. 2010. 'Adult stem cels and their niches', Adv
Exp Med Biol, 695: 155-68.
Fingar, D. C., C. J. Richardson, A. R. Tee, L. Cheatham, C. Tsou, and J. Blenis. 2004.
'mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4EBP1/eukaryotic translation initiation factor 4E', Mol Cell Biol, 24: 200-16.
Fisher, R. P., and D. O. Morgan. 1994. 'A Novel Cyclin Associates with Mo15/Cdk7 to
Form the Cdk-Activating Kinase', Cell, 78: 713-24.
177

Fox, P. M., and T. Schedl. 2015. 'Analysis of Germline Stem Cell Differentiation
Following Loss of GLP-1 Notch Activity in Caenorhabditis elegans', Genetics, 201:
167-84.
Fox, P. M., V. E. Vought, M. Hanazawa, M. H. Lee, E. M. Maine, and T. Schedl. 2011.
'Cyclin E and CDK-2 regulate proliferative cell fate and cell cycle progression in the C.
elegans germline', Development, 138: 2223-34.
Franckhauser, C., D. Mamaeva, L. Heron-Milhavet, A. Fernandez, and N. J. Lamb.
2010. 'Distinct pools of cdc25C are phosphorylated on specific TP sites and
differentially localized in human mitotic cells', PLoS One, 5: e11798.
Franke, T. F., S. I. Yang, T. O. Chan, K. Datta, A. Kazlauskas, D. K. Morrison, D. R.
Kaplan, and P. N. Tsichlis. 1995. 'The protein kinase encoded by the Akt protooncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase', Cell, 81:
727-36.
Fukumoto, H., T. Kayano, J. B. Buse, Y. Edwards, P. F. Pilch, G. I. Bell, and S. Seino.
1989. 'Cloning and characterization of the major insulin-responsive glucose
transporter expressed in human skeletal muscle and other insulin-responsive tissues',
J Biol Chem, 264: 7776-9.
Fukuyama, M., A. E. Rougvie, and J. H. Rothman. 2006. 'C. elegans DAF-18/PTEN
mediates nutrient-dependent arrest of cell cycle and growth in the germline', Curr Biol,
16: 773-9.
Fung, T. K., H. T. Ma, and R. Y. Poon. 2007. 'Specialized roles of the two mitotic
cyclins in somatic cells: cyclin A as an activator of M phase-promoting factor', Mol Biol
Cell, 18: 1861-73.

178

Furuta, T., H. J. Joo, K. A. Trimmer, S. Y. Chen, and S. Arur. 2018. 'GSK-3 promotes
S-phase entry and progression in C. elegans germline stem cells to maintain tissue
output', Development, 145.
Gangloff, Y. G., M. Mueller, S. G. Dann, P. Svoboda, M. Sticker, J. F. Spetz, S. H. Um,
E. J. Brown, S. Cereghini, G. Thomas, and S. C. Kozma. 2004. 'Disruption of the
mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic
stem cell development', Mol Cell Biol, 24: 9508-16.
Gao, Z., Z. Qiu, M. Lu, J. Shu, and D. Tang. 2017. 'Hybridization chain reaction-based
colorimetric aptasensor of adenosine 5'-triphosphate on unmodified gold
nanoparticles and two label-free hairpin probes', Biosens Bioelectron, 89: 1006-12.
Garcia-Muse, T., and S. J. Boulton. 2005. 'Distinct modes of ATR activation after
replication stress and DNA double-strand breaks in Caenorhabditis elegans', EMBO J,
24: 4345-55.
Gardner, R. L. 1983. 'Origin and differentiation of extraembryonic tissues in the mouse',
Int Rev Exp Pathol, 24: 63-133.
Gardner, R. L., and M. H. Johnson. 1973. 'Investigation of early mammalian
development using interspecific chimaeras between rat and mouse', Nat New Biol,
246: 86-9.
Gardner, R. L., and J. Rossant. 1979. 'Investigation of the fate of 4-5 day post-coitum
mouse inner cell mass cells by blastocyst injection', J Embryol Exp Morphol, 52: 14152.
Gartner, A., S. Milstein, S. Ahmed, J. Hodgkin, and M. O. Hengartner. 2000. 'A
conserved checkpoint pathway mediates DNA damage--induced apoptosis and cell
cycle arrest in C. elegans', Mol Cell, 5: 435-43.

179

Gerhold, A. R., J. Ryan, J. N. Vallee-Trudeau, J. F. Dorn, J. C. Labbe, and P. S.
Maddox. 2015. 'Investigating the regulation of stem and progenitor cell mitotic
progression by in situ imaging', Curr Biol, 25: 1123-34.
Girard, F., U. Strausfeld, A. Fernandez, and N. J. Lamb. 1991. 'Cyclin A is required for
the onset of DNA replication in mammalian fibroblasts', Cell, 67: 1169-79.
Gleason, J. E., E. A. Szyleyko, and D. M. Eisenmann. 2006. 'Multiple redundant Wnt
signaling components function in two processes during C. elegans vulval
development', Dev Biol, 298: 442-57.
Golden, J. W., and D. L. Riddle. 1984. 'The Caenorhabditis elegans dauer larva:
developmental effects of pheromone, food, and temperature', Dev Biol, 102: 368-78.
Goss, A. M., Y. Tian, T. Tsukiyama, E. D. Cohen, D. Zhou, M. M. Lu, T. P. Yamaguchi,
and E. E. Morrisey. 2009. 'Wnt2/2b and beta-catenin signaling are necessary and
sufficient to specify lung progenitors in the foregut', Dev Cell, 17: 290-8.
Goto, H., T. Natsume, M. T. Kanemaki, A. Kaito, S. Wang, E. C. Gabazza, M. Inagaki,
and A. Mizoguchi. 2019. 'Chk1-mediated Cdc25A degradation as a critical mechanism
for normal cell cycle progression', J Cell Sci, 132.
Gould, K. L., S. Moreno, D. J. Owen, S. Sazer, and P. Nurse. 1991. 'Phosphorylation at
Thr167 is required for Schizosaccharomyces pombe p34cdc2 function', EMBO J, 10:
3297-309.
Graham, C. F. 1966a. 'The effect of cell size and DNA content on the cellular regulation
of DNA synthesis in haploid and diploid embryos', Exp Cell Res, 43: 13-9.
———. 1966b. 'The regulation of DNA synthesis and mitosis in multinucleate frog
eggs', J Cell Sci, 1: 363-74.
Gu, Y., J. Rosenblatt, and D. O. Morgan. 1992. 'Cell cycle regulation of CDK2 activity
by phosphorylation of Thr160 and Tyr15', EMBO J, 11: 3995-4005.
180

Guan, K. L., C. W. Jenkins, Y. Li, M. A. Nichols, X. Wu, C. L. O'Keefe, A. G. Matera,
and Y. Xiong. 1994. 'Growth suppression by p18, a p16INK4/MTS1- and
p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function',
Genes Dev, 8: 2939-52.
Guedes, S., and J. R. Priess. 1997. 'The C. elegans MEX-1 protein is present in
germline blastomeres and is a P granule component', Development, 124: 731-9.
Guertin, D. A., D. M. Stevens, C. C. Thoreen, A. A. Burds, N. Y. Kalaany, J. Moffat, M.
Brown, K. J. Fitzgerald, and D. M. Sabatini. 2006. 'Ablation in mice of the mTORC
components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to
Akt-FOXO and PKCalpha, but not S6K1', Dev Cell, 11: 859-71.
Gwinn, D. M., D. B. Shackelford, D. F. Egan, M. M. Mihaylova, A. Mery, D. S. Vasquez,
B. E. Turk, and R. J. Shaw. 2008. 'AMPK phosphorylation of raptor mediates a
metabolic checkpoint', Mol Cell, 30: 214-26.
Hagting, A., M. Jackman, K. Simpson, and J. Pines. 1999. 'Translocation of cyclin B1 to
the nucleus at prophase requires a phosphorylation-dependent nuclear import signal',
Curr Biol, 9: 680-9.
Hamperl, S., M. J. Bocek, J. C. Saldivar, T. Swigut, and K. A. Cimprich. 2017.
'Transcription-Replication Conflict Orientation Modulates R-Loop Levels and Activates
Distinct DNA Damage Responses', Cell, 170: 774-86 e19.
Hannon, G. J., and D. Beach. 1994. 'p15INK4B is a potential effector of TGF-betainduced cell cycle arrest', Nature, 371: 257-61.
Hansen, D., E. J. Hubbard, and T. Schedl. 2004. 'Multi-pathway control of the
proliferation versus meiotic development decision in the Caenorhabditis elegans
germline', Dev Biol, 268: 342-57.

181

Hansen, D., L. Wilson-Berry, T. Dang, and T. Schedl. 2004. 'Control of the proliferation
versus meiotic development decision in the C. elegans germline through regulation of
GLD-1 protein accumulation', Development, 131: 93-104.
Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. 'The p21
Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases', Cell,
75: 805-16.
Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L. H. Tsai, P. Zhang, S.
Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, and et al. 1995. 'Inhibition of
cyclin-dependent kinases by p21', Mol Biol Cell, 6: 387-400.
Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. 'Mdm2 promotes the rapid
degradation of p53', Nature, 387: 296-9.
Henderson, S. T., D. Gao, E. J. Lambie, and J. Kimble. 1994. 'lag-2 may encode a
signaling ligand for the GLP-1 and LIN-12 receptors of C. elegans', Development,
120: 2913-24.
Hermeking, H., C. Lengauer, K. Polyak, T. C. He, L. Zhang, S. Thiagalingam, K. W.
Kinzler, and B. Vogelstein. 1997. '14-3-3sigma is a p53-regulated inhibitor of G2/M
progression', Mol Cell, 1: 3-11.
Hima Bindu, A., and B. Srilatha. 2011. 'Potency of Various Types of Stem Cells and
their Transplantation', Journal of Stem Cell Research & Therapy, 1: 6.
Hirai, H., M. F. Roussel, J. Y. Kato, R. A. Ashmun, and C. J. Sherr. 1995. 'Novel INK4
proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4
and CDK6', Mol Cell Biol, 15: 2672-81.
Hirao, A., Y. Y. Kong, S. Matsuoka, A. Wakeham, J. Ruland, H. Yoshida, D. Liu, S. J.
Elledge, and T. W. Mak. 2000. 'DNA damage-induced activation of p53 by the
checkpoint kinase Chk2', Science, 287: 1824-7.
182

Hixson, D. C., J. M. Yep, J. R. Glenney, Jr., T. Hayes, and E. F. Walborg, Jr. 1981.
'Evaluation of periodate/lysine/paraformaldehyde fixation as a method for cross-linking
plasma membrane glycoproteins', J Histochem Cytochem, 29: 561-6.
Hosoyama, T., K. Nishijo, S. I. Prajapati, G. Li, and C. Keller. 2011. 'Rb1 gene
inactivation expands satellite cell and postnatal myoblast pools', J Biol Chem, 286:
19556-64.
Hsu, H. J., L. LaFever, and D. Drummond-Barbosa. 2008. 'Diet controls normal and
tumorous germline stem cells via insulin-dependent and -independent mechanisms in
Drosophila', Dev Biol, 313: 700-12.
Illmensee, K., and A. P. Mahowald. 1974. 'Transplantation of posterior polar plasm in
Drosophila. Induction of germ cells at the anterior pole of the egg', Proc Natl Acad Sci
U S A, 71: 1016-20.
———. 1976. 'The autonomous function of germ plasm in a somatic region of the
Drosophila egg', Exp Cell Res, 97: 127-40.
Inoki, K., Y. Li, T. Xu, and K. L. Guan. 2003. 'Rheb GTPase is a direct target of TSC2
GAP activity and regulates mTOR signaling', Genes Dev, 17: 1829-34.
Inoki, K., T. Zhu, and K. L. Guan. 2003. 'TSC2 mediates cellular energy response to
control cell growth and survival', Cell, 115: 577-90.
Jacinto, E., V. Facchinetti, D. Liu, N. Soto, S. Wei, S. Y. Jung, Q. Huang, J. Qin, and B.
Su. 2006. 'SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt
phosphorylation and substrate specificity', Cell, 127: 125-37.
Jan, E., C. K. Motzny, L. E. Graves, and E. B. Goodwin. 1999. 'The STAR protein,
GLD-1, is a translational regulator of sexual identity in Caenorhabditis elegans',
EMBO J, 18: 258-69.

183

Jia, K., D. Chen, and D. L. Riddle. 2004. 'The TOR pathway interacts with the insulin
signaling pathway to regulate C. elegans larval development, metabolism and life
span', Development, 131: 3897-906.
Jin, P., Y. Gu, and D. O. Morgan. 1996. 'Role of inhibitory CDC2 phosphorylation in
radiation-induced G2 arrest in human cells', J Cell Biol, 134: 963-70.
Johnson, M. H., and C. A. Ziomek. 1981. 'The foundation of two distinct cell lineages
within the mouse morula', Cell, 24: 71-80.
Jones, K. T., E. R. Greer, D. Pearce, and K. Ashrafi. 2009. 'Rictor/TORC2 regulates
Caenorhabditis elegans fat storage, body size, and development through sgk-1', PLoS
Biol, 7: e60.
Jope, R. S., and G. V. Johnson. 2004. 'The glamour and gloom of glycogen synthase
kinase-3', Trends Biochem Sci, 29: 95-102.
Kadyk, L. C., and J. Kimble. 1998. 'Genetic regulation of entry into meiosis in
Caenorhabditis elegans', Development, 125: 1803-13.
Kalchhauser, I., B. M. Farley, S. Pauli, S. P. Ryder, and R. Ciosk. 2011. 'FBF represses
the Cip/Kip cell-cycle inhibitor CKI-2 to promote self-renewal of germline stem cells in
C. elegans', EMBO J, 30: 3823-9.
Kasuga, M., J. A. Hedo, K. M. Yamada, and C. R. Kahn. 1982. 'The structure of insulin
receptor and its subunits. Evidence for multiple nonreduced forms and a 210,000
possible proreceptor', J Biol Chem, 257: 10392-9.
Kasuga, M., Y. Zick, D. L. Blith, F. A. Karlsson, H. U. Haring, and C. R. Kahn. 1982.
'Insulin stimulation of phosphorylation of the beta subunit of the insulin receptor.
Formation of both phosphoserine and phosphotyrosine', J Biol Chem, 257: 9891-4.

184

Kasuga, M., Y. Zick, D. L. Blithe, M. Crettaz, and C. R. Kahn. 1982. 'Insulin stimulates
tyrosine phosphorylation of the insulin receptor in a cell-free system', Nature, 298:
667-9.
Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. 'Direct
binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation
by the cyclin D-dependent kinase CDK4', Genes Dev, 7: 331-42.
Kato, J. Y., M. Matsuoka, D. K. Strom, and C. J. Sherr. 1994. 'Regulation of cyclin Ddependent kinase 4 (cdk4) by cdk4-activating kinase', Mol Cell Biol, 14: 2713-21.
Kawano, T., Y. Ito, M. Ishiguro, K. Takuwa, T. Nakajima, and Y. Kimura. 2000.
'Molecular cloning and characterization of a new insulin/IGF-like peptide of the
nematode Caenorhabditis elegans', Biochem Biophys Res Commun, 273: 431-6.
Kawasome, H., P. Papst, S. Webb, G. M. Keller, G. L. Johnson, E. W. Gelfand, and N.
Terada. 1998. 'Targeted disruption of p70(s6k) defines its role in protein synthesis and
rapamycin sensitivity', Proc Natl Acad Sci U S A, 95: 5033-8.
Kermi, C., E. Lo Furno, and D. Maiorano. 2017. 'Regulation of DNA Replication in Early
Embryonic Cleavages', Genes (Basel), 8.
Kimble, J. E., and J. G. White. 1981. 'On the control of germ cell development in
Caenorhabditis elegans', Dev Biol, 81: 208-19.
Kimura, K. D., H. A. Tissenbaum, Y. Liu, and G. Ruvkun. 1997. 'daf-2, an insulin
receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans',
Science, 277: 942-6.
King, R. W., P. K. Jackson, and M. W. Kirschner. 1994. 'Mitosis in transition', Cell, 79:
563-71.

185

Kiyokawa, H., and D. Ray. 2008. 'In vivo roles of CDC25 phosphatases: biological
insight into the anti-cancer therapeutic targets', Anticancer Agents Med Chem, 8: 8326.
Klippel, A., C. Reinhard, W. M. Kavanaugh, G. Apell, M. A. Escobedo, and L. T.
Williams. 1996. 'Membrane localization of phosphatidylinositol 3-kinase is sufficient to
activate multiple signal-transducing kinase pathways', Mol Cell Biol, 16: 4117-27.
Kodoyianni, V., E. M. Maine, and J. Kimble. 1992. 'Molecular basis of loss-of-function
mutations in the glp-1 gene of Caenorhabditis elegans', Mol Biol Cell, 3: 1199-213.
Korta, D. Z., and E. J. Hubbard. 2010. 'Soma-germline interactions that influence
germline proliferation in Caenorhabditis elegans', Dev Dyn, 239: 1449-59.
Korta, D. Z., S. Tuck, and E. J. Hubbard. 2012. 'S6K links cell fate, cell cycle and
nutrient response in C. elegans germline stem/progenitor cells', Development, 139:
859-70.
Kunkel, T. A. 2004. 'DNA replication fidelity', J Biol Chem, 279: 16895-8.
Ladha, M. H., K. Y. Lee, T. M. Upton, M. F. Reed, and M. E. Ewen. 1998. 'Regulation
of exit from quiescence by p27 and cyclin D1-CDK4', Mol Cell Biol, 18: 6605-15.
LaFever, L., A. Feoktistov, H. J. Hsu, and D. Drummond-Barbosa. 2010. 'Specific roles
of Target of rapamycin in the control of stem cells and their progeny in the Drosophila
ovary', Development, 137: 2117-26.
Lambie, E. J., and J. Kimble. 1991. 'Two homologous regulatory genes, lin-12 and glp1, have overlapping functions', Development, 112: 231-40.
Larner, J., C. Villar-Palasi, N. D. Goldberg, J. S. Bishop, F. Huijing, J. I. Wenger, H.
Sasko, and N. B. Brown. 1968. 'Hormonal and non-hormonal control of glycogen
synthesis-control of transferase phosphatase and transferase I kinase', Adv Enzyme
Regul, 6: 409-23.
186

Lawson, K. A., N. R. Dunn, B. A. Roelen, L. M. Zeinstra, A. M. Davis, C. V. Wright, J. P.
Korving, and B. L. Hogan. 1999. 'Bmp4 is required for the generation of primordial
germ cells in the mouse embryo', Genes Dev, 13: 424-36.
Lee, J. Y., A. E. Bielawska, and L. M. Obeid. 2000. 'Regulation of cyclin-dependent
kinase 2 activity by ceramide', Exp Cell Res, 261: 303-11.
Lee, M. H., I. Reynisdottir, and J. Massague. 1995. 'Cloning of p57KIP2, a cyclindependent kinase inhibitor with unique domain structure and tissue distribution',
Genes Dev, 9: 639-49.
Lee, S. J., A. Gartner, M. Hyun, B. Ahn, and H. S. Koo. 2010. 'The Caenorhabditis
elegans Werner syndrome protein functions upstream of ATR and ATM in response to
DNA replication inhibition and double-strand DNA breaks', PLoS Genet, 6: e1000801.
Levine, A. J. 1997. 'p53, the cellular gatekeeper for growth and division', Cell, 88: 32331.
Li, C., and J. Jin. 2010. 'DNA replication licensing control and rereplication prevention',
Protein Cell, 1: 227-36.
Li, J., M. Deng, Q. Wei, T. Liu, X. Tong, and X. Ye. 2011. 'Phosphorylation of MCM3
protein by cyclin E/cyclin-dependent kinase 2 (Cdk2) regulates its function in cell
cycle', J Biol Chem, 286: 39776-85.
Li, W., S. G. Kennedy, and G. Ruvkun. 2003. 'daf-28 encodes a C. elegans insulin
superfamily member that is regulated by environmental cues and acts in the DAF-2
signaling pathway', Genes Dev, 17: 844-58.
Liu, B., Q. Xue, Y. Tang, J. Cao, F. P. Guengerich, and H. Zhang. 2016. 'Mechanisms
of mutagenesis: DNA replication in the presence of DNA damage', Mutat Res Rev
Mutat Res, 768: 53-67.

187

Liu, F., J. J. Stanton, Z. Wu, and H. Piwnica-Worms. 1997. 'The human Myt1 kinase
preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic
reticulum and Golgi complex', Mol Cell Biol, 17: 571-83.
Liu, P., D. M. Slater, M. Lenburg, K. Nevis, J. G. Cook, and C. Vaziri. 2009. 'Replication
licensing promotes cyclin D1 expression and G1 progression in untransformed human
cells', Cell Cycle, 8: 125-36.
Liu, S., B. Shiotani, M. Lahiri, A. Marechal, A. Tse, C. C. Leung, J. N. Glover, X. H.
Yang, and L. Zou. 2011. 'ATR autophosphorylation as a molecular switch for
checkpoint activation', Mol Cell, 43: 192-202.
Long, X., C. Spycher, Z. S. Han, A. M. Rose, F. Muller, and J. Avruch. 2002. 'TOR
deficiency in C. elegans causes developmental arrest and intestinal atrophy by
inhibition of mRNA translation', Curr Biol, 12: 1448-61.
Lopez-Aviles, S., M. Grande, M. Gonzalez, A. L. Helgesen, V. Alemany, M. SanchezPiris, O. Bachs, J. B. Millar, and R. Aligue. 2005. 'Inactivation of the Cdc25
phosphatase by the stress-activated Srk1 kinase in fission yeast', Mol Cell, 17: 49-59.
Lopez-Aviles, S., E. Lambea, A. Moldon, M. Grande, A. Fajardo, M. A. RodriguezGabriel, E. Hidalgo, and R. Aligue. 2008. 'Activation of Srk1 by the mitogen-activated
protein kinase Sty1/Spc1 precedes its dissociation from the kinase and signals its
degradation', Mol Biol Cell, 19: 1670-9.
Lopez-Girona, A., B. Furnari, O. Mondesert, and P. Russell. 1999. 'Nuclear localization
of Cdc25 is regulated by DNA damage and a 14-3-3 protein', Nature, 397: 172-5.
Lopez-Onieva, L., A. Fernandez-Minan, and A. Gonzalez-Reyes. 2008. 'Jak/Stat
signalling in niche support cells regulates dpp transcription to control germline stem
cell maintenance in the Drosophila ovary', Development, 135: 533-40.

188

Lopez, A. L., 3rd, J. Chen, H. J. Joo, M. Drake, M. Shidate, C. Kseib, and S. Arur.
2013a. 'DAF-2 and ERK couple nutrient availability to meiotic progression during
Caenorhabditis elegans oogenesis', Dev Cell, 27: 227-40.
———. 2013b. 'DAF-2 and ERK couple nutrient availability to meiotic progression
during Caenorhabditis elegans oogenesis', Dev Cell, 27: 227-40.
MacNeill, S. A. 2001. 'DNA replication: partners in the Okazaki two-step', Curr Biol, 11:
R842-4.
Maduro, M. F., M. D. Meneghini, B. Bowerman, G. Broitman-Maduro, and J. H.
Rothman. 2001. 'Restriction of mesendoderm to a single blastomere by the combined
action of SKN-1 and a GSK-3beta homolog is mediated by MED-1 and -2 in C.
elegans', Mol Cell, 7: 475-85.
Mailand, N., J. Falck, C. Lukas, R. G. Syljuasen, M. Welcker, J. Bartek, and J. Lukas.
2000. 'Rapid destruction of human Cdc25A in response to DNA damage', Science,
288: 1425-9.
Mairet-Coello, G., A. Tury, and E. DiCicco-Bloom. 2009. 'Insulin-like growth factor-1
promotes G(1)/S cell cycle progression through bidirectional regulation of cyclins and
cyclin-dependent kinase inhibitors via the phosphatidylinositol 3-kinase/Akt pathway in
developing rat cerebral cortex', J Neurosci, 29: 775-88.
Marin, V. A., and T. C. Evans. 2003. 'Translational repression of a C. elegans Notch
mRNA by the STAR/KH domain protein GLD-1', Development, 130: 2623-32.
Martin, G. R. 1981. 'Isolation of a pluripotent cell line from early mouse embryos
cultured in medium conditioned by teratocarcinoma stem cells', Proc Natl Acad Sci U
S A, 78: 7634-8.

189

Masai, H., S. Matsumoto, Z. You, N. Yoshizawa-Sugata, and M. Oda. 2010. 'Eukaryotic
chromosome DNA replication: where, when, and how?', Annu Rev Biochem, 79: 89130.
Matsumoto, A., S. Takeishi, T. Kanie, E. Susaki, I. Onoyama, Y. Tateishi, K.
Nakayama, and K. I. Nakayama. 2011. 'p57 is required for quiescence and
maintenance of adult hematopoietic stem cells', Cell Stem Cell, 9: 262-71.
Matsuoka, S., M. C. Edwards, C. Bai, S. Parker, P. Zhang, A. Baldini, J. W. Harper,
and S. J. Elledge. 1995. 'p57KIP2, a structurally distinct member of the p21CIP1 Cdk
inhibitor family, is a candidate tumor suppressor gene', Genes Dev, 9: 650-62.
Matsushime, H., M. F. Roussel, R. A. Ashmun, and C. J. Sherr. 1991. 'Colonystimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle', Cell,
65: 701-13.
McGowan, C. H., and P. Russell. 1995. 'Cell cycle regulation of human WEE1', EMBO
J, 14: 2166-75.
McManus, E. J., K. Sakamoto, L. J. Armit, L. Ronaldson, N. Shpiro, R. Marquez, and D.
R. Alessi. 2005. 'Role that phosphorylation of GSK3 plays in insulin and Wnt signalling
defined by knockin analysis', EMBO J, 24: 1571-83.
Menon, S., C. C. Dibble, G. Talbott, G. Hoxhaj, A. J. Valvezan, H. Takahashi, L. C.
Cantley, and B. D. Manning. 2014. 'Spatial control of the TSC complex integrates
insulin and nutrient regulation of mTORC1 at the lysosome', Cell, 156: 771-85.
Merritt, C., D. Rasoloson, D. Ko, and G. Seydoux. 2008. '3' UTRs are the primary
regulators of gene expression in the C. elegans germline', Curr Biol, 18: 1476-82.
Michaelson, D., D. Z. Korta, Y. Capua, and E. J. Hubbard. 2010. 'Insulin signaling
promotes germline proliferation in C. elegans', Development, 137: 671-80.

190

Molyneaux, K. A., J. Stallock, K. Schaible, and C. Wylie. 2001. 'Time-lapse analysis of
living mouse germ cell migration', Dev Biol, 240: 488-98.
Morgan, D. O. 1995. 'Principles of Cdk Regulation', Nature, 374: 131-34.
Muller, H., M. C. Moroni, E. Vigo, B. O. Petersen, J. Bartek, and K. Helin. 1997.
'Induction of S-phase entry by E2F transcription factors depends on their nuclear
localization', Mol Cell Biol, 17: 5508-20.
Munoz, M. J., and D. L. Riddle. 2003. 'Positive selection of Caenorhabditis elegans
mutants with increased stress resistance and longevity', Genetics, 163: 171-80.
Nakashima, A., Y. Maruki, Y. Imamura, C. Kondo, T. Kawamata, I. Kawanishi, H.
Takata, A. Matsuura, K. S. Lee, U. Kikkawa, Y. Ohsumi, K. Yonezawa, and Y.
Kamada. 2008. 'The yeast Tor signaling pathway is involved in G2/M transition via
polo-kinase', PLoS One, 3: e2223.
Nevis, K. R., M. Cordeiro-Stone, and J. G. Cook. 2009. 'Origin licensing and p53 status
regulate Cdk2 activity during G(1)', Cell Cycle, 8: 1952-63.
Nishijima, H., H. Nishitani, N. Saito, and T. Nishimoto. 2003. 'Caffeine mimics adenine
and 2'-deoxyadenosine, both of which inhibit the guanine-nucleotide exchange activity
of RCC1 and the kinase activity of ATR', Genes Cells, 8: 423-35.
Norbury, C., J. Blow, and P. Nurse. 1991. 'Regulatory phosphorylation of the p34cdc2
protein kinase in vertebrates', EMBO J, 10: 3321-9.
Ohinata, Y., H. Ohta, M. Shigeta, K. Yamanaka, T. Wakayama, and M. Saitou. 2009. 'A
signaling principle for the specification of the germ cell lineage in mice', Cell, 137:
571-84.
Ohtsubo, M., A. M. Theodoras, J. Schumacher, J. M. Roberts, and M. Pagano. 1995.
'Human cyclin E, a nuclear protein essential for the G1-to-S phase transition', Mol Cell
Biol, 15: 2612-24.
191

Ohtsuka, S., and S. Dalton. 2008. 'Molecular and biological properties of pluripotent
embryonic stem cells', Gene Ther, 15: 74-81.
Olson, T. S., M. J. Bamberger, and M. D. Lane. 1988. 'Post-translational changes in
tertiary and quaternary structure of the insulin proreceptor. Correlation with acquisition
of function', J Biol Chem, 263: 7342-51.
Pages, V., and R. P. Fuchs. 2003. 'Uncoupling of leading- and lagging-strand DNA
replication during lesion bypass in vivo', Science, 300: 1300-3.
Paix, A., A. Folkmann, and G. Seydoux. 2017. 'Precision genome editing using
CRISPR-Cas9 and linear repair templates in C. elegans', Methods, 121-122: 86-93.
Papaioannou, V. E., M. W. McBurney, R. L. Gardner, and M. J. Evans. 1975. 'Fate of
teratocarcinoma cells injected into early mouse embryos', Nature, 258: 70-73.
Pardee, A. B. 1974. 'A restriction point for control of normal animal cell proliferation',
Proc Natl Acad Sci U S A, 71: 1286-90.
Parisi, F., S. Riccardo, M. Daniel, M. Saqcena, N. Kundu, A. Pession, D. Grifoni, H.
Stocker, E. Tabak, and P. Bellosta. 2011. 'Drosophila insulin and target of rapamycin
(TOR) pathways regulate GSK3 beta activity to control Myc stability and determine
Myc expression in vivo', BMC Biol, 9: 65.
Peng, C. Y., P. R. Graves, R. S. Thoma, Z. Wu, A. S. Shaw, and H. Piwnica-Worms.
1997. 'Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by
phosphorylation of Cdc25C on serine-216', Science, 277: 1501-5.
Pepper, A. S., D. J. Killian, and E. J. Hubbard. 2003. 'Genetic analysis of
Caenorhabditis elegans glp-1 mutants suggests receptor interaction or competition',
Genetics, 163: 115-32.
Pierce, S. B., M. Costa, R. Wisotzkey, S. Devadhar, S. A. Homburger, A. R. Buchman,
K. C. Ferguson, J. Heller, D. M. Platt, A. A. Pasquinelli, L. X. Liu, S. K. Doberstein,
192

and G. Ruvkun. 2001. 'Regulation of DAF-2 receptor signaling by human insulin and
ins-1, a member of the unusually large and diverse C. elegans insulin gene family',
Genes Dev, 15: 672-86.
Pilch, P. F., and M. P. Czech. 1979. 'Interaction of cross-linking agents with the insulin
effector system of isolated fat cells. Covalent linkage of 125I-insulin to a plasma
membrane receptor protein of 140,000 daltons', J Biol Chem, 254: 3375-81.
Pilkinton, M., R. Sandoval, and O. R. Colamonici. 2007. 'Mammalian Mip/LIN-9
interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cyclephase-dependent context distinct from the Drosophila dREAM complex', Oncogene,
26: 7535-43.
Pines, J. 1991. 'Cyclins: wheels within wheels', Cell Growth Differ, 2: 305-10.
Pines, J., and T. Hunter. 1994. 'The differential localization of human cyclins A and B is
due to a cytoplasmic retention signal in cyclin B', EMBO J, 13: 3772-81.
Pinkston-Gosse, J., and C. Kenyon. 2007. 'DAF-16/FOXO targets genes that regulate
tumor growth in Caenorhabditis elegans', Nat Genet, 39: 1403-9.
Polager, S., Y. Kalma, E. Berkovich, and D. Ginsberg. 2002. 'E2Fs up-regulate
expression of genes involved in DNA replication, DNA repair and mitosis', Oncogene,
21: 437-46.
Polyak, K., J. Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A.
Koff. 1994. 'p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and
contact inhibition to cell cycle arrest', Genes Dev, 8: 9-22.
Polyak, K., M. H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J.
Massague. 1994. 'Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a
potential mediator of extracellular antimitogenic signals', Cell, 78: 59-66.

193

Popov, B., L. S. Chang, and V. Serikov. 2005. 'Cell cycle-related transformation of the
E2F4-p130 repressor complex', Biochem Biophys Res Commun, 336: 762-9.
Praitis, V. 2006. 'Creation of transgenic lines using microparticle bombardment
methods', Methods Mol Biol, 351: 93-107.
Qi, W., X. Huang, E. Neumann-Haefelin, E. Schulze, and R. Baumeister. 2012. 'Cellnonautonomous signaling of FOXO/DAF-16 to the stem cells of Caenorhabditis
elegans', PLoS Genet, 8: e1002836.
Qi, W., Y. Yan, D. Pfeifer, V. Gromoff E. Donner, Y. Wang, W. Maier, and R.
Baumeister. 2017. 'C. elegans DAF-16/FOXO interacts with TGF-ss/BMP signaling to
induce germline tumor formation via mTORC1 activation', PLoS Genet, 13: e1006801.
Qiao, L., J. L. Lissemore, P. Shu, A. Smardon, M. B. Gelber, and E. M. Maine. 1995.
'Enhancers of glp-1, a gene required for cell-signaling in Caenorhabditis elegans,
define a set of genes required for germline development', Genetics, 141: 551-69.
Rawlins, E. L., C. P. Clark, Y. Xue, and B. L. Hogan. 2009. 'The Id2+ distal tip lung
epithelium contains individual multipotent embryonic progenitor cells', Development,
136: 3741-5.
Reddien, P. W., E. C. Andersen, M. C. Huang, and H. R. Horvitz. 2007. 'DPL-1 DP,
LIN-35 Rb and EFL-1 E2F act with the MCD-1 zinc-finger protein to promote
programmed cell death in Caenorhabditis elegans', Genetics, 175: 1719-33.
Rohde, J., J. Heitman, and M. E. Cardenas. 2001. 'The TOR kinases link nutrient
sensing to cell growth', J Biol Chem, 276: 9583-6.
Rosen, O. M., R. Herrera, Y. Olowe, L. M. Petruzzelli, and M. H. Cobb. 1983.
'Phosphorylation activates the insulin receptor tyrosine protein kinase', Proc Natl Acad
Sci U S A, 80: 3237-40.

194

Rosu, S., and O. Cohen-Fix. 2017. 'Live-imaging analysis of germ cell proliferation in
the C. elegans adult supports a stochastic model for stem cell proliferation', Dev Biol,
423: 93-100.
Rubin, S. M., A. L. Gall, N. Zheng, and N. P. Pavletich. 2005. 'Structure of the Rb Cterminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F
release', Cell, 123: 1093-106.
Rumman, M., J. Dhawan, and M. Kassem. 2015. 'Concise Review: Quiescence in Adult
Stem Cells: Biological Significance and Relevance to Tissue Regeneration', Stem
Cells, 33: 2903-12.
Russell, P., and P. Nurse. 1987. 'Negative regulation of mitosis by wee1+, a gene
encoding a protein kinase homolog', Cell, 49: 559-67.
Ryder, S. P., L. A. Frater, D. L. Abramovitz, E. B. Goodwin, and J. R. Williamson. 2004.
'RNA target specificity of the STAR/GSG domain post-transcriptional regulatory
protein GLD-1', Nat Struct Mol Biol, 11: 20-8.
Rylatt, D. B., A. Aitken, T. Bilham, G. D. Condon, N. Embi, and P. Cohen. 1980.
'Glycogen synthase from rabbit skeletal muscle. Amino acid sequence at the sites
phosphorylated by glycogen synthase kinase-3, and extension of the N-terminal
sequence containing the site phosphorylated by phosphorylase kinase', Eur J
Biochem, 107: 529-37.
Sa, G., M. Hitomi, J. Harwalkar, A. W. Stacey, G. C. Gc, and D. W. Stacey. 2002. 'Ras
is active throughout the cell cycle, but is able to induce cyclin D1 only during G2
phase', Cell Cycle, 1: 50-8.
Sanchez, Y., C. Wong, R. S. Thoma, R. Richman, Z. Wu, H. Piwnica-Worms, and S. J.
Elledge. 1997. 'Conservation of the Chk1 checkpoint pathway in mammals: linkage of
DNA damage to Cdk regulation through Cdc25', Science, 277: 1497-501.
195

Sankaran, V. G., S. H. Orkin, and C. R. Walkley. 2008. 'Rb intrinsically promotes
erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis', Genes Dev,
22: 463-75.
Sarbassov, D. D., D. A. Guertin, S. M. Ali, and D. M. Sabatini. 2005. 'Phosphorylation
and regulation of Akt/PKB by the rictor-mTOR complex', Science, 307: 1098-101.
Saxton, R. A., and D. M. Sabatini. 2017. 'mTOR Signaling in Growth, Metabolism, and
Disease', Cell, 168: 960-76.
Schenker, E., and R. A. Kohanski. 1991. 'The native alpha 2 beta 2 tetramer is the only
subunit structure of the insulin receptor in intact cells and purified receptor
preparations', Arch Biochem Biophys, 290: 79-85.
Schlegel, R., and A. B. Pardee. 1986. 'Caffeine-induced uncoupling of mitosis from the
completion of DNA replication in mammalian cells', Science, 232: 1264-6.
Schlesinger, A., C. A. Shelton, J. N. Maloof, M. Meneghini, and B. Bowerman. 1999.
'Wnt pathway components orient a mitotic spindle in the early Caenorhabditis elegans
embryo without requiring gene transcription in the responding cell', Genes Dev, 13:
2028-38.
Schubert, C. M., R. Lin, C. J. de Vries, R. H. Plasterk, and J. R. Priess. 2000. 'MEX-5
and MEX-6 function to establish soma/germline asymmetry in early C. elegans
embryos', Mol Cell, 5: 671-82.
Schultz, E., M. C. Gibson, and T. Champion. 1978. 'Satellite cells are mitotically
quiescent in mature mouse muscle: an EM and radioautographic study', J Exp Zool,
206: 451-6.
Schumacher, B., K. Hofmann, S. Boulton, and A. Gartner. 2001. 'The C. elegans
homolog of the p53 tumor suppressor is required for DNA damage-induced
apoptosis', Curr Biol, 11: 1722-7.
196

Seidel, H. S., and J. Kimble. 2015. 'Cell-cycle quiescence maintains Caenorhabditis
elegans germline stem cells independent of GLP-1/Notch', Elife, 4.
Serrano, M., G. J. Hannon, and D. Beach. 1993. 'A new regulatory motif in cell-cycle
control causing specific inhibition of cyclin D/CDK4', Nature, 366: 704-7.
Seydoux, G., and A. Fire. 1994. 'Soma-germline asymmetry in the distributions of
embryonic RNAs in Caenorhabditis elegans', Development, 120: 2823-34.
Shah, S., E. Lubeck, M. Schwarzkopf, T. F. He, A. Greenbaum, C. H. Sohn, A. Lignell,
H. M. Choi, V. Gradinaru, N. A. Pierce, and L. Cai. 2016. 'Single-molecule RNA
detection at depth by hybridization chain reaction and tissue hydrogel embedding and
clearing', Development, 143: 2862-7.
Shea, K. L., W. Xiang, V. S. LaPorta, J. D. Licht, C. Keller, M. A. Basson, and A. S.
Brack. 2010. 'Sprouty1 regulates reversible quiescence of a self-renewing adult
muscle stem cell pool during regeneration', Cell Stem Cell, 6: 117-29.
Shen, T., H. Zhou, C. Shang, Y. Luo, Y. Wu, and S. Huang. 2018. 'Ciclopirox activates
ATR-Chk1 signaling pathway leading to Cdc25A protein degradation', Genes Cancer,
9: 39-52.
Sherr, C. J. 1994. 'G1 phase progression: cycling on cue', Cell, 79: 551-5.
Sherr, C. J., and J. M. Roberts. 1999. 'CDK inhibitors: positive and negative regulators
of G1-phase progression', Genes Dev, 13: 1501-12.
Shia, M. A., and P. F. Pilch. 1983. 'The beta subunit of the insulin receptor is an insulinactivated protein kinase', Biochemistry, 22: 717-21.
Shieh, S. Y., J. Ahn, K. Tamai, Y. Taya, and C. Prives. 2000. 'The human homologs of
checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA
damage-inducible sites', Genes Dev, 14: 289-300.

197

Shieh, S. Y., M. Ikeda, Y. Taya, and C. Prives. 1997. 'DNA damage-induced
phosphorylation of p53 alleviates inhibition by MDM2', Cell, 91: 325-34.
Shiloh, Y. 2003. 'ATM and related protein kinases: safeguarding genome integrity', Nat
Rev Cancer, 3: 155-68.
Shima, N., A. Alcaraz, I. Liachko, T. R. Buske, C. A. Andrews, R. J. Munroe, S. A.
Hartford, B. K. Tye, and J. C. Schimenti. 2007. 'A viable allele of Mcm4 causes
chromosome instability and mammary adenocarcinomas in mice', Nat Genet, 39: 938.
Sigmond, T., J. Barna, M. L. Toth, K. Takacs-Vellai, G. Pasti, A. L. Kovacs, and T.
Vellai. 2008. 'Autophagy in Caenorhabditis elegans', Methods Enzymol, 451: 521-40.
Smith, E. J., G. Leone, J. DeGregori, L. Jakoi, and J. R. Nevins. 1996. 'The
accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state
from a G1 cell state', Mol Cell Biol, 16: 6965-76.
Smith, P., W. M. Leung-Chiu, R. Montgomery, A. Orsborn, K. Kuznicki, E. GressmanCoberly, L. Mutapcic, and K. Bennett. 2002. 'The GLH proteins, Caenorhabditis
elegans P granule components, associate with CSN-5 and KGB-1, proteins necessary
for fertility, and with ZYX-1, a predicted cytoskeletal protein', Dev Biol, 251: 333-47.
Snow, M. H. 1977. 'Myogenic cell formation in regenerating rat skeletal muscle injured
by mincing. II. An autoradiographic study', Anat Rec, 188: 201-17.
So, S., A. J. Davis, and D. J. Chen. 2009. 'Autophosphorylation at serine 1981
stabilizes ATM at DNA damage sites', J Cell Biol, 187: 977-90.
Sonneville, R., M. Querenet, A. Craig, A. Gartner, and J. J. Blow. 2012. 'The dynamics
of replication licensing in live Caenorhabditis elegans embryos', J Cell Biol, 196: 23346.

198

Soukas, A. A., E. A. Kane, C. E. Carr, J. A. Melo, and G. Ruvkun. 2009. 'Rictor/TORC2
regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans',
Genes Dev, 23: 496-511.
Spangrude, G. J., S. Heimfeld, and I. L. Weissman. 1988. 'Purification and
characterization of mouse hematopoietic stem cells', Science, 241: 58-62.
Spencer, S. L., S. D. Cappell, F. C. Tsai, K. W. Overton, C. L. Wang, and T. Meyer.
2013. 'The proliferation-quiescence decision is controlled by a bifurcation in CDK2
activity at mitotic exit', Cell, 155: 369-83.
Spradling, A., M. T. Fuller, R. E. Braun, and S. Yoshida. 2011. 'Germline stem cells',
Cold Spring Harb Perspect Biol, 3: a002642.
Stead, E., J. White, R. Faast, S. Conn, S. Goldstone, J. Rathjen, U. Dhingra, P.
Rathjen, D. Walker, and S. Dalton. 2002. 'Pluripotent cell division cycles are driven by
ectopic Cdk2, cyclin A/E and E2F activities', Oncogene, 21: 8320-33.
Stergiou, L., K. Doukoumetzidis, A. Sendoel, and M. O. Hengartner. 2007. 'The
nucleotide excision repair pathway is required for UV-C-induced apoptosis in
Caenorhabditis elegans', Cell Death Differ, 14: 1129-38.
Stiernagle, T. 2006. 'Maintenance of C. elegans', WormBook: 1-11.
Suen, K. M., C. C. Lin, R. George, F. A. Melo, E. R. Biggs, Z. Ahmed, M. N. Drake, S.
Arur, S. T. Arold, and J. E. Ladbury. 2013. 'Interaction with Shc prevents aberrant Erk
activation in the absence of extracellular stimuli', Nat Struct Mol Biol, 20: 620-7.
Suzuki, K., and T. Kono. 1980. 'Evidence that insulin causes translocation of glucose
transport activity to the plasma membrane from an intracellular storage site', Proc Natl
Acad Sci U S A, 77: 2542-5.
Takada, S., and B. J. Cha. 2011. 'In vivo live-analysis of cell cycle checkpoints in
Drosophila early embryos', Methods Mol Biol, 782: 75-92.
199

Tam, P. P., and M. H. Snow. 1981. 'Proliferation and migration of primordial germ cells
during compensatory growth in mouse embryos', J Embryol Exp Morphol, 64: 133-47.
Taniguchi, C. M., B. Emanuelli, and C. R. Kahn. 2006. 'Critical nodes in signalling
pathways: insights into insulin action', Nat Rev Mol Cell Biol, 7: 85-96.
Tee, A. R., B. D. Manning, P. P. Roux, L. C. Cantley, and J. Blenis. 2003. 'Tuberous
sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by
acting as a GTPase-activating protein complex toward Rheb', Curr Biol, 13: 1259-68.
Tenenhaus, C., C. Schubert, and G. Seydoux. 1998. 'Genetic requirements for PIE-1
localization and inhibition of gene expression in the embryonic germ lineage of
Caenorhabditis elegans', Dev Biol, 200: 212-24.
Thomson, J. A., J. Itskovitz-Eldor, S. S. Shapiro, M. A. Waknitz, J. J. Swiergiel, V. S.
Marshall, and J. M. Jones. 1998. 'Embryonic stem cell lines derived from human
blastocysts', Science, 282: 1145-7.
Tibbetts, R. S., K. M. Brumbaugh, J. M. Williams, J. N. Sarkaria, W. A. Cliby, S. Y.
Shieh, Y. Taya, C. Prives, and R. T. Abraham. 1999. 'A role for ATR in the DNA
damage-induced phosphorylation of p53', Genes Dev, 13: 152-7.
Timofeev, O., O. Cizmecioglu, E. Hu, T. Orlik, and I. Hoffmann. 2009. 'Human Cdc25A
phosphatase has a non-redundant function in G2 phase by activating Cyclin Adependent kinases', FEBS Lett, 583: 841-7.
Toyoshima-Morimoto, F., E. Taniguchi, N. Shinya, A. Iwamatsu, and E. Nishida. 2001.
'Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during
prophase', Nature, 410: 215-20.
Toyoshima, H., and T. Hunter. 1994. 'p27, a novel inhibitor of G1 cyclin-Cdk protein
kinase activity, is related to p21', Cell, 78: 67-74.

200

Tran, H., A. Brunet, E. C. Griffith, and M. E. Greenberg. 2003. 'The many forks in
FOXO's road', Sci STKE, 2003: RE5.
Vakifahmetoglu, H., M. Olsson, and B. Zhivotovsky. 2008. 'Death through a tragedy:
mitotic catastrophe', Cell Death Differ, 15: 1153-62.
Van Obberghen, E., B. Rossi, A. Kowalski, H. Gazzano, and G. Ponzio. 1983.
'Receptor-mediated phosphorylation of the hepatic insulin receptor: evidence that the
Mr 95,000 receptor subunit is its own kinase', Proc Natl Acad Sci U S A, 80: 945-9.
Van Zant, G. 1984. 'Studies of hematopoietic stem cells spared by 5-fluorouracil', J Exp
Med, 159: 679-90.
Vanhaesebroeck, B., J. Guillermet-Guibert, M. Graupera, and B. Bilanges. 2010. 'The
emerging mechanisms of isoform-specific PI3K signalling', Nat Rev Mol Cell Biol, 11:
329-41.
Vermeulen, K., D. R. Van Bockstaele, and Z. N. Berneman. 2003. 'The cell cycle: a
review of regulation, deregulation and therapeutic targets in cancer', Cell Prolif, 36:
131-49.
Viatour, P., T. C. Somervaille, S. Venkatasubrahmanyam, S. Kogan, M. E. McLaughlin,
I. L. Weissman, A. J. Butte, E. Passegue, and J. Sage. 2008. 'Hematopoietic stem cell
quiescence is maintained by compound contributions of the retinoblastoma gene
family', Cell Stem Cell, 3: 416-28.
Walker, D. H., and J. L. Maller. 1991. 'Role for cyclin A in the dependence of mitosis on
completion of DNA replication', Nature, 354: 314-7.
Wang, L., Z. Li, and Y. Cai. 2008. 'The JAK/STAT pathway positively regulates DPP
signaling in the Drosophila germline stem cell niche', J Cell Biol, 180: 721-8.
Weintraub, S. J., C. A. Prater, and D. C. Dean. 1992. 'Retinoblastoma protein switches
the E2F site from positive to negative element', Nature, 358: 259-61.
201

White, J., and S. Dalton. 2005. 'Cell cycle control of embryonic stem cells', Stem Cell
Rev, 1: 131-8.
Wobbe, C. R., L. Weissbach, J. A. Borowiec, F. B. Dean, Y. Murakami, P. Bullock, and
J. Hurwitz. 1987. 'Replication of simian virus 40 origin-containing DNA in vitro with
purified proteins', Proc Natl Acad Sci U S A, 84: 1834-8.
Wold, M. S. 1997. 'Replication protein A: a heterotrimeric, single-stranded DNA-binding
protein required for eukaryotic DNA metabolism', Annu Rev Biochem, 66: 61-92.
Wold, M. S., and T. Kelly. 1988. 'Purification and characterization of replication protein
A, a cellular protein required for in vitro replication of simian virus 40 DNA', Proc Natl
Acad Sci U S A, 85: 2523-7.
Wolf, N., J. Priess, and D. Hirsh. 1983. 'Segregation of germline granules in early
embryos of Caenorhabditis elegans: an electron microscopic analysis', J Embryol Exp
Morphol, 73: 297-306.
Wu, A. M., J. E. Till, L. Siminovitch, and E. A. McCulloch. 1968. 'Cytological evidence
for a relationship between normal hemotopoietic colony-forming cells and cells of the
lymphoid system', J Exp Med, 127: 455-64.
Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. 'p21
is a universal inhibitor of cyclin kinases', Nature, 366: 701-4.
Xuan, F., and I. M. Hsing. 2014. 'Triggering hairpin-free chain-branching growth of
fluorescent DNA dendrimers for nonlinear hybridization chain reaction', J Am Chem
Soc, 136: 9810-3.
Yang, H., D. G. Rudge, J. D. Koos, B. Vaidialingam, H. J. Yang, and N. P. Pavletich.
2013. 'mTOR kinase structure, mechanism and regulation', Nature, 497: 217-23.

202

Yang, J., E. S. Bardes, J. D. Moore, J. Brennan, M. A. Powers, and S. Kornbluth. 1998.
'Control of cyclin B1 localization through regulated binding of the nuclear export factor
CRM1', Genes Dev, 12: 2131-43.
Yip, C. C., M. L. Moule, and C. W. Yeung. 1982. 'Subunit structure of insulin receptor of
rat adipocytes as demonstrated by photoaffinity labeling', Biochemistry, 21: 2940-5.
Zeiser, E., C. Frokjaer-Jensen, E. Jorgensen, and J. Ahringer. 2011. 'MosSCI and
gateway compatible plasmid toolkit for constitutive and inducible expression of
transgenes in the C. elegans germline', PLoS One, 6: e20082.
Zeman, M. K., and K. A. Cimprich. 2014. 'Causes and consequences of replication
stress', Nat Cell Biol, 16: 2-9.
Zeng, Y., K. C. Forbes, Z. Wu, S. Moreno, H. Piwnica-Worms, and T. Enoch. 1998.
'Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1
or Chk1', Nature, 395: 507-10.
Zou, L., and S. J. Elledge. 2003. 'Sensing DNA damage through ATRIP recognition of
RPA-ssDNA complexes', Science, 300: 1542-8.
Zou, L., and B. Stillman. 2000. 'Assembly of a complex containing Cdc45p, replication
protein A, and Mcm2p at replication origins controlled by S-phase cyclin-dependent
kinases and Cdc7p-Dbf4p kinase', Mol Cell Biol, 20: 3086-96.
Zou, P., H. Yoshihara, K. Hosokawa, I. Tai, K. Shinmyozu, F. Tsukahara, Y. Maru, K.
Nakayama, K. I. Nakayama, and T. Suda. 2011. 'p57(Kip2) and p27(Kip1) cooperate
to maintain hematopoietic stem cell quiescence through interactions with Hsc70', Cell
Stem Cell, 9: 247-61.

203

VITA
Kenneth Andrew Trimmer was born in Dallas, TX, the son of Mrs. Clara T. Trimmer,
and Charles A. Trimmer. He graduated from Sherwood High School in Sandy Spring,
Maryland in May 2004. The following August of 2004, he enrolled at the University of
Maryland, Baltimore County, receiving his Bachelor of Science in Biochemistry and
Molecular Biology in 2008. In August of 2012, he began his doctoral studies at The
University of Texas MD Anderson Cancer Center UTHealth Graduate School of
Biomedical Sciences, joining the Genes and Development graduate program under the
mentorship of Dr. Swathi Arur.

204

